Eggerthella lenta 1899 B is an anaerobe, mesophilic human pathogen that was isolated from rectal tumor.
anaerobe mesophilic human pathogen genome sequence 16S sequence| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Coriobacteriia |
| Order Eggerthellales |
| Family Eggerthellaceae |
| Genus Eggerthella |
| Species Eggerthella lenta |
| Full scientific name Eggerthella lenta (Eggerth 1935) Wade et al. 1999 |
| Synonyms (3) |
| @ref | Gram stain | Confidence | |
|---|---|---|---|
| 125439 | negative | 99 |
| @ref: | 66793 |
| multimedia content: | EM_DSM_2243_1.jpg |
| multimedia.multimedia content: | EM_DSM_2243_1.jpg |
| caption: | electron microscopic image |
| intellectual property rights: | © HZI/Manfred Rohde |
| manual_annotation: | 1 |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 1003 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 1003 | CHOPPED MEAT MEDIUM (DSMZ Medium 78) | Medium recipe at MediaDive | Name: CHOPPED MEAT MEDIUM (DSMZ Medium 78) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l Ethanol 9.5 g/l (optional) K2HPO4 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl 0.5 g/l Haemin 0.005 g/l (optional) Resazurin 0.001 g/l Vitamin K3 0.0005 g/l (optional) Vitamin K1 (optional) NaOH (optional) Distilled water | ||
| 1003 | WILKINS-CHALGREN ANAEROBE BROTH (DSMZ Medium 339) | Medium recipe at MediaDive | Name: WILKINS-CHALGREN ANAEROBE BROTH (DSMZ Medium 339) Composition: dehydrated Wilkins-Chalgren medium 33.0 g/l L-Cysteine HCl 0.3 g/l Sodium resazurin 0.0005 g/l Distilled water |
| 1003 | Oxygen toleranceanaerobe |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 99.2 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 68380 | 27897 ChEBI | tryptophan | - | energy source | from API rID32A |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | from API rID32A |
| @ref | Chebi-ID | Metabolite | Indole test | |
|---|---|---|---|---|
| 68380 | 35581 ChEBI | indole | - | from API rID32A |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 68380 | alkaline phosphatase | - | 3.1.3.1 | from API rID32A |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68380 | alpha-galactosidase | - | 3.2.1.22 | from API rID32A |
| 68380 | alpha-glucosidase | - | 3.2.1.20 | from API rID32A |
| 68380 | beta-galactosidase | - | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 68380 | beta-glucosidase | - | 3.2.1.21 | from API rID32A |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 68380 | glycin arylamidase | - | from API rID32A | |
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 68380 | tryptophan deaminase | - | 4.1.99.1 | from API rID32A |
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| @ref | pathway | enzyme coverage | annotated reactions | external links | |
|---|---|---|---|---|---|
| 66794 | sulfopterin metabolism | 100 | 4 of 4 | ||
| 66794 | coenzyme A metabolism | 100 | 4 of 4 | ||
| 66794 | vitamin K metabolism | 100 | 5 of 5 | ||
| 66794 | ppGpp biosynthesis | 100 | 4 of 4 | ||
| 66794 | reductive acetyl coenzyme A pathway | 100 | 7 of 7 | ||
| 66794 | metabolism of amino sugars and derivatives | 100 | 5 of 5 | ||
| 66794 | hydrogen production | 100 | 5 of 5 | ||
| 66794 | cardiolipin biosynthesis | 100 | 7 of 7 | ||
| 66794 | L-lactaldehyde degradation | 100 | 3 of 3 | ||
| 66794 | CDP-diacylglycerol biosynthesis | 100 | 2 of 2 | ||
| 66794 | UDP-GlcNAc biosynthesis | 100 | 3 of 3 | ||
| 66794 | anapleurotic synthesis of oxalacetate | 100 | 1 of 1 | ||
| 66794 | suberin monomers biosynthesis | 100 | 2 of 2 | ||
| 66794 | folate polyglutamylation | 100 | 1 of 1 | ||
| 66794 | palmitate biosynthesis | 95.45 | 21 of 22 | ||
| 66794 | vitamin B1 metabolism | 92.31 | 12 of 13 | ||
| 66794 | threonine metabolism | 90 | 9 of 10 | ||
| 66794 | valine metabolism | 88.89 | 8 of 9 | ||
| 66794 | aspartate and asparagine metabolism | 88.89 | 8 of 9 | ||
| 66794 | chorismate metabolism | 88.89 | 8 of 9 | ||
| 66794 | C4 and CAM-carbon fixation | 87.5 | 7 of 8 | ||
| 66794 | photosynthesis | 85.71 | 12 of 14 | ||
| 66794 | glycolysis | 82.35 | 14 of 17 | ||
| 66794 | phenylacetate degradation (aerobic) | 80 | 4 of 5 | ||
| 66794 | peptidoglycan biosynthesis | 80 | 12 of 15 | ||
| 66794 | pyrimidine metabolism | 75.56 | 34 of 45 | ||
| 66794 | purine metabolism | 75.53 | 71 of 94 | ||
| 66794 | butanoate fermentation | 75 | 3 of 4 | ||
| 66794 | isoleucine metabolism | 75 | 6 of 8 | ||
| 66794 | acetate fermentation | 75 | 3 of 4 | ||
| 66794 | alanine metabolism | 72.41 | 21 of 29 | ||
| 66794 | propanol degradation | 71.43 | 5 of 7 | ||
| 66794 | heme metabolism | 71.43 | 10 of 14 | ||
| 66794 | phenylalanine metabolism | 69.23 | 9 of 13 | ||
| 66794 | acetoin degradation | 66.67 | 2 of 3 | ||
| 66794 | NAD metabolism | 66.67 | 12 of 18 | ||
| 66794 | serine metabolism | 66.67 | 6 of 9 | ||
| 66794 | selenocysteine biosynthesis | 66.67 | 4 of 6 | ||
| 66794 | enterobactin biosynthesis | 66.67 | 2 of 3 | ||
| 66794 | CO2 fixation in Crenarchaeota | 66.67 | 6 of 9 | ||
| 66794 | formaldehyde oxidation | 66.67 | 2 of 3 | ||
| 66794 | cyanate degradation | 66.67 | 2 of 3 | ||
| 66794 | methane metabolism | 66.67 | 2 of 3 | ||
| 66794 | d-mannose degradation | 66.67 | 6 of 9 | ||
| 66794 | molybdenum cofactor biosynthesis | 66.67 | 6 of 9 | ||
| 66794 | histidine metabolism | 65.52 | 19 of 29 | ||
| 66794 | tetrahydrofolate metabolism | 64.29 | 9 of 14 | ||
| 66794 | pentose phosphate pathway | 63.64 | 7 of 11 | ||
| 66794 | dTDPLrhamnose biosynthesis | 62.5 | 5 of 8 | ||
| 66794 | gluconeogenesis | 62.5 | 5 of 8 | ||
| 66794 | glutamate and glutamine metabolism | 60.71 | 17 of 28 | ||
| 66794 | oxidative phosphorylation | 60.44 | 55 of 91 | ||
| 66794 | methylglyoxal degradation | 60 | 3 of 5 | ||
| 66794 | degradation of aromatic, nitrogen containing compounds | 58.33 | 7 of 12 | ||
| 66794 | isoprenoid biosynthesis | 57.69 | 15 of 26 | ||
| 66794 | citric acid cycle | 57.14 | 8 of 14 | ||
| 66794 | non-pathway related | 55.26 | 21 of 38 | ||
| 66794 | proline metabolism | 54.55 | 6 of 11 | ||
| 66794 | methionine metabolism | 53.85 | 14 of 26 | ||
| 66794 | leucine metabolism | 53.85 | 7 of 13 | ||
| 66794 | urea cycle | 53.85 | 7 of 13 | ||
| 66794 | ethanol fermentation | 50 | 1 of 2 | ||
| 66794 | cis-vaccenate biosynthesis | 50 | 1 of 2 | ||
| 66794 | glycolate and glyoxylate degradation | 50 | 3 of 6 | ||
| 66794 | aminopropanol phosphate biosynthesis | 50 | 1 of 2 | ||
| 66794 | kanosamine biosynthesis II | 50 | 1 of 2 | ||
| 66794 | glycogen biosynthesis | 50 | 2 of 4 | ||
| 66794 | Entner Doudoroff pathway | 50 | 5 of 10 | ||
| 66794 | adipate degradation | 50 | 1 of 2 | ||
| 66794 | phenylmercury acetate degradation | 50 | 1 of 2 | ||
| 66794 | ketogluconate metabolism | 50 | 4 of 8 | ||
| 66794 | arginine metabolism | 50 | 12 of 24 | ||
| 66794 | glycine metabolism | 50 | 5 of 10 | ||
| 66794 | degradation of sugar alcohols | 50 | 8 of 16 | ||
| 66794 | glutathione metabolism | 50 | 7 of 14 | ||
| 66794 | vitamin B6 metabolism | 45.45 | 5 of 11 | ||
| 66794 | metabolism of disaccharids | 45.45 | 5 of 11 | ||
| 66794 | lipid metabolism | 45.16 | 14 of 31 | ||
| 66794 | cysteine metabolism | 44.44 | 8 of 18 | ||
| 66794 | nitrate assimilation | 44.44 | 4 of 9 | ||
| 66794 | ubiquinone biosynthesis | 42.86 | 3 of 7 | ||
| 66794 | lysine metabolism | 42.86 | 18 of 42 | ||
| 66794 | ethylmalonyl-CoA pathway | 40 | 2 of 5 | ||
| 66794 | coenzyme M biosynthesis | 40 | 4 of 10 | ||
| 66794 | O-antigen biosynthesis | 40 | 2 of 5 | ||
| 66794 | glycogen metabolism | 40 | 2 of 5 | ||
| 66794 | lipoate biosynthesis | 40 | 2 of 5 | ||
| 66794 | bacilysin biosynthesis | 40 | 2 of 5 | ||
| 66794 | myo-inositol biosynthesis | 40 | 4 of 10 | ||
| 66794 | propionate fermentation | 40 | 4 of 10 | ||
| 66794 | arachidonic acid metabolism | 38.89 | 7 of 18 | ||
| 66794 | degradation of hexoses | 38.89 | 7 of 18 | ||
| 66794 | carnitine metabolism | 37.5 | 3 of 8 | ||
| 66794 | 6-hydroxymethyl-dihydropterin diphosphate biosynthesis | 37.5 | 3 of 8 | ||
| 66794 | tryptophan metabolism | 36.84 | 14 of 38 | ||
| 66794 | bile acid biosynthesis, neutral pathway | 35.29 | 6 of 17 | ||
| 66794 | pantothenate biosynthesis | 33.33 | 2 of 6 | ||
| 66794 | acetyl CoA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | octane oxidation | 33.33 | 1 of 3 | ||
| 66794 | IAA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | lipid A biosynthesis | 33.33 | 3 of 9 | ||
| 66794 | degradation of pentoses | 32.14 | 9 of 28 | ||
| 66794 | sulfate reduction | 30.77 | 4 of 13 | ||
| 66794 | benzoyl-CoA degradation | 28.57 | 2 of 7 | ||
| 66794 | tyrosine metabolism | 28.57 | 4 of 14 | ||
| 66794 | dolichyl-diphosphooligosaccharide biosynthesis | 27.27 | 3 of 11 | ||
| 66794 | d-xylose degradation | 27.27 | 3 of 11 | ||
| 66794 | flavin biosynthesis | 26.67 | 4 of 15 | ||
| 66794 | catecholamine biosynthesis | 25 | 1 of 4 | ||
| 66794 | lactate fermentation | 25 | 1 of 4 | ||
| 66794 | cyclohexanol degradation | 25 | 1 of 4 | ||
| 66794 | toluene degradation | 25 | 1 of 4 | ||
| 66794 | CMP-KDO biosynthesis | 25 | 1 of 4 | ||
| 66794 | methanogenesis from CO2 | 25 | 3 of 12 | ||
| 66794 | degradation of sugar acids | 24 | 6 of 25 | ||
| 66794 | ascorbate metabolism | 22.73 | 5 of 22 | ||
| 66794 | 4-hydroxymandelate degradation | 22.22 | 2 of 9 |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1003 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1003 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1003 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 1003 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 46592 | - | + | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | + | + | - | - | - | - | - | - | - | - | - | + |
Global distribution of 16S sequence AB558167 (>99% sequence identity) for Eggerthella lenta subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2426v1 assembly for Eggerthella lenta DSM 2243 | complete | 479437 | 98.9 | ||||
| 67770 | ASM333997v1 assembly for Eggerthella lenta DSM 2243 | scaffold | 84112 | 64.9 | ||||
| 124043 | ASM333994v1 assembly for Eggerthella lenta UCSF2243 | scaffold | 84112 | 64.55 | ||||
| 67770 | ASM334010v1 assembly for Eggerthella lenta ATCC 25559 | scaffold | 84112 | 63.91 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Eggerthella lenta 16S ribosomal RNA gene, partial sequence | AF292375 | 1500 | 479437 | ||
| 1003 | Eubacterium lentum gene for 16S rRNA, partial sequence | AB011817 | 1472 | 479437 | ||
| 67770 | Eggerthella lenta gene for 16S ribosomal RNA, partial sequence, strain: JCM 9979 | AB558167 | 1470 | 84112 | ||
| 124043 | Eggerthella lenta strain DSM 2243 16S ribosomal RNA gene, partial sequence. | ON197174 | 921 | 84112 |
| @ref | GC-content (mol%) | Method | |
|---|---|---|---|
| 1003 | 65.0 | thermal denaturation, midpoint method (Tm) |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | spore_formation | BacteriaNetⓘ | no | 99.20 | no |
| 125439 | motility | BacteriaNetⓘ | yes | 82.60 | no |
| 125439 | gram_stain | BacteriaNetⓘ | negative | 99.00 | no |
| 125439 | oxygen_tolerance | BacteriaNetⓘ | facultative aerobe | 64.40 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 71.98 | no |
| 125438 | anaerobic | anaerobicⓘ | yes | 89.64 | yes |
| 125438 | aerobic | aerobicⓘ | no | 93.95 | no |
| 125438 | spore-forming | spore-formingⓘ | no | 71.50 | no |
| 125438 | thermophilic | thermophileⓘ | no | 92.12 | no |
| 125438 | flagellated | motile2+ⓘ | no | 74.61 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors. | Kyaw TS, Zhang C, Sandy M, Trepka K, Zhang S, Ramirez Hernandez LA, Ramirez L, Goh JJN, Yu K, Dimassa V, Bess EN, Brockert JG, Dumlao DS, Bisanz JE, Turnbaugh PJ. | iScience | 10.1016/j.isci.2024.110122 | 2024 | ||
| Enantiocomplementary Gut Bacterial Enzymes Metabolize Dietary Polyphenols. | Dong X, Bae M, Le C, Aguilar Ramos MA, Balskus EP. | J Am Chem Soc | 10.1021/jacs.4c09892 | 2025 | ||
| Systems biology elucidates the distinctive metabolic niche filled by the human gut microbe Eggerthella lenta. | Noecker C, Sanchez J, Bisanz JE, Escalante V, Alexander M, Trepka K, Heinken A, Liu Y, Dodd D, Thiele I, DeFelice BC, Turnbaugh PJ. | PLoS Biol | 10.1371/journal.pbio.3002125 | 2023 | ||
| Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators. | Dong X, Guthrie BGH, Alexander M, Noecker C, Ramirez L, Glasser NR, Turnbaugh PJ, Balskus EP. | Nat Commun | 10.1038/s41467-022-33576-3 | 2022 | ||
| Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas. | McCurry MD, D'Agostino GD, Walsh JT, Bisanz JE, Zalosnik I, Dong X, Morris DJ, Korzenik JR, Edlow AG, Balskus EP, Turnbaugh PJ, Huh JR, Devlin AS. | Cell | 10.1016/j.cell.2024.05.005 | 2024 | ||
| Pathogenicity | Metatranscriptomics-guided discovery and characterization of a polyphenol-metabolizing gut microbial enzyme. | Bae M, Le C, Mehta RS, Dong X, Pieper LM, Ramirez L, Alexander M, Kiamehr S, Turnbaugh PJ, Huttenhower C, Chan AT, Balskus EP. | Cell Host Microbe | 10.1016/j.chom.2024.10.002 | 2024 | |
| Identification of age-associated microbial changes via long-read 16S sequencing. | Toh KY, Toh TS, Chua KP, Rajakumar P, Lee JWJ, Chong CW. | Gut Pathog | 10.1186/s13099-024-00650-8 | 2024 | ||
| Metabolism | Identification of volatile metabolites produced from levodopa metabolism by different bacteria strains of the gut microbiome. | Pennington T, Eshima J, Smith BS. | BMC Microbiol | 10.1186/s12866-024-03373-7 | 2024 | |
| Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature. | Jiang S, E J, Wang D, Zou Y, Liu X, Xiao H, Wen Y, Chen Z. | Eur J Med Res | 10.1186/s40001-021-00582-y | 2021 | ||
| The Gut-Brain-Microbiota Connection and Its Role in Autism Spectrum Disorders. | Mlynarska E, Barszcz E, Budny E, Gajewska A, Kopec K, Wasiak J, Rysz J, Franczyk B. | Nutrients | 10.3390/nu17071135 | 2025 | ||
| Genetics | Morphological and Genetic Characterization of Eggerthella lenta Bacteriophage PMBT5. | Sprotte S, Rasmussen TS, Cho GS, Brinks E, Lametsch R, Neve H, Vogensen FK, Nielsen DS, Franz CMAP. | Viruses | 10.3390/v14081598 | 2022 | |
| Genetics | A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria. | Bisanz JE, Soto-Perez P, Noecker C, Aksenov AA, Lam KN, Kenney GE, Bess EN, Haiser HJ, Kyaw TS, Yu FB, Rekdal VM, Ha CWY, Devkota S, Balskus EP, Dorrestein PC, Allen-Vercoe E, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2020.04.006 | 2020 | |
| Simvastatin induces human gut bacterial cell surface genes. | Escalante V, Nayak RR, Noecker C, Babdor J, Spitzer M, Deutschbauer AM, Turnbaugh PJ. | Mol Microbiol | 10.1111/mmi.15151 | 2024 | ||
| Genetics | Alterations in Gut Glutamate Metabolism Associated with Changes in Gut Microbiota Composition in Children with Autism Spectrum Disorder. | Wang M, Wan J, Rong H, He F, Wang H, Zhou J, Cai C, Wang Y, Xu R, Yin Z, Zhou W. | mSystems | 10.1128/msystems.00321-18 | 2019 | |
| CRISPR-Cas provides limited phage immunity to a prevalent gut bacterium in gnotobiotic mice. | Rasmussen TS, Koefoed AK, Deng L, Muhammed MK, Rousseau GM, Kot W, Sprotte S, Neve H, Franz CMAP, Hansen AK, Vogensen FK, Moineau S, Nielsen DS. | ISME J | 10.1038/s41396-023-01358-4 | 2023 | ||
| CRISPR-Cas System of a Prevalent Human Gut Bacterium Reveals Hyper-targeting against Phages in a Human Virome Catalog. | Soto-Perez P, Bisanz JE, Berry JD, Lam KN, Bondy-Denomy J, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2019.08.008 | 2019 | ||
| Safety evaluation of Butyricicoccus faecihominis DSM 34943. | Pitt J, Bauter MR, Kumar R, Hasselwander O, Hibberd AA, Kane H, Wang Q, Auzanneau I, Bry S, David E, Seguinot P, Burns F, Smith AB, Carnovale M. | Toxicol Rep | 10.1016/j.toxrep.2025.102145 | 2025 | ||
| Gut microbiota in regulatory T cell generation and function: mechanisms and health implications. | Sharma A, Sharma G, Im SH. | Gut Microbes | 10.1080/19490976.2025.2516702 | 2025 | ||
| Metabolism | Human gut bacterial metabolism drives Th17 activation and colitis. | Alexander M, Ang QY, Nayak RR, Bustion AE, Sandy M, Zhang B, Upadhyay V, Pollard KS, Lynch SV, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2021.11.001 | 2022 | |
| Metabolism | Microbial transformation of dietary xenobiotics shapes gut microbiome composition. | Culp EJ, Nelson NT, Verdegaal AA, Goodman AL. | Cell | 10.1016/j.cell.2024.08.038 | 2024 | |
| Development of culture methods capable of culturing a wide range of predominant species of intestinal bacteria. | Hirano R, Nishita I, Nakai R, Bito A, Sasabe R, Kurihara S. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1056866 | 2023 | ||
| Metabolism | Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins. | Koppel N, Bisanz JE, Pandelia ME, Turnbaugh PJ, Balskus EP. | Elife | 10.7554/elife.33953 | 2018 | |
| Metabolism | A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. | Li W, Hang S, Fang Y, Bae S, Zhang Y, Zhang M, Wang G, McCurry MD, Bae M, Paik D, Franzosa EA, Rastinejad F, Huttenhower C, Yao L, Devlin AS, Huh JR. | Cell Host Microbe | 10.1016/j.chom.2021.07.013 | 2021 | |
| Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma. | Zhang W, Xu X, Cai L, Cai X. | Sci Rep | 10.1038/s41598-023-34765-w | 2023 | ||
| Metabolism | Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease. | Heinken A, Ravcheev DA, Baldini F, Heirendt L, Fleming RMT, Thiele I. | Microbiome | 10.1186/s40168-019-0689-3 | 2019 | |
| Phylogeny | Multiple classes and isoforms of the RNA polymerase recycling motor protein HelD. | Larsen JS, Miller M, Oakley AJ, Dixon NE, Lewis PJ. | Microbiologyopen | 10.1002/mbo3.1251 | 2021 | |
| Metabolism | Metabolism of Oxo-Bile Acids and Characterization of Recombinant 12alpha-Hydroxysteroid Dehydrogenases from Bile Acid 7alpha-Dehydroxylating Human Gut Bacteria. | Doden H, Sallam LA, Devendran S, Ly L, Doden G, Daniel SL, Alves JMP, Ridlon JM. | Appl Environ Microbiol | 10.1128/aem.00235-18 | 2018 | |
| Enzymology | Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega. | Doden HL, Ridlon JM. | Microorganisms | 10.3390/microorganisms9030469 | 2021 | |
| Complete Genome Sequence of Coriobacteriaceae Strain 68-1-3, a Novel Mucus-Degrading Isolate from the Swine Intestinal Tract. | Looft T, Bayles DO, Alt DP, Stanton TB. | Genome Announc | 10.1128/genomea.01143-15 | 2015 | ||
| Metabolism | SIMMER employs similarity algorithms to accurately identify human gut microbiome species and enzymes capable of known chemical transformations. | Bustion AE, Nayak RR, Agrawal A, Turnbaugh PJ, Pollard KS. | Elife | 10.7554/elife.82401 | 2023 | |
| Genetics | Longitudinal flux balance analyses of a patient with episodic colonic inflammation reveals microbiome metabolic dynamics. | Basile A, Heinken A, Hertel J, Smarr L, Li W, Treu L, Valle G, Campanaro S, Thiele I. | Gut Microbes | 10.1080/19490976.2023.2226921 | 2023 | |
| Complete Genome Sequence of the Equol-Producing Bacterium Adlercreutzia equolifaciens DSM 19450T. | Toh H, Oshima K, Suzuki T, Hattori M, Morita H. | Genome Announc | 10.1128/genomea.00742-13 | 2013 | ||
| Quantification of Slackia and Eggerthella spp. in Human Feces and Adhesion of Representatives Strains to Caco-2 Cells. | Cho GS, Ritzmann F, Eckstein M, Huch M, Briviba K, Behsnilian D, Neve H, Franz CM. | Front Microbiol | 10.3389/fmicb.2016.00658 | 2016 | ||
| Metabolism | Metabolism of Daidzein and Genistein by Gut Bacteria of the Class Coriobacteriia. | Soukup ST, Stoll DA, Danylec N, Schoepf A, Kulling SE, Huch M. | Foods | 10.3390/foods10112741 | 2021 | |
| Metabolism | A Novel Locally c-di-GMP-Controlled Exopolysaccharide Synthase Required for Bacteriophage N4 Infection of Escherichia coli. | Junkermeier EH, Hengge R. | mBio | 10.1128/mbio.03249-21 | 2021 | |
| Metabolism | Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism. | Kayser BD, Prifti E, Lhomme M, Belda E, Dao MC, Aron-Wisnewsky J, MICRO-Obes Consortium, Kontush A, Zucker JD, Rizkalla SW, Dugail I, Clement K. | Metabolomics | 10.1007/s11306-019-1596-0 | 2019 | |
| Metabolism | A biosynthetic pathway for a prominent class of microbiota-derived bile acids. | Devlin AS, Fischbach MA. | Nat Chem Biol | 10.1038/nchembio.1864 | 2015 | |
| Design, construction, and in vivo augmentation of a complex gut microbiome. | Cheng AG, Ho PY, Aranda-Diaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. | Cell | 10.1016/j.cell.2022.08.003 | 2022 | ||
| Carbohydrate complexity limits microbial growth and reduces the sensitivity of human gut communities to perturbations. | Ostrem Loss E, Thompson J, Cheung PLK, Qian Y, Venturelli OS. | Nat Ecol Evol | 10.1038/s41559-022-01930-9 | 2023 | ||
| Genetics | Towards a mechanistic understanding of reciprocal drug-microbiome interactions. | Zimmermann M, Patil KR, Typas A, Maier L. | Mol Syst Biol | 10.15252/msb.202010116 | 2021 | |
| Metabolism | Structural and functional properties of a magnesium transporter of the SLC11/NRAMP family. | Ramanadane K, Straub MS, Dutzler R, Manatschal C. | Elife | 10.7554/elife.74589 | 2022 | |
| Metabolism | Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome. | Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. | Cell | 10.1016/j.cell.2023.05.037 | 2023 | |
| Evolution of endonuclease IV protein family: an in silico analysis. | Kanchan S, Sharma P, Chowdhury S. | 3 Biotech | 10.1007/s13205-019-1696-6 | 2019 | ||
| Enzymology | Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes. | Lam KN, Alexander M, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2019.06.011 | 2019 | |
| Deciphering microbial interactions in synthetic human gut microbiome communities. | Venturelli OS, Carr AC, Fisher G, Hsu RH, Lau R, Bowen BP, Hromada S, Northen T, Arkin AP. | Mol Syst Biol | 10.15252/msb.20178157 | 2018 | ||
| Metabolism | Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. | Nayak RR, Alexander M, Deshpande I, Stapleton-Gray K, Rimal B, Patterson AD, Ubeda C, Scher JU, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2020.12.008 | 2021 | |
| Metabolism | Prospecting for unannotated enzymes: discovery of a 3',5'-nucleotide bisphosphate phosphatase within the amidohydrolase superfamily. | Cummings JA, Vetting M, Ghodge SV, Xu C, Hillerich B, Seidel RD, Almo SC, Raushel FM. | Biochemistry | 10.1021/bi401640r | 2014 | |
| Dissemination of 6S RNA among bacteria. | Wehner S, Damm K, Hartmann RK, Marz M. | RNA Biol | 10.4161/rna.29894 | 2014 | ||
| Enzymology | The desA and desB genes from Clostridium scindens ATCC 35704 encode steroid-17,20-desmolase. | Devendran S, Mythen SM, Ridlon JM. | J Lipid Res | 10.1194/jlr.m083949 | 2018 | |
| Development of an in vitro Model of Human Gut Microbiota for Screening the Reciprocal Interactions With Antibiotics, Drugs, and Xenobiotics. | El Houari A, Ecale F, Mercier A, Crapart S, Laparre J, Soulard B, Ramnath M, Berjeaud JM, Rodier MH, Crepin A. | Front Microbiol | 10.3389/fmicb.2022.828359 | 2022 | ||
| Crystal structures of two transcriptional regulators from Bacillus cereus define the conserved structural features of a PadR subfamily. | Fibriansah G, Kovacs AT, Pool TJ, Boonstra M, Kuipers OP, Thunnissen AM. | PLoS One | 10.1371/journal.pone.0048015 | 2012 | ||
| Dominant Bacterial Phyla from the Human Gut Show Widespread Ability To Transform and Conjugate Bile Acids. | Lucas LN, Barrett K, Kerby RL, Zhang Q, Cattaneo LE, Stevenson D, Rey FE, Amador-Noguez D. | mSystems | 10.1128/msystems.00805-21 | 2021 | ||
| Metabolism | Expansion of ribosomally produced natural products: a nitrile hydratase- and Nif11-related precursor family. | Haft DH, Basu MK, Mitchell DA. | BMC Biol | 10.1186/1741-7007-8-70 | 2010 | |
| Metabolism | Recurrent neural networks enable design of multifunctional synthetic human gut microbiome dynamics. | Baranwal M, Clark RL, Thompson J, Sun Z, Hero AO, Venturelli OS. | Elife | 10.7554/elife.73870 | 2022 | |
| Metabolism | Cloning and analysis of the planosporicin lantibiotic biosynthetic gene cluster of Planomonospora alba. | Sherwood EJ, Hesketh AR, Bibb MJ. | J Bacteriol | 10.1128/jb.02291-12 | 2013 | |
| Annotation of Protein Domains Reveals Remarkable Conservation in the Functional Make up of Proteomes Across Superkingdoms. | Nasir A, Naeem A, Khan MJ, Nicora HD, Caetano-Anolles G. | Genes (Basel) | 10.3390/genes2040869 | 2011 | ||
| Phylogeny | Bioinformatic characterization of the 4-Toluene Sulfonate Uptake Permease (TSUP) family of transmembrane proteins. | Shlykov MA, Zheng WH, Chen JS, Saier MH. | Biochim Biophys Acta | 10.1016/j.bbamem.2011.12.005 | 2012 | |
| Genetics | Genomic basis for natural product biosynthetic diversity in the actinomycetes. | Nett M, Ikeda H, Moore BS. | Nat Prod Rep | 10.1039/b817069j | 2009 | |
| Genetics | Genome sequence of Desulfitobacterium hafniense DCB-2, a Gram-positive anaerobe capable of dehalogenation and metal reduction. | Kim SH, Harzman C, Davis JK, Hutcheson R, Broderick JB, Marsh TL, Tiedje JM. | BMC Microbiol | 10.1186/1471-2180-12-21 | 2012 | |
| Genetics | Developmental biology of Streptomyces from the perspective of 100 actinobacterial genome sequences. | Chandra G, Chater KF. | FEMS Microbiol Rev | 10.1111/1574-6976.12047 | 2014 | |
| A novel extracellular metallopeptidase domain shared by animal host-associated mutualistic and pathogenic microbes. | Nakjang S, Ndeh DA, Wipat A, Bolam DN, Hirt RP. | PLoS One | 10.1371/journal.pone.0030287 | 2012 | ||
| Defense against cannibalism: the SdpI family of bacterial immunity/signal transduction proteins. | Povolotsky TL, Orlova E, Tamang DG, Saier MH. | J Membr Biol | 10.1007/s00232-010-9260-7 | 2010 | ||
| Phylogeny | Phylogenetic framework and molecular signatures for the main clades of the phylum Actinobacteria. | Gao B, Gupta RS. | Microbiol Mol Biol Rev | 10.1128/mmbr.05011-11 | 2012 | |
| Eggerthella lenta augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritis. | Balakrishnan B, Luckey D, Wright K, Davis JM, Chen J, Taneja V. | Sci Adv | 10.1126/sciadv.adg1129 | 2023 | ||
| Hormone Replacement Therapy Reverses Gut Microbiome and Serum Metabolome Alterations in Premature Ovarian Insufficiency. | Jiang L, Fei H, Tong J, Zhou J, Zhu J, Jin X, Shi Z, Zhou Y, Ma X, Yu H, Yang J, Zhang S. | Front Endocrinol (Lausanne) | 10.3389/fendo.2021.794496 | 2021 | ||
| Analytical Performance Characteristics of a New Transcription-Mediated Amplification Assay for Treponema pallidum. | Getman D, Lin M, Barakat N, Skvoretz R, Godornes C, Swenson P, Nenninger A, Golden MR, Lukehart SA. | J Clin Microbiol | 10.1128/jcm.00511-21 | 2021 | ||
| Metabolism | Discovery of a cyclic phosphodiesterase that catalyzes the sequential hydrolysis of both ester bonds to phosphorus. | Ghodge SV, Cummings JA, Williams HJ, Raushel FM. | J Am Chem Soc | 10.1021/ja409376k | 2013 | |
| Pathogenicity | In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria. | Tran CM, Tanaka K, Yamagishi Y, Goto T, Mikamo H, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.01038-10 | 2011 | |
| Pathogenicity | In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria. | Tanaka K, Mikamo H, Nakao K, Ichiishi T, Goto T, Yamagishi Y, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00595-08 | 2009 | |
| Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. | Cunningham SA, Mandrekar JN, Rosenblatt JE, Patel R. | Int J Bacteriol | 10.1155/2013/168742 | 2013 | ||
| Filifactor alocis--involvement in periodontal biofilms. | Schlafer S, Riep B, Griffen AL, Petrich A, Hubner J, Berning M, Friedmann A, Gobel UB, Moter A. | BMC Microbiol | 10.1186/1471-2180-10-66 | 2010 | ||
| Enzymology | Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. | Grys TE, Sloan LM, Rosenblatt JE, Patel R. | J Clin Microbiol | 10.1128/jcm.02013-08 | 2009 | |
| Pathogenicity | In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone. | Tanaka K, Mikamo H, Nakao K, Watanabe K. | Antimicrob Agents Chemother | 10.1128/aac.00639-06 | 2006 | |
| Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. | Mennink-Kersten MA, Ruegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJ, Verweij PE. | J Clin Microbiol | 10.1128/jcm.43.8.3925-3931.2005 | 2005 | ||
| The microbial metabolite imidazole propionate modulates hypothalamic activity and stress-induced behaviors. | Agirman G, Quicho MNB, Connelley KK, Zhang X, Lynch JB, Ha SM, Schmidt HM, Ozcan E, Liang AX, Yu KB, Ahn IS, Qian C, Paramo J, Zhang S, Espinoza A, Turnbaugh PJ, de Aguiar Vallim TQ, Yang X, Church A, Hsiao EY. | Cell Host Microbe | 10.1016/j.chom.2025.10.019 | 2025 | ||
| Metabolism | Microbial modulation of digoxin bioavailability: A pharmacomicrobiome perspective on Eggerthella lenta's role in steroid-like drug metabolism and precision therapeutics. | Ganamurali N, Sabarathinam S. | J Steroid Biochem Mol Biol | 10.1016/j.jsbmb.2025.106792 | 2025 | |
| Gut microbiome signatures predict cognitive impairment in older cancer survivors. | Miller BC, Haggler JA, Chaudhari DS, Shukla R, Kumar V, Mishra SP, Masternak MM, Holland P, Labyak C, Golden A, Dangiolo M, Arikawa AY, Kociolek J, Fraser A, Williams C, Agronin M, Aymat M, Pledger W, Yadav H, Jain S. | Geroscience | 10.1007/s11357-025-01917-x | 2025 | ||
| A gut Eggerthella lenta-derived metabolite impairs neutrophil function to aggravate bacterial lung infection. | Wang LL, Shen X, Xie Y, Ge A, Lu H, Gu S, Kong L, Narayana JK, Mattner J, Chotirmall SH, Xu JF. | Sci Transl Med | 10.1126/scitranslmed.adq4409 | 2025 | ||
| Lutein augments the hypoglycemic effect of metformin through the gut microbiota-imidazole propionate axis in type 2 diabetic model mice. | Liu K, Han Y, Zhang J, Yin Z, Yan H, Gao W, Tong H, Zhu H, Hui S, Liang L, Yu H. | Sci Rep | 10.1038/s41598-025-16133-y | 2025 | ||
| Clinical and microbiological characteristics of Eggerthella lenta causing bacteremia. | Fernandez Vecilla D, Urrutikoetxea Gutierrez MJ, Roche Matheus MP, Calvo Muro FE, Diaz de Tuesta Del Arco JL. | Enferm Infecc Microbiol Clin (Engl Ed) | 10.1016/j.eimce.2024.05.014 | 2024 | ||
| Eggerthella lenta down regulated flavone and flavonol biosynthesis promoted Kawasaki disease. | Yeh YT, Chen KD, Huang CH, Tsai JR, Kuo HC. | Virulence | 10.1080/21505594.2025.2512401 | 2025 | ||
| Necrotizing myometritis following vaginal delivery complicated by retained placenta and uterine artery embolization: A case report. | Guo G, Zhang Y, Cao J, Fan Y, Fan L. | SAGE Open Med Case Rep | 10.1177/2050313x251388740 | 2025 | ||
| Genetics | Limitations of MALDI-TOF MS in identifying anaerobic bacteremia: challenges in polymicrobial infections and the role of whole-genome sequencing. | Hosoda T, Suzuki M, Matsuno T, Matsui K, Ohyama K, Doi Y. | Microbiol Spectr | 10.1128/spectrum.01014-25 | 2025 | |
| Alterations in the gut microbiome and metabolome in elderly patients with postoperative delirium: A prospective nested case-control study. | Huo J, Han S, Hao X, Zhou Z, Lou J, Li H, Cao J, Yu Y, Mi W, Liu Y. | J Clin Anesth | 10.1016/j.jclinane.2025.111833 | 2025 | ||
| Pathogenicity | Eggerthella lenta Produces a Cryptic Pro-inflammatory Lipid. | Shin YH, Bang S, Xavier R, Clardy J. | J Am Chem Soc | 10.1021/jacs.5c08613 | 2025 | |
| The human intestinal bacterium Eggerthella lenta influences gut metabolomes in gnotobiotic mice. | Viehof A, Haange SB, Streidl T, Schubert K, Engelmann B, Haller D, Rolle-Kampczyk U, von Bergen M, Clavel T. | Microbiome Res Rep | 10.20517/mrr.2023.65 | 2024 | ||
| Clinical characteristics and antimicrobial susceptibility of Eggerthella lenta infection over a 5-year trend at a university hospital in Japan. | Mori N, Nakamura A, Hirai J, Asai N, Shibata Y, Takayama M, Kawamoto Y, Miyazaki N, Sakanashi D, Ohno T, Yamada A, Suematsu H, Koita I, Chida S, Ohta T, Mikamo H. | Nagoya J Med Sci | 10.18999/nagjms.86.4.683 | 2024 | ||
| Genetics | Metagenomics Analysis of Altered Gut Microbiome in Psoriasis and the Mediation Analysis: A Case-Control Study. | Xiao Y, Jing D, Xiao H, Mao M, Kuang Y, Shen M, Lv C, Jian X, Peng C, Chen X. | Psoriasis (Auckl) | 10.2147/ptt.s505283 | 2025 | |
| Reduced Sulfur Diet Reshapes the Microbiome and Metabolome in Mild-Moderate Ulcerative Colitis. | Ye J, Raman M, Taylor LM, Yousuf M, Panaccione R, Turbide C, Sinha SR, Haskey N. | Int J Mol Sci | 10.3390/ijms26104596 | 2025 | ||
| Comparative evaluation of antimicrobial activity of spinel structured transition metal ferrites supported on reduced graphene oxide against pathogenic strains of bacteria and fungi. | Lakshmi Priya R, Dhayanithi CA, Hariprasad BS, Vidya R, Ganesh Babu S. | Nanotechnology | 10.1088/1361-6528/ad4710 | 2024 | ||
| Otitis Media and Its Intracranial Complications: A Delicate Scenario. | Lobo M, Lopes Freitas R, Viana M, Duarte F, Camoes S. | Cureus | 10.7759/cureus.76561 | 2024 | ||
| Genetics | nf-UnO pipeline: A metagenomic co-assembly pipeline for novel pathogen detection from mNGS outbreak sets. | Guzman-Cole C, Huang AD. | Bioinformatics | 10.1093/bioinformatics/btaf436 | 2025 | |
| Exploring the role of acylated ghrelin and gut microbiome in delineating cognitive health in the elderly. | Rout S, Dash R, Satish V, Venugopal G, Rao BN, Bandhyopadhyay D, Bhoi SK, Ramadass B. | Aging (Albany NY) | 10.18632/aging.206200 | 2025 | ||
| Successful Treatment of Complicated Pyogenic Spondylitis Due to Advanced Rectosigmoid Cancer Utilizing Vigorous Antibiotic Therapy and Minimally Invasive Robotic Colorectal Surgery: A Case Report. | Tanaka K, Fujikawa T, Kojima D, Nagata K, Hasegawa S. | Cureus | 10.7759/cureus.67536 | 2024 | ||
| Polymicrobial anaerobic sepsis due to Bacteroides fragilis, Eggerthella lenta, Ruminoccocus gnavus, and Bilophila wadsworthia in a patient with myeloproliferative neoplasm. | Acker E, George M, Farooqi T, Raval M, Ramani A. | Anaerobe | 10.1016/j.anaerobe.2022.102641 | 2022 | ||
| First periprosthetic hip infection caused by Eggerthella lenta. | Krekosch P, Jonen V, Abdelaziz H. | J Clin Orthop Trauma | 10.1016/j.jcot.2023.102234 | 2023 | ||
| Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumors. | Gao Y, Zheng H, Ye M, Zhou G, Chen J, Qiang X, Bai J, Lu X, Tang Q. | J Cancer | 10.7150/jca.103297 | 2025 | ||
| A case of bacteremia caused by Dialister micraerophilus with Enterocloster clostridioformis and Eggerthella lenta in a patient with pyometra. | Kitagawa H, Tadera K, Omori K, Nomura T, Shigemoto N, Ohge H. | BMC Infect Dis | 10.1186/s12879-024-08999-6 | 2024 | ||
| Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidity. | Du J-Y, Zhang Z-J, Tan L, Yang J-Y, Yang R-N, Chen Y-L, Tan G-F, Li J, Li W-J, Yang L, Cai J, Shen D-L, Zhu H-R, Fan Z-X, Yuan M-L, Zhang W. | mBio | 10.1128/mbio.02447-25 | 2025 | ||
| Microbial threads in the tapestry of rheumatoid arthritis. | Li J, Kuhn KA. | J Clin Invest | 10.1172/jci195374 | 2025 | ||
| The Majority of Bacillus subtilis Strains Isolated From Blood Cultures Were Derived From Traditional Japanese Fermented Soybeans Natto: A Single-center Retrospective Study. | Sada RM, Yamamoto G, Hamaguchi S, Kuroda E, Okura A, Cai M, Nakanishi K, Abe N, Yamamoto S, Kutsuna S. | Open Forum Infect Dis | 10.1093/ofid/ofaf574 | 2025 | ||
| Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial. | Fan L, Chen J, Zhang Q, Ren J, Chen Y, Yang J, Wang L, Guo Z, Bu P, Zhu B, Zhao Y, Wang Y, Liu X, Wang W, Chen Z, Gao Q, Zheng L, Cai J. | Microbiome | 10.1186/s40168-025-02118-6 | 2025 | ||
| An Eleven-Year Retrospective Survey of Anaerobic Bloodstream Infection in Adults in a General Hospital. | Yang R, Wang W, Yin G, Ma T, Tao J. | Infect Drug Resist | 10.2147/idr.s482698 | 2024 | ||
| Cardiotonic Steroids as a Potential Novel Approach for Immunomodulation in Inflammatory Bowel Disease. | Cavalcante-Silva LHA, Sales-Neto JM, Soares MM, Ferreira DA, Medeiros ABA, Rodrigues-Mascarenhas S. | J Clin Med | 10.3390/jcm14124132 | 2025 | ||
| The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives. | Epelde F. | Medicina (Kaunas) | 10.3390/medicina61040720 | 2025 | ||
| FEATURE OF GUT MICROBIOTA IN PATIENTS WITH MIGRAINE AND HEALTHY INDIVIDUALS. | Kopchak O, Hrytsenko O. | Georgian Med News | 2022 | |||
| Genetics | Metagenomic association analysis of cognitive impairment in community-dwelling older adults. | Li J, Zhu S, Wang Y, Fan M, Dai J, Zhu C, Xu K, Cui M, Suo C, Jin L, Jiang Y, Chen X. | Neurobiol Dis | 10.1016/j.nbd.2023.106081 | 2023 | |
| Comparison of the gut microbiota in older people with and without sarcopenia: a systematic review and meta-analysis. | Ren Y, He X, Wang L, Chen N. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1480293 | 2025 | ||
| Dietary probiotic ingestion is associated with elevated enterolignans concentration in the United States population, evidenced by NHANES 1999-2010. | Dong J, Huang L, Wang C, Luo X, Wei J, Abuduxukuer K, Luo J, Zhou Y, Peng Q. | Front Nutr | 10.3389/fnut.2025.1527029 | 2025 | ||
| The Role Played by Imidazole Propionic Acid in Modulating Gut-Heart Axis and the Development of Atherosclerosis: An Explorative Review. | Pinnelli VB, Ca J, Kandi V, P S, Gr M, Hussain MH, As A, R K, Jp R, T SB, Vadakedath S. | Cureus | 10.7759/cureus.94362 | 2025 | ||
| The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies. | Lauricella S, Brucchi F, Cirocchi R, Cassini D, Vitellaro M. | J Pers Med | 10.3390/jpm15110552 | 2025 | ||
| Diversity in gut microbiota among colorectal cancer patients: findings from a case-control study conducted at a Tunisian University Hospital. | Zrelli M, Ferjani A, Nouira M, Hammami S, Ghithia N, Mouelhi L, Debbeche R, Raoult D, Boutiba Ben Boubaker I. | Discov Oncol | 10.1007/s12672-024-01232-5 | 2024 | ||
| Fatal C-reactive Protein-less Sepsis with Anti-IL-6 Autoantibody Production after Administration of Durvalumab. | Igarashi S, Ogawa T, Kushibiki T, Ito K, Matsukida A, Kato Y, Nagao K, Kawana A, Kimizuka Y. | Intern Med | 10.2169/internalmedicine.4754-24 | 2025 | ||
| PECULIARITIES OF THE GUT MICROBIOTA IN PATIENTS WITH MIGRAINE COMPARING TO HEALTHY INDIVIDUALS. | Kopchak OO, Hrytsenko OY, Pulyk OR. | Wiad Lek | 10.36740/wlek202209207 | 2022 | ||
| Synthesis and Characterization of Tween-20 Capped Biosynthesized Silver Nanoparticles for Anticancer and Antimicrobial Property. | Nithya P, Raghunathan S, Prabakaran M, Antony SA, MubarakAli D. | Appl Biochem Biotechnol | 10.1007/s12010-022-04069-2 | 2023 | ||
| Rapidly Progressive Malignant Pelvic Perivascular Epithelioid Cell Neoplasm (PEComa) Associated with Eggerthella lenta Bloodstream Infection. | Cacciatore S, Recupero C, Massaro C, Elmi D, Fusco D, Badiali V, Brandi V, Arciuolo D, Marazzi F, Landi F. | Ann Geriatr Med Res | 10.4235/agmr.22.0138 | 2022 | ||
| Microbial Cgr2 will let your Th17 cells ROR(gammaT). | Rodriguez-Marino N, Cervantes-Barragan L. | Cell Host Microbe | 10.1016/j.chom.2021.12.014 | 2022 | ||
| Gut bacteria and the host synergies promote resveratrol metabolism and induce tolerance in ALD mice. | Zhang SX, Hu FF, Chen H, Guo J, Xiang ZW, Ding X, Ye ML, Ye WL, Chen JH, Wang X, Han WJ, Zhou HH, Zhang W, Huang Y, Wu LL, Lian GH, Chen Y. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00766-y | 2025 | ||
| The Impact of Bacterial-Fungal Interactions on Childhood Caries Pathogenesis. | Huang S, Wang H, Tian J, Qin M, Gao R, Zhao B, Wang J, Wu H, Xu H. | Pathogens | 10.3390/pathogens14101033 | 2025 | ||
| Altered Gut Microbiota and Predicted Immune Dysregulation in Early Childhood SARS-CoV-2 Infection | Kim D, Kwak B, Cho K. | Microorganisms | 2025 | |||
| Gut Microbiota Affects Mouse Social Behavior via Hippuric Acid Metabolism. | Tsukui M, Yagishita S, Tokunaga S, Wakatsuki S, Araki T. | Neurol Int | 10.3390/neurolint17110185 | 2025 | ||
| Straining to define a healthy microbiome. | Seekatz AM. | mSphere | 10.1128/msphere.00797-24 | 2025 | ||
| Genetics | Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors. | Diop K, Mbaye B, Nili S, Filin A, Benlaifaoui M, Malo J, Renaud AS, Belkaid W, Hunter S, Messaoudene M, Lee KA, Elkrief A, Routy B. | Gut Pathog | 10.1186/s13099-025-00694-4 | 2025 | |
| Enzymology | Antimicrobial susceptibility testing of Eggerthella lenta blood culture isolates at a university hospital in Belgium from 2004 to 2018. | Declerck B, Van der Beken Y, De Geyter D, Pierard D, Wybo I. | Anaerobe | 10.1016/j.anaerobe.2021.102348 | 2021 | |
| Bacteremia caused by Desulfovibrio desulfuricans with the intestinal tract as the portal of entry: two case reports and a literature review. | Yamaizumi K, Kyotani M, Kenzaka T. | BMC Infect Dis | 10.1186/s12879-024-09623-3 | 2024 | ||
| Lutein augments the hypoglycemic effect of metformin through the gut microbiota-imidazole propionate axis in type 2 diabetic model mice | Liu K, Han Y, Zhang J, Yin Z, Yan H, Gao W, Tong H, Zhu H, Hui S, Liang L, Yu H. | Sci Rep | 2025 | |||
| The endogenous hydrogen gas (H2) drives women's health: a comment on "Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas". | Yang S, Zhang J, Xu L, Guan Y, Fang C, Zheng S, Yang H, Liu H, Zhang Y. | Front Endocrinol (Lausanne) | 10.3389/fendo.2024.1504814 | 2024 | ||
| Identification and Antibiotic Susceptibility of Eggerthella lenta in Bloodstream Infections. | Li X, Xu E, Shi C, Qiao G, Chen S, Xu Y, Liu Y, Bao X. | Pol J Microbiol | 10.33073/pjm-2022-024 | 2022 | ||
| Evaluating the prebiotic activity of arabinogalactan on the human gut microbiota using 16S rRNA gene sequencing and Raman-activated cell sorting. | Rasoulimehrabani H, Khadem S, Hodzic A, Philipp M, Gallo R, Nikolov G, Seneca J, Ramesmayer J, Sivulic P, Berry D. | Microbiome Res Rep | 10.20517/mrr.2025.29 | 2025 | ||
| Phylogeny | Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease. | Hertz S, Anderson JM, Nielsen HL, Schachtschneider C, McCauley KE, Ozcam M, Larsen L, Lynch SV, Nielsen H. | Ann Med | 10.1080/07853890.2024.2338244 | 2024 | |
| Vitamin K deficiency as a cause of oral bleeding in a dog with intestinal malabsorption due to lymphocytic-plasmacytic enteritis. | Marceglia G, Petini M. | Open Vet J | 10.5455/ovj.2025.v15.i5.46 | 2025 | ||
| Specific Bacterial Co-abundance Groups Are Associated With Inflammatory Status in Patients With Ulcerative Colitis. | Jangi S, Zhao N, Hsia K, Park YS, Michaud DS, Yoon H. | J Crohns Colitis | 10.1093/ecco-jcc/jjae125 | 2025 | ||
| Clinical and microbiological characteristics of Eggerthella lenta bacteremia at a Japanese tertiary hospital. | Nagaoka R, Kitagawa H, Koba Y, Tadera K, Hara T, Kashiyama S, Nomura T, Omori K, Shigemoto N, Yokozaki M, Ohge H. | J Infect Chemother | 10.1016/j.jiac.2021.03.019 | 2021 | ||
| Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation. | Wang C, Liu H, Li X, Kong W, Wu H, Huang C. | Front Allergy | 10.3389/falgy.2025.1562832 | 2025 | ||
| Eggerthella lenta bacteraemia in endometrial adenocarcinoma - a case report from Pakistan. | Fatima T, Hasan R, Tariq S. | J Pak Med Assoc | 10.5455/jpma.285088 | 2020 | ||
| Enzymology | Eggerthella lenta bloodstream infections: two cases and review of the literature. | Bo J, Wang S, Bi Y, Ma S, Wang M, Du Z. | Future Microbiol | 10.2217/fmb-2019-0338 | 2020 | |
| A 15-day pilot biodiversity intervention with horses in a farm system leads to gut microbiome rewilding in 10 urban Italian children. | Scicchitano D, Foresto L, Laczny CC, Cinti N, Vitagliano R, Halder R, Morri G, Turroni S, D'Amico F, Palladino G, Fiori J, Wilmes P, Rampelli S, Candela M. | One Health | 10.1016/j.onehlt.2024.100902 | 2024 | ||
| Metagenomic Next-Generation Sequencing Direct Diagnosis of Mixed Bacterial Meningitis in a Child: A Case Report. | Wang W, Wang Y, Xin X, Yin Y, Zhao C, Jin Y. | Infect Drug Resist | 10.2147/idr.s476781 | 2024 | ||
| The human intestinal bacterium Eggerthella lenta influences gut metabolomes in gnotobiotic mice | Viehof A, Haange S, Streidl T, Schubert K, Engelmann B, Haller D, Rolle-Kampczyk U, von Bergen M, Clavel T. | Microbiome Res Rep | 2024 | |||
| Targeted Gut Microbiota Modulation Enhances Levodopa Bioavailability and Motor Recovery in MPTP Parkinson's Disease Models. | Ai P, Xu S, Yuan Y, Xu Z, He X, Mo C, Zhang Y, Yang X, Xiao Q. | Int J Mol Sci | 10.3390/ijms26115282 | 2025 | ||
| Exploring the causal role of gut microbiota and inflammatory proteins in neuromyelitis optica spectrum disorder: A Mendelian randomization study with mediation analysis. | Yin Z, Qiu Y, Yang Y, Yue S, Chen Z, Wu J. | Medicine (Baltimore) | 10.1097/md.0000000000043967 | 2025 | ||
| A Narrative Review of Intestinal Microbiota's Impact on Migraine with Psychopathologies. | Francavilla M, Facchetti S, Demartini C, Zanaboni AM, Amoroso C, Bottiroli S, Tassorelli C, Greco R. | Int J Mol Sci | 10.3390/ijms25126655 | 2024 | ||
| Microbiome gut community structure and functionality are associated with symptom severity in non-responsive celiac disease patients undergoing a gluten-free diet. | Marcos-Zambrano LJ, Lacruz-Pleguezuelos B, Aguilar-Aguilar E, Marcos-Pasero H, Valdes A, Loria-Kohen V, Cifuentes A, Ramirez de Molina A, Diaz-Ruiz A, Pancaldi V, Carrillo de Santa Pau E. | mSystems | 10.1128/msystems.00143-25 | 2025 | ||
| Epidemiology and antibiotic susceptibility in anaerobic bacteraemia: a 15-year retrospective study in South-Eastern Hungary. | Sarvari KP, Racz NB, Burian K. | Infect Dis (Lond) | 10.1080/23744235.2021.1963469 | 2022 | ||
| Pathogenicity | SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patients. | Basting CM, Langat R, Broedlow CA, Guerrero CR, Bold TD, Bailey M, Velez A, Schroeder T, Short-Miller J, Cromarty R, Mayer ZJ, Southern PJ, Schacker TW, Safo SE, Bramante CT, Tignanelli CJ, Schifanella L, Klatt NR. | Microbiol Spectr | 10.1128/spectrum.00680-24 | 2024 | |
| Bariatric Surgery Is Associated with Lower Concentrations of Fecal Secondary Bile Acids and Their Metabolizing Microbial Enzymes: A Pilot Study. | Hussan H, Ali MR, Lyo V, Webb A, Pietrzak M, Zhu J, Choueiry F, Li H, Cummings BP, Marco ML, Medici V, Clinton SK. | Obes Surg | 10.1007/s11695-024-07420-0 | 2024 | ||
| Identification of inulin-responsive bacteria in the gut microbiota via multi-modal activity-based sorting. | Riva A, Rasoulimehrabani H, Cruz-Rubio JM, Schnorr SL, von Baeckmann C, Inan D, Nikolov G, Herbold CW, Hausmann B, Pjevac P, Schintlmeister A, Spittler A, Palatinszky M, Kadunic A, Hieger N, Del Favero G, von Bergen M, Jehmlich N, Watzka M, Lee KS, Lee KS, Wiesenbauer J, Khadem S, Viernstein H, Stocker R, Wagner M, Kaiser C, Richter A, Kleitz F, Berry D. | Nat Commun | 10.1038/s41467-023-43448-z | 2023 | ||
| Characterization of bacterial composition of surgical site infections after gynecologic surgery. | Cowley ES, Jacques L, Powell AM, Al-Niaimi A, Pop-Vicas A. | Am J Obstet Gynecol | 10.1016/j.ajog.2022.02.033 | 2022 | ||
| National antibiotic consumption is strongly related to the prevalence of antibiotic resistance across bacterial clades. | Louca S. | iScience | 10.1016/j.isci.2024.111712 | 2025 | ||
| Microbial Features Linked to Medication Strategies in Cardiometabolic Disease Management. | Shearer J, Shah S, Shen-Tu G, Schlicht K, Laudes M, Mu C. | ACS Pharmacol Transl Sci | 10.1021/acsptsci.3c00261 | 2024 | ||
| Phylogeny | Deciphering Bacterial Community Succession and Pathogen Dynamics in ICU Ventilator Circuits Through Full-Length 16S rRNA Sequencing for Mitigating the Risk of Nosocomial Infections. | Tsai HC, Chen JS, Hsu GJ, Hussain B, Lin IC, Hsu TK, Han J, Huang SW, Wu CC, Hsu BM. | Microorganisms | 10.3390/microorganisms13091982 | 2025 | |
| Acute pancreatitis gut dysbiosis persists at 1-year follow-up and is associated with clinical outcomes. | Dike CR, Duan Q, Ahmed F, Denson LA, Haslam D, Minar P, Ollberding NJ, Papachristou GI, Setchell KDR, Thompson T, Vitale DS, Zhao X, Abu-El-Haija M. | J Pediatr Gastroenterol Nutr | 10.1002/jpn3.70135 | 2025 | ||
| Clinical evaluation of an in-house Xpert Lysate-based Method combined with MALDI-TOF MS for the rapid identification of positive blood cultures. | Ping Y, Chen Q, Sun X, Wang H, Lin S, Zhu B, Wang Z, Lu J, Cao J. | BMC Microbiol | 10.1186/s12866-025-03996-4 | 2025 | ||
| Longitudinal Fecal Microbiota Profiles in A Cohort of Non-Hospitalized Adolescents and Young Adults with COVID-19: Associations with SARS-CoV-2 Status and Long-Term Fatigue. | Olbjorn C, Hagen M, Moen AEF, Havdal LB, Sommen SL, Berven LL, Thiis-Evensen E, Stiansen-Sonerud T, Selvakumar J, Wyller VBB. | Pathogens | 10.3390/pathogens13110953 | 2024 | ||
| Hawai'i's First Published Case of Eggerthella lenta Sepsis. | Peter-Bibb TK, Tokeshi J. | Hawaii J Health Soc Welf | 2020 | |||
| Gut microbiota changes associated with frailty in older adults: A systematic review of observational studies. | Wen NN, Sun LW, Geng Q, Zheng GH. | World J Clin Cases | 10.12998/wjcc.v12.i35.6815 | 2024 | ||
| Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection. | Ke S, Villafuerte Galvez JA, Sun Z, Cao Y, Pollock NR, Chen X, Kelly CP, Liu YY. | J Infect Dis | 10.1093/infdis/jiae470 | 2025 | ||
| A retrospective study of the detection of sepsis pathogens comparing blood culture and culture-independent digital PCR. | Zhao Z, Wang Y, Kang Y, Wu G, He J, Wang Z, Yang J, Wang Y, Yang X, Jia W. | Heliyon | 10.1016/j.heliyon.2024.e27523 | 2024 | ||
| Preliminary Study to Understand the Role of Gut Microbiota in Coronary Slow Flow Phenomenon (CSFP). | Gurol T, Karaman T, Gurol Y, Sezerman OU, Oktem Okullu S. | Metabolites | 10.3390/metabo15070475 | 2025 | ||
| Genetics | Bacteraemia Associated with Bilophila wadsworthia: A Rare Case Presentation from Hungary. | Kovacs R, Arokszallasi T, Bozo A, Jakab A, Babel KS, Heja M, Kovacs KB, Balazs B, Vitalis E, Majoros L, Toth Z. | Pathogens | 10.3390/pathogens13090749 | 2024 | |
| Genome-scale metabolic model-guided systematic framework for designing customized live biotherapeutic products. | Lee YQ, Choi YM, Park SY, Kim SK, Lee M, Kim D, Koduru L, Lakshmanan M, Jung S, Kim MJ, Choe YH, Lee DY. | NPJ Syst Biol Appl | 10.1038/s41540-025-00555-5 | 2025 | ||
| The Causal Role of Esophageal Cancer and Gut Microbiota: A Bidirectional Mendelian Randomization Study. | Su W, Chen H, Hu D, Ye B, Zhang W, Zhang G, Si X, Zhou X. | J Evid Based Integr Med | 10.1177/2515690x251324793 | 2025 | ||
| Flavonifractor plautii Bacteremia With Generalized Peritonitis: A Case Report and Literature Review. | Saito S, Baba S, Nikai H, Fujisawa R, Fujiwara T. | Cureus | 10.7759/cureus.63890 | 2024 | ||
| Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT. | Fabbrini M, D'Amico F, Leardini D, Muratore E, Barone M, Belotti T, Forchielli ML, Zama D, Pession A, Prete A, Brigidi P, Rampelli S, Candela M, Turroni S, Masetti R. | Commun Biol | 10.1038/s42003-023-04436-7 | 2023 | ||
| A rare case of an infected aortoiliac graft complicated with Eggerthella lenta bacteremia and septic shock. | Alataby HA, Muzangwa LG, Atere MK, Bibawy J, Diaz KT, Nfonoyim JM. | J Community Hosp Intern Med Perspect | 10.1080/20009666.2020.1809260 | 2020 | ||
| Pathogenicity | The Impact of a 10-Month Synbiotic Intake on eGFR, Uremic Toxins, Oxidative Stress, and Inflammatory Markers in Non-Dialysis Chronic Kidney Disease Patients: A Prospective, Non-Randomized, Placebo-Controlled Study. | Kuskunov T, Tilkiyan E, Zdravkova I, Valova S, Boyanov K, Bivolarska A. | Medicina (Kaunas) | 10.3390/medicina61071199 | 2025 | |
| Bacteremia Caused by the Eggerthella lenta in a Previously Healthy 30-Year-Old Man with Acute Suppurative Appendicitis: A Case Report from China. | Jiang J, She B, Zheng R. | Infect Drug Resist | 10.2147/idr.s274494 | 2020 | ||
| Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome. | Mugo CW, Church E, Horniblow RD, Mollan SP, Botfield H, Hill LJ, Sinclair AJ, Grech O. | J Headache Pain | 10.1186/s10194-025-02039-7 | 2025 | ||
| Interaction between gut microbiota and immunity in health and intestinal disease. | Wang Q, Meng Q, Chen Y, Liu Y, Li X, Zhou J, Ma Y, Yu Z, Chen X. | Front Immunol | 10.3389/fimmu.2025.1673852 | 2025 | ||
| Enzymology | Septic shock caused by the under-recognized bacterium Eggerthella lenta in a 61-year-old male with a periurethral abscess: a case report. | Cordoba G, Kim ML, Sharma S, Paniagua J, Folgarait G, Berger J. | Rev Soc Bras Med Trop | 10.1590/0037-8682-0081-2019 | 2019 | |
| Polyphenols and Microbiota Modulation: Insights from Swine and Other Animal Models for Human Therapeutic Strategies. | Anghel AC, Taranu I, Ortan A, Marcu Spinu S, Dragoi Cudalbeanu M, Rosu PM, Babeanu NE. | Molecules | 10.3390/molecules29246026 | 2024 | ||
| Association Studies on Gut and Lung Microbiomes in Patients with Lung Adenocarcinoma. | Guo Y, Yuan W, Lyu N, Pan Y, Cao X, Wang Y, Han Y, Zhu B. | Microorganisms | 10.3390/microorganisms11030546 | 2023 | ||
| Microbes and GFR in Health and CKD in Mice. | Xu J, Verma E, Sanchez J, Gharaie S, Jeong S, Patel SK, Gooya M, Rosa X, Gupta K, Rinschen MM, Rabb H, Pluznick JL. | J Am Soc Nephrol | 10.1681/asn.0000000814 | 2025 | ||
| Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C). | Suskun C, Kilic O, Yilmaz Ciftdogan D, Guven S, Karbuz A, Ozkaya Parlakay A, Kara Y, Kacmaz E, Sahin A, Boga A, Kizmaz Isancli D, Gulhan B, Kanik-Yuksek S, Kiral E, Bozan G, Arslanoglu MO, Kizil MC, Dinleyici M, Us T, Varis A, Kaya M, Vandenplas Y, Dinleyici EC. | Eur J Pediatr | 10.1007/s00431-022-04494-9 | 2022 | ||
| Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda. | Agudelo C, Kateete DP, Nasinghe E, Kamulegeya R, Lubega C, Mbabazi M, Baker N, Lin KY, Liu CC, Kasambula AS, Kigozi E, Komakech K, Mukisa J, Mulumba K, Mwachan P, Nakalanda BS, Nalubega GP, Nsubuga J, Sitenda D, Ssenfuka H, Cirolia GT, Gustafson JT, Wang R, Nsubuga ML, Yiga F, Stanley SA, Bagaya BS, Elliott A, Joloba M, Wolf AR. | Gut Pathog | 10.1186/s13099-025-00678-4 | 2025 | ||
| Pathogenicity | Cytokine release and NLRP3 inflammasome activation induced by low-abundance oral bacterial biofilms. | Karched M, Guleri Bhardwaj R, Abu Al-Melh M, Qudeimat MA. | J Oral Microbiol | 10.1080/20002297.2025.2552167 | 2025 | |
| Postpartum endometritis and obstetrical sepsis associated with Eggerthella lenta. Case report and review of the literature. | Priputnevich T, Lyubasovskaya L, Muravieva V, Kondrakhin A, Ignateva A, Gordeev A, Shmakov R, Sukhikh G, Yarotskaya E. | J Matern Fetal Neonatal Med | 10.1080/14767058.2019.1602602 | 2021 | ||
| Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial. | Wong MK, Armstrong E, Heirali AA, Schneeberger PHH, Chen H, Cochrane K, Sherriff K, Allen-Vercoe E, Siu LL, Spreafico A, Coburn B. | mBio | 10.1128/mbio.01904-25 | 2025 | ||
| Supplementation with a cranberry extract favors the establishment of butyrogenic guilds in the human fermentation SHIME system. | Cattero V, Roussel C, Lessard-Lord J, Roy D, Desjardins Y. | Microbiome Res Rep | 10.20517/mrr.2024.17 | 2024 | ||
| Network pharmacology-based insights into the role of gut microbiota metabolites in insulin resistance. | Xiao B, Chen X, Zong R, Guan Y, Zhu Z, Bi S. | Front Microbiol | 10.3389/fmicb.2025.1617496 | 2025 | ||
| microbetag: simplifying microbial network interpretation through annotation, enrichment tests, and metabolic complementarity analysis. | Zafeiropoulos H, Delopoulos EIM, Erega A, Schneider A, Geirnaert A, Morris J, Faust K. | Genome Biol | 10.1186/s13059-025-03769-2 | 2025 | ||
| The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs). | Mohamed A, Asa SL, McCormick T, Al-Shakhshir H, Dasari A, Mauricio R, Salem I, Ocuin LM, Bajor D, Lee RT, Selfridge JE, Kardan A, Lee Z, Avril N, Kopp S, Winter JM, Hardacre JM, Ammori JB, Ghannoum MA. | Curr Issues Mol Biol | 10.3390/cimb44050136 | 2022 | ||
| Pathogenicity | Impact of gut microbiome on atrial fibrillation: Mechanistic insights and future directions in individualized medicine. | Brar AS, Vemula SL, Yanamaladoddi V, Sodhi S, Hatwal J, Sohal A, Batta A. | World J Cardiol | 10.4330/wjc.v17.i6.107386 | 2025 | |
| Comprehensive retrospect and future perspective on bacteriophage and cancer. | Liping Z, Sheng Y, Yinhang W, Yifei S, Jiaqun H, Xiaojian Y, Shuwen H, Jing Z. | Virol J | 10.1186/s12985-024-02553-1 | 2024 | ||
| Draft Genome Sequences of 13 Isolates of Adlercreutzia equolifaciens, Eggerthella lenta, and Gordonibacter urolithinfaciens, Isolated from Human Fecal Samples in Karlsruhe, Germany. | Danylec N, Stoll DA, Gobl A, Huch M. | Microbiol Resour Announc | 10.1128/mra.00017-20 | 2020 | ||
| Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis. | Goudman L, Demuyser T, Pilitsis JG, Billot M, Roulaud M, Rigoard P, Moens M. | Front Immunol | 10.3389/fimmu.2024.1342833 | 2024 | ||
| Red meat consumption in higher healthy eating index diets is associated with brain health critical nutritional adequacy, and fecal microbial diversity. | Dhakal S, Hossain M, Parajuli S. | Sci Rep | 10.1038/s41598-025-18907-w | 2025 | ||
| A population-scale analysis of 36 gut microbiome studies reveals universal species signatures for common diseases. | Sun W, Zhang Y, Guo R, Sha S, Chen C, Ullah H, Zhang Y, Ma J, You W, Meng J, Lv Q, Cheng L, Fan S, Li R, Mu X, Li S, Yan Q. | NPJ Biofilms Microbiomes | 10.1038/s41522-024-00567-9 | 2024 | ||
| Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting. | Navarra A, Cicalini S, D'Arezzo S, Pica F, Selleri M, Nisii C, Venditti C, Cannas A, Mazzarelli A, Vulcano A, Carrara S, Vincenti D, Bartolini B, Giacomini P, Bocci MG, Fontana C. | Antibiotics (Basel) | 10.3390/antibiotics14030304 | 2025 | ||
| [Gut microbiota and systemic inflammation in patients with chronic heart failure]. | Vlasov AA, Salikova SP, Grinevich VB, Bystrova OV, Osipov GA, Meshkova ME. | Kardiologiia | 10.18087/cardio.2020.5.n859 | 2020 | ||
| Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease. | Zhang Y, Mo C, Ai P, He X, Xiao Q, Yang X. | Gut Microbes | 10.1080/19490976.2025.2454937 | 2025 | ||
| Deciphering the impact of dietary habits and behavioral patterns on colorectal cancer. | Yuan Q, Liu J, Wang X, Du C, Zhang Y, Lin L, Wang C, Hong Z. | Int J Surg | 10.1097/js9.0000000000002229 | 2025 | ||
| Genetics | StrainR2 accurately deconvolutes strain-level abundances in synthetic microbial communities. | Heber K, Tian S, Betancurt-Anzola D, Koo H, Bisanz JE. | Bioinformatics | 10.1093/bioinformatics/btaf440 | 2025 | |
| Metabolism | Gut microbiota and metabolites of alpha-synuclein transgenic monkey models with early stage of Parkinson's disease. | Yan Y, Ren S, Duan Y, Lu C, Niu Y, Wang Z, Inglis B, Ji W, Zheng Y, Si W. | NPJ Biofilms Microbiomes | 10.1038/s41522-021-00242-3 | 2021 | |
| Different Fecal Microbiota in Hirschsprung's Patients With and Without Associated Enterocolitis. | Arnaud AP, Cousin I, Schmitt F, Petit T, Parmentier B, Levard G, Podevin G, Guinot A, DeNapoli S, Hervieux E, Flaum V, De Vries P, Randuineau G, David-Le Gall S, Buffet-Bataillon S, Boudry G. | Front Microbiol | 10.3389/fmicb.2022.904758 | 2022 | ||
| Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson's Disease. | He X, Lai Y, Mo C, Zhang Y, Ai P, Xu S, Qian Y, Xiao Q, Yang X. | Microorganisms | 10.3390/microorganisms12071432 | 2024 | ||
| Accounting Gut Microbiota as the Mediator of Beneficial Effects of Dietary (Poly)phenols on Skeletal Muscle in Aging. | Ticinesi A, Nouvenne A, Cerundolo N, Parise A, Meschi T. | Nutrients | 10.3390/nu15102367 | 2023 | ||
| Metabolism | Gut microbiome association with brain imaging markers, APOE genotype, calcium and vegetable intakes, and obesity in healthy aging adults. | Hammond TC, Green SJ, Jacobs Y, Chlipala GE, Xing X, Heil S, Chen A, Aware C, Flemister A, Stromberg A, Balchandani P, Lin AL. | Front Aging Neurosci | 10.3389/fnagi.2023.1227203 | 2023 | |
| mNFE: microbiome network flow entropy for detecting pre-disease states of type 1 diabetes. | Gao R, Li P, Ni Y, Peng X, Ren J, Chen L. | Gut Microbes | 10.1080/19490976.2024.2327349 | 2024 | ||
| Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study. | Ugarte-Torres A, Gillrie MR, Griener TP, Church DL. | Clin Infect Dis | 10.1093/cid/ciy057 | 2018 | ||
| Vitamin A carotenoids, but not retinoids, mediate the impact of a healthy diet on gut microbial diversity. | Valdes AM, Louca P, Visconti A, Asnicar F, Bermingham K, Nogal A, Wong K, Michelotti GA, Wolf J, Segata N, Spector TD, Berry SE, Falchi M, Menni C. | BMC Med | 10.1186/s12916-024-03543-4 | 2024 | ||
| Pelvic abscess caused by a slow growing anaerobic bacterium, Eggerthella lenta: First case report from Pakistan. | Mal PB, Rafiq I, Iftikhar I, Irfan S. | J Pak Med Assoc | 2017 | |||
| Pathogenicity | Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study. | Veloo ACM, Tokman HB, Jean-Pierre H, Dumont Y, Jeverica S, Lienhard R, Novak A, Rodloff A, Rotimi V, Wybo I, Nagy E, ESGAI study group. | Anaerobe | 10.1016/j.anaerobe.2019.102111 | 2020 | |
| Lactiplantibacillus plantarum P470 Isolated from Fermented Chinese Chives Has the Potential to Improve In Vitro the Intestinal Microbiota and Biological Activity in Feces of Coronary Heart Disease (CHD) Patients. | Yang L, Wu Y, Yang J, Li Y, Zhao X, Liang T, Li L, Jiang T, Zhang T, Zhang J, Zhong H, Xie X, Wu Q. | Nutrients | 10.3390/nu16172945 | 2024 | ||
| Phylogeny | Evaluation of the Correlation between Gut Microbiota and Renal Function in Chronic Kidney Disease Patients. | Xi J, Xu J, Sun J, Li H, Zhang S, Xie H, Wang H, Zhang R, Zhao M, Wang M, Zheng T. | J Microbiol Biotechnol | 10.4014/jmb.2502.02039 | 2025 | |
| Pathogenicity | Tuo-Min-Ding-Chuan Decoction Alleviates Asthma via Spatial Regulation of Gut Microbiota and Treg Cell Promotion. | Hong Y, Yang Z, Liu Z, Li N, Qin J, Ge D, Peng G, Wang J, Wang Q. | Pharmaceuticals (Basel) | 10.3390/ph18050646 | 2025 | |
| High-resolution analysis of the treated coeliac disease microbiome reveals strain-level variation. | Slager J, Simpson HL, Gacesa R, Chen L, Tan IL, Gelderloos J, Maatman A, Wijmenga C, Zhernakova A, Fu J, Weersma RK, Gonera G, Jonkers IH, Withoff S. | Gut Microbes | 10.1080/19490976.2025.2489071 | 2025 | ||
| Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses. | Kibria MK, Ali MA, Mollah MNH. | PLoS One | 10.1371/journal.pone.0312493 | 2024 | ||
| Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria. | Wolf LJ, Stingu CS. | Antibiotics (Basel) | 10.3390/antibiotics12010063 | 2022 | ||
| Effects of N-Carbamylglutamate supplementation on cecal morphology, microbiota composition, and short-chain fatty acids contents of broiler breeder roosters. | Liu N, Zhang Z, Zhang J, Ma W, Wang C. | Sci Rep | 10.1038/s41598-025-91577-w | 2025 | ||
| Metabolism | Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes. | Lamichhane S, Sen P, Dickens AM, Alves MA, Harkonen T, Honkanen J, Vatanen T, Xavier RJ, Hyotylainen T, Knip M, Oresic M. | Cell Rep Med | 10.1016/j.xcrm.2022.100762 | 2022 | |
| Eggerthella lenta Bacteremia in a Middle-Aged Healthy Man with Acute Hepatic Abscess: Case Report and Literature Review, 1970-2020. | Wang J, Guo R, Ma W, Dong X, Yan S, Xie W. | Infect Drug Resist | 10.2147/idr.s321282 | 2021 | ||
| Metabolism | Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. | Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, Zhao L, Li C, Zhou Y, Wang G, Kang W, Ng EK, Yu J. | Gut | 10.1136/gutjnl-2021-325021 | 2022 | |
| Phylogeny | Changes in the Gut and Oral Microbiome in Children with Phenylketonuria in the Context of Dietary Restrictions-A Preliminary Study. | Ostrowska M, Nowosad K, Mikoluc B, Szczerba H, Komon-Janczara E. | Nutrients | 10.3390/nu16223915 | 2024 | |
| Gut microbiota analysis reveals microbial signature for multi-autoimmune diseases based on machine learning model. | An T, Zhang S, Li J, Wang H, Chen L, Shi Y, Wang J, Han S, Wang R, Wang L, Huan Z, Yang R, Hao D, Liu Y, Liu X, Yuan C. | Front Microbiol | 10.3389/fmicb.2025.1660775 | 2025 | ||
| Genetics | The Gut Microbiome Obesity Index: A New Analytical Tool in the Metagenomics Workflow for the Evaluation of Gut Dysbiosis in Obese Humans. | Kulecka M, Jaworski P, Zeber-Lubecka N, Balabas A, Piatkowska M, Czarnowski P, Fraczek B, Tarnowski W, Mikula M, Ostrowski J. | Nutrients | 10.3390/nu17142320 | 2025 | |
| Pathogenicity | Jian-Pi-Yi-Shen formula improves kidney function by regulating gut microbiome in rats with chronic kidney disease. | Wang Y, Lu J, Dai W, Yang S. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1526863 | 2025 | |
| DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy. | Oh M, Zhang L. | Sci Rep | 10.1038/s41598-023-31210-w | 2023 | ||
| Genetics | Machine learning integrates region-specific microbial signatures to distinguish geographically adjacent populations within a province. | Luo L, Chen B, Zeng S, Li Y, Chen X, Zhang J, Guo X, Li S, Ruan L, Zhu S, Gao C, Zhang C, Li T. | Front Microbiol | 10.3389/fmicb.2025.1586195 | 2025 | |
| To analyze the relationship between gut microbiota, metabolites and migraine: a two-sample Mendelian randomization study. | Qu K, Li MX, Gan L, Cui ZT, Li JJ, Yang R, Dong M. | Front Microbiol | 10.3389/fmicb.2024.1325047 | 2024 | ||
| Genetics | Pathogenesis diagnosis of a pediatric patient suffering from multi-organ abscesses. | Wu M, Xiao H, Xiao Y, Chen T, Wang X, Xiao X, Wang Y, Wang J, Ren L, Liu G. | Diagn Pathol | 10.1186/s13000-023-01360-6 | 2023 | |
| A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection. | Fouladi F, Chen Y, Bera S, Jarmusch AK, Van Tyne D, Palella FJ, Margolick JB, Chew KW, Sun J, Martinson J, Rinaldo CR, Peddada SD. | Nat Commun | 10.1038/s41467-025-64822-z | 2025 | ||
| Pathogenicity | Associations Between Uraemic Toxins and Gut Microbiota in Adults Initiating Peritoneal Dialysis. | James P, Stanford J, Dixit OVA, Nicdao MA, McWhinney B, Sud K, Ryan M, Read S, Ahlenstiel G, Lambert K, O'Brien C, Chau K. | Toxins (Basel) | 10.3390/toxins17070334 | 2025 | |
| Phylogeny | The impact of different gastrointestinal reconstruction techniques on gut microbiota after gastric cancer surgery. | Yang Y, Zhou HY, Zhou GM, Chen J, Ming R, Zhang D, Jiang HW. | Front Microbiol | 10.3389/fmicb.2024.1494049 | 2024 | |
| Genetics | Genomic and ecological approaches to identify the Bifidobacterium breve prototype of the healthy human gut microbiota. | Argentini C, Lugli GA, Tarracchini C, Fontana F, Mancabelli L, Viappiani A, Anzalone R, Angelini L, Alessandri G, Longhi G, Bianchi MG, Taurino G, Bussolati O, Milani C, van Sinderen D, Turroni F, Ventura M. | Front Microbiol | 10.3389/fmicb.2024.1349391 | 2024 | |
| Enzymology | Eggerthella lenta bacteremia in solid tumor cancer patients: Pathogen or witness of frailty? | Woerther PL, Antoun S, Chachaty E, Merad M. | Anaerobe | 10.1016/j.anaerobe.2017.04.010 | 2017 | |
| High-throughput transcriptomics of 409 bacteria-drug pairs reveals drivers of gut microbiota perturbation. | Ricaurte D, Huang Y, Sheth RU, Gelsinger DR, Kaufman A, Wang HH. | Nat Microbiol | 10.1038/s41564-023-01581-x | 2024 | ||
| Genetics | A metagenome-wide association study of gut microbiota in hepatitis B virus-related cirrhosis in northwest China. | Feng M, Chai Y, Li J, Wang Q, Zhang D. | Front Genet | 10.3389/fgene.2025.1619911 | 2025 | |
| Investigating causal relationships between the gut microbiota and allergic diseases: A mendelian randomization study. | Wang Y, Liu T, Wan Z, Wang L, Hou J, Shi M, Tsui SKW. | Front Genet | 10.3389/fgene.2023.1153847 | 2023 | ||
| Lactiplantibacillus plantarum Interstrain Variability in the Production of Bioactive Phenolic Metabolites from Flavan-3-ols. | Pulido-Mateos EC, Lessard-Lord J, Desjardins Y, Roy D. | J Agric Food Chem | 10.1021/acs.jafc.4c07890 | 2024 | ||
| Pathogenicity | Assembled human microbiome and metabolome in chronic kidney disease: Dysbiosis a double-edged sword interlinking Circ-YAP1, Circ-APOE & Circ-SLC8A1. | Zaki EA, Afifi SM, Ammar NM, Kadry MO. | Toxicol Rep | 10.1016/j.toxrep.2025.102058 | 2025 | |
| Autoimmunity-Associated Gut Commensals Modulate Gut Permeability and Immunity in Humanized Mice. | Balakrishnan B, Luckey D, Taneja V. | Mil Med | 10.1093/milmed/usy309 | 2019 | ||
| Streptomyces uses both polar and dispersed cell wall synthesis during exploratory growth. | Zambri MP, Baglio CR, Irazoki O, Jones SE, Garner EC, Cava F, Elliot MA. | Nat Microbiol | 10.1038/s41564-025-02080-x | 2025 | ||
| Distinct microbial and metabolic shifts characterize acute coronary syndrome and recovery. | Xu J, Dai D, Yang Y, Gao S, Yang J, Dong C, Yang W, Yuan J, Wang T, Tian T, Yang Y, Luo F, Jiang P, Wu C, Sun X, Sui Y, Gao G, Ma W, Wu Y, Zhang J, Li J, Guo C, Cui C, Guo T, Zhao X, Yuan J, Qiao S, Hu F, Gao X, Luo X, Peng H, Wang D, Wu J, Wu C, He J, Chen WH, Yang Y, Fu J. | Imeta | 10.1002/imt2.70079 | 2025 | ||
| Genetics | Association between gut microbiota and central retinal artery occlusion: A two-sample Mendelian randomization study. | Chen J, Wang X, Yang J, Huang J, Xie M, Su Z, Jiang F. | Indian J Ophthalmol | 10.4103/ijo.ijo_3304_23 | 2024 | |
| Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study. | Liu K, Zou J, Fan H, Hu H, You Z. | Front Immunol | 10.3389/fimmu.2022.930318 | 2022 | ||
| MagMD: Database summarizing the metabolic action of gut microbiota to drugs. | Zhou J, Ouyang J, Gao Z, Qin H, Jun W, Shi T. | Comput Struct Biotechnol J | 10.1016/j.csbj.2022.11.021 | 2022 | ||
| Consumption of only wild foods induces large scale, partially persistent alterations to the gut microbiome. | Rampelli S, Pomstra D, Barone M, Fabbrini M, Turroni S, Candela M, Henry AG. | Sci Rep | 10.1038/s41598-025-00319-5 | 2025 | ||
| Probiotic-mediated modulation of gut microbiome in students exposed to academic stress: a randomized controlled trial. | Vazquez-Castellanos JF, Maciel LF, Wauters L, Gregory A, Van Oudenhove L, Geboers K, Verbeke K, Smokvina T, Tack J, Vanuytsel T, Derrien M, Raes J. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00776-w | 2025 | ||
| Molecular Mechanisms and Emerging Precision Therapeutics in the Gut Microbiota-Cardiovascular Axis. | Ponce Alencastro JA, Salinas Lucero DA, Solis RP, Herrera Giron CG, Estrella Lopez AS, Anda Suarez PX. | Cureus | 10.7759/cureus.83022 | 2025 | ||
| A plug-and-play system for polycyclic tetramate macrolactam production and functionalization. | Glockle A, Schuler S, Einsiedler M, Gulder TAM. | Microb Cell Fact | 10.1186/s12934-024-02630-8 | 2025 | ||
| Bibliometric analysis of mucosal immunity in IgA nephropathy from 1990 to 2022. | Chen X, Yan Z, Pan Q, Zhang C, Chen Y, Liang X, Li S, Wu G. | Immun Inflamm Dis | 10.1002/iid3.1156 | 2024 | ||
| In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes. | Hackel MA, Karlowsky JA, Canino MA, Sahm DF, Scangarella-Oman NE. | Antimicrob Agents Chemother | 10.1128/aac.02165-21 | 2022 | ||
| Functional recovery outcomes following acute stroke is associated with abundance of gut microbiota related to inflammation, butyrate and secondary bile acid. | Hammond TC, Powell E, Green SJ, Chlipala G, Frank J, Yackzan AT, Yanckello LM, Chang YH, Xing X, Heil S, Springer JE, Pennypacker K, Stromberg A, Sawaki L, Lin AL. | Front Rehabil Sci | 10.3389/fresc.2022.1017180 | 2022 | ||
| Enzymology | Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters). | Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Suzuki T, Suzuki N. | Clin Rheumatol | 10.1007/s10067-018-04419-8 | 2019 | |
| Potential risk factors and outcomes of infection with multidrug resistance among diabetic patients having ulcers: 7 years study. | Zubair M, Ahmad J. | Diabetes Metab Syndr | 10.1016/j.dsx.2018.10.014 | 2019 | ||
| Effects of live and pasteurized forms of Lactobacillus casei Zhang on acute kidney injury and chronic renal fibrosis. | Wang X, Shi M, Cao C, Zeng R, Yao Y. | Braz J Microbiol | 10.1007/s42770-024-01491-y | 2024 | ||
| Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. | Dong W, Wang Y, Li H, Ma H, Gong Y, Luo G, Gao X. | Metabolites | 10.3390/metabo15070433 | 2025 | ||
| Prediction of microbe-drug associations based on a modified graph attention variational autoencoder and random forest. | Wang B, Ma F, Du X, Zhang G, Li J. | Front Microbiol | 10.3389/fmicb.2024.1394302 | 2024 | ||
| Metabolism | Gut microbiota-derived arginine metabolism mitigates intestinal ischemia-reperfusion injury. | Li X, Hou M, Lyu J, Min X, Han X, Wang X, Liu Z, Leng Y. | J Transl Med | 10.1186/s12967-025-07225-4 | 2025 | |
| Altered fecal microbial and metabolic profiles reveal potential mechanisms underlying anemia in patients with chronic renal failure. | Wang H, Xue W, Cheng J, He Y, Song Y, Hu D, Peng A, Li C, Bao H. | Microbiol Spectr | 10.1128/spectrum.03166-24 | 2025 | ||
| Metabolism | Relationship Between Gut Bacteria and Levodopa Metabolism. | Xu K, Sheng S, Zhang F. | Curr Neuropharmacol | 10.2174/1570159x21666221019115716 | 2023 | |
| Phylogeny | Selective Isolation of Eggerthella lenta from Human Faeces and Characterisation of the Species Prophage Diversity. | Buttimer C, Bottacini F, Shkoporov AN, Draper LA, Ross P, Hill C. | Microorganisms | 10.3390/microorganisms10010195 | 2022 | |
| Gut Bacterial Dysbiosis in Children with Intractable Epilepsy. | Lee K, Kim N, Shim JO, Kim GH. | J Clin Med | 10.3390/jcm10010005 | 2020 | ||
| Bifidobacterium as a Potential Biomarker of Sarcopenia in Elderly Women. | Wang Z, Xu X, Deji Y, Gao S, Wu C, Song Q, Shi Z, Xiang X, Zang J, Su J. | Nutrients | 10.3390/nu15051266 | 2023 | ||
| Metabolism | Computational analysis of the gut microbiota-mediated drug metabolism. | Chum S, Naveira Montalvo A, Hassoun S. | Comput Struct Biotechnol J | 10.1016/j.csbj.2025.03.016 | 2025 | |
| Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. | Cai J, Sun L, Gonzalez FJ. | Cell Host Microbe | 10.1016/j.chom.2022.02.004 | 2022 | ||
| The gut microbiota during tamoxifen therapy in patients with breast cancer. | Hillege LE, Barnett DJM, Ziemons J, Aarnoutse R, de Vos-Geelen J, van Geel R, de Boer M, van Riet YEA, Vincent J, Penders J, Smidt ML. | Sci Rep | 10.1038/s41598-025-91734-1 | 2025 | ||
| Expansion of Colorectal Cancer Biomarkers Based on Gut Bacteria and Viruses. | Zhang J, He Y, Xia L, Yi J, Wang Z, Zhao Y, Song X, Li J, Liu H, Liang X, Nie S, Liu L. | Cancers (Basel) | 10.3390/cancers14194662 | 2022 | ||
| Pathogenicity | Metabolic modeling of host-microbe interactions. | Srinak N, Kruger F, Kaleta C, Taubenheim J. | Comput Struct Biotechnol J | 10.1016/j.csbj.2025.10.006 | 2025 | |
| Targeted high-level production of chuangxinmycin and its halogenated derivatives with antitubercular activity. | Zhao X, Lu Y, Zhang X, Zhang X, Du Y, Han X, Zhu Y, Yu W, Wu L, Li X, Shi Y, Zhang T, Hong B. | Microb Cell Fact | 10.1186/s12934-025-02740-x | 2025 | ||
| Oral administration of pioglitazone inhibits pulmonary hypertension by regulating the gut microbiome and plasma metabolome in male rats. | Zhang Z, Liang Y, Mo S, Zhao M, Li Y, Zhang C, Shan X, Liu S, Liao J, Luo X, Zhu J, Wang C, Jiang Q, Hou C, Hong W, Lai N, Chen Y, Xu L, Lu W, Wang J, Wang Z, Yang K. | Physiol Rep | 10.14814/phy2.70174 | 2025 | ||
| Correlation between postmortem microbial signatures and substance abuse disorders. | Javan GT, Wells T, Allen J, Visona S, Moretti M, Tipton C, Scott L, Finley SJ. | PLoS One | 10.1371/journal.pone.0274401 | 2022 | ||
| Metabolism | Multi-Omics Analysis Reveals Aberrant Gut-Metabolome-Immune Network in Schizophrenia. | Fan Y, Gao Y, Ma Q, Yang Z, Zhao B, He X, Yang J, Yan B, Gao F, Qian L, Wang W, Zhu F, Ma X. | Front Immunol | 10.3389/fimmu.2022.812293 | 2022 | |
| Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship. | Menchinelli G, Oliveti A, Fiori B, D'Inzeo T, Spanu T, Murri R, Fantoni M, Sanguinetti M, Posteraro B, De Angelis G. | Heliyon | 10.1016/j.heliyon.2024.e27849 | 2024 | ||
| Phylogeny | A Sample-to-Report Solution for Taxonomic Identification of Cultured Bacteria in the Clinical Setting Based on Nanopore Sequencing. | Neuenschwander SM, Terrazos Miani MA, Amlang H, Perroulaz C, Bittel P, Casanova C, Droz S, Flandrois JP, Leib SL, Suter-Riniker F, Ramette A. | J Clin Microbiol | 10.1128/jcm.00060-20 | 2020 | |
| Enzymology | Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: Rapid identification and antimicrobial susceptibility profile. | Liderot K, Ratcliffe P, Luthje P, Thidholm E, Ozenci V. | Anaerobe | 10.1016/j.anaerobe.2015.11.005 | 2016 | |
| Uncovering the complexity of childhood undernutrition through strain-level analysis of the gut microbiome. | Chang B, Zhang W, Wang Y, Zhang Y, Zhong S, Gao P, Wang L, Zhao Z. | BMC Microbiol | 10.1186/s12866-024-03211-w | 2024 | ||
| Predicting microbial interactions with approaches based on flux balance analysis: an evaluation. | Joseph C, Zafeiropoulos H, Bernaerts K, Faust K. | BMC Bioinformatics | 10.1186/s12859-024-05651-7 | 2024 | ||
| Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review. | Wang JH, Choi Y, Lee JS, Hwang SJ, Gu J, Son CG. | Eur J Med Res | 10.1186/s40001-024-01747-1 | 2024 | ||
| Application of artificial intelligence approaches to predict the metabolism of xenobiotic molecules by human gut microbiome. | Malwe AS, Sharma VK. | Front Microbiol | 10.3389/fmicb.2023.1254073 | 2023 | ||
| Pathogenicity | [Effect of silver nanoparticles on anaerobic bacteria]. | Vecerova R, Panacek A, Kolar M. | Klin Mikrobiol Infekc Lek | 2017 | ||
| Microbiological Assessment of the FilmArray Blood Culture Identification 2 Panel: Potential Impact in Critically Ill Patients. | Mauri C, Consonni A, Briozzo E, Giubbi C, Meroni E, Tonolo S, Luzzaro F. | Antibiotics (Basel) | 10.3390/antibiotics12081247 | 2023 | ||
| Phylogeny | Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples. | Nowicki C, Ray L, Engen P, Madrigrano A, Witt T, Lad T, Cobleigh M, Mutlu EA. | Front Microbiol | 10.3389/fmicb.2023.1148097 | 2023 | |
| Exploring the role of gut microbiota in advancing personalized medicine. | Huang G, Khan R, Zheng Y, Lee PC, Li Q, Khan I. | Front Microbiol | 10.3389/fmicb.2023.1274925 | 2023 | ||
| Blood lipids mediate the effects of gut microbiome on endometriosis: a mendelian randomization study. | Su C, Wan S, Ding J, Ni G, Ding H. | Lipids Health Dis | 10.1186/s12944-024-02096-y | 2024 | ||
| Genetics | Host origin of microbiota drives functional recovery and Clostridioides difficile clearance in mice. | Millard SA, Vendrov KC, Young VB, Seekatz AM. | mBio | 10.1128/mbio.01108-25 | 2025 | |
| Severe Cognitive Decline in Long-term Care Is Related to Gut Microbiome Production of Metabolites Involved in Neurotransmission, Immunomodulation, and Autophagy. | Shoubridge AP, Carpenter L, Flynn E, Papanicolas LE, Collins J, Gordon D, Lynn DJ, Whitehead C, Leong LEX, Cations M, De Souza DP, Narayana VK, Choo JM, Wesselingh SL, Crotty M, Inacio MC, Ivey K, Taylor SL, Rogers GB. | J Gerontol A Biol Sci Med Sci | 10.1093/gerona/glaf053 | 2025 | ||
| Chronological age estimation from human microbiomes with transformer-based Robust Principal Component Analysis. | Myers T, Song SJ, Chen Y, De Pessemier B, Khatib L, McDonald D, Huang S, Gallo R, Callewaert C, Havulinna AS, Lahti L, Roeselers G, Laiola M, Shetty SA, Kelley ST, Knight R, Bartko A. | Commun Biol | 10.1038/s42003-025-08590-y | 2025 | ||
| Pathogenicity | Bibliometric and visual analysis of human microbiome-breast cancer interactions: current insights and future directions. | Zhou Y, Jiang M, Li X, Shen K, Zong H, Lv Q, Shen B. | Front Microbiol | 10.3389/fmicb.2024.1490007 | 2024 | |
| Genetics | Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy. | Liang X, Zhang S, Zhang D, Hu L, Zhang, Peng Y, Xu Y, Hou H, Zou C, Liu X, Chen Y, Lu F. | Front Mol Biosci | 10.3389/fmolb.2022.970723 | 2022 | |
| Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response. | Sun J, Chen J, Xie Q, Sun M, Zhang W, Wang H, Liu N, Wang Q, Wang M. | J Inflamm (Lond) | 10.1186/s12950-023-00363-w | 2023 | ||
| Pathogenicity | Cocoa Polyphenols Alter the Fecal Microbiome Without Mitigating Colitis in Mice Fed Healthy or Western Basal Diets | Stewart E, Almatani M, Hayden M, Rompato G, Case J, Rice S, Hintze K, Benninghoff A. | Nutrients | 2025 | ||
| Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions. | Speckmann B, Ehring E, Hu J, Rodriguez Mateos A. | Gut Microbes | 10.1080/19490976.2024.2305716 | 2024 | ||
| Deciphering unique and shared interactions between the human gut microbiota and oral antidiabetic drugs. | Ren H, Shi Z, Yang F, Wang S, Yuan F, Li T, Li M, Zhu J, Li J, Wu K, Zhang Y, Ning G, Kristiansen K, Wang W, Gu Y, Zhong H. | Imeta | 10.1002/imt2.179 | 2024 | ||
| Pathogenicity | Alterations in Gut Microbiota and Serum Metabolites in Children with Mycoplasma pneumoniae Pneumonia. | Wang S, Liu C, Ding R, Wang S, Ye Y, He M. | Infect Drug Resist | 10.2147/idr.s490547 | 2024 | |
| Participation of gut microbiota and bacterial translocation in chronic systemic inflammation in recently diagnosed rheumatoid arthritis patients. | Dunyach-Remy C, Pouget C, Pers YM, Gaujoux-Viala C, Demattei C, Salipante F, Grenga L, Armengaud J, Lavigne JP, Jorgensen C. | Curr Res Microb Sci | 10.1016/j.crmicr.2025.100366 | 2025 | ||
| Stimulation of Codonopsis pilosula Polysaccharide on Bifidobacterium of Human Gut Bacteria In Vitro. | Li J, Dong L, Liu Y, Gao J. | Evid Based Complement Alternat Med | 10.1155/2021/9524913 | 2021 | ||
| Pathogenicity | The swine IsoLoop model of the gut host-microbiota interface enables intra-animal treatment comparisons to advance 3R principles. | Bayne J, Charavaryamath C, Hu Y, Yousefi F, Murphy M, Law A, Michael A, Muyyarikkandy MS, Nibbering B, Smits WK, Kuijper E, Opriessnig T, Sauer M, Scaria J, Sponseller B, Ramirez A, Mooyottu S. | Gut Microbes | 10.1080/19490976.2025.2568706 | 2025 | |
| Smoking-induced gut microbial dysbiosis mediates cancer progression through modulation of anti-tumor immune response. | Sharma P, Jain T, Sorgen A, Iyer S, Tarique M, Roy P, Kurtom S, Sethi V, Bava EP, Gutierrez-Garcia AK, Vaish U, Suresh DS, Sahay P, Edwards D, Afghani J, Putluri S, Reddy KRK, Amara CS, Kamal AHM, Fodor A, Dudeja V. | iScience | 10.1016/j.isci.2025.112002 | 2025 | ||
| Echinacea purpurea (L.) Moench Polysaccharide Alleviates DSS-Induced Colitis in Rats by Restoring Th17/Treg Balance and Regulating Intestinal Flora. | Li Y, Lin Y, Zheng X, Zheng X, Yan M, Wang H, Liu C. | Foods | 10.3390/foods12234265 | 2023 | ||
| The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers. | Carbia C, Bastiaanssen TFS, Iannone LF, Garcia-Cabrerizo R, Boscaini S, Berding K, Strain CR, Clarke G, Stanton C, Dinan TG, Cryan JF. | EBioMedicine | 10.1016/j.ebiom.2023.104442 | 2023 | ||
| The gut microbiome, chronic kidney disease, and sarcopenia. | Zheng G, Cao J, Wang XH, He W, Wang B. | Cell Commun Signal | 10.1186/s12964-024-01922-1 | 2024 | ||
| Antimicrobial Susceptibility Patterns and Wild-Type MIC Distributions of Anaerobic Bacteria at a German University Hospital: A Five-Year Retrospective Study (2015-2019). | Badr MT, Blumel B, Baumgartner S, Komp JMA, Hacker G. | Antibiotics (Basel) | 10.3390/antibiotics9110823 | 2020 | ||
| Phylogeny | The influence of blood on the human gut microbiome. | Chenard T, Malick M, Dube J, Masse E. | BMC Microbiol | 10.1186/s12866-020-01724-8 | 2020 | |
| Enzymology | Performance of two blood culture systems to detect anaerobic bacteria. Is there any difference? | Mueller-Premru M, Jeverica S, Papst L, Nagy E. | Anaerobe | 10.1016/j.anaerobe.2017.03.006 | 2017 | |
| Metabolism | The influence of the gut microbiome on BCG-induced trained immunity. | Strazar M, Mourits VP, Koeken VACM, de Bree LCJ, Moorlag SJCFM, Joosten LAB, van Crevel R, Vlamakis H, Netea MG, Xavier RJ. | Genome Biol | 10.1186/s13059-021-02482-0 | 2021 | |
| Precision microbiota therapy for IBD: premise and promise. | Nagayama M, Gogokhia L, Longman RS. | Gut Microbes | 10.1080/19490976.2025.2489067 | 2025 | ||
| Bacterial pathogens in pediatric appendicitis: a comprehensive retrospective study. | Felber J, Gross B, Rahrisch A, Waltersbacher E, Trips E, Schrottner P, Fitze G, Schultz J. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1027769 | 2023 | ||
| Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome. | Brushett S, Gacesa R, Vich Vila A, Brandao Gois MF, Andreu-Sanchez S, Swarte JC, Klaassen MAY, Collij V, Sinha T, Bolte LA, Wu J, Swertz M, de Kroon MLA, Reijneveld SA, Wijmenga C, Weersma RK, Fu J, van Loo HM, Kurilshikov A, Zhernakova A. | Gut Microbes | 10.1080/19490976.2023.2281360 | 2023 | ||
| Genetics | Loss of Novel Diversity in Human Gut Microbiota Associated with Ongoing Urbanization in China. | Sun S, Wang H, Howard AG, Zhang J, Su C, Wang Z, Du S, Fodor AA, Gordon-Larsen P, Zhang B. | mSystems | 10.1128/msystems.00200-22 | 2022 | |
| Intestinal microbiome and maternal mental health: preventing parental stress and enhancing resilience in mothers. | Matsunaga M, Takeuchi M, Watanabe S, Takeda AK, Kikusui T, Mogi K, Nagasawa M, Hagihara K, Myowa M. | Commun Biol | 10.1038/s42003-024-05884-5 | 2024 | ||
| Astragalus Polysaccharide Modulates the Gut Microbiota and Metabolites of Patients with Type 2 Diabetes in an In Vitro Fermentation Model. | Zhang X, Jia L, Ma Q, Zhang X, Chen M, Liu F, Zhang T, Jia W, Zhu L, Qi W, Wang N. | Nutrients | 10.3390/nu16111698 | 2024 | ||
| Genetics | Quercetin positively affects gene expression profiles and metabolic pathway of antibiotic-treated mouse gut microbiota. | Mi W, Hu Z, Xu L, Bian X, Lian W, Yin S, Zhao S, Gao W, Guo C, Shi T. | Front Microbiol | 10.3389/fmicb.2022.983358 | 2022 | |
| Exposure to environmental pollutants selects for xenobiotic-degrading functions in the human gut microbiome. | De Filippis F, Valentino V, Sequino G, Borriello G, Riccardi MG, Pierri B, Cerino P, Pizzolante A, Pasolli E, Esposito M, Limone A, Ercolini D. | Nat Commun | 10.1038/s41467-024-48739-7 | 2024 | ||
| Enteric Fistulous Communication with an Aortobifemoral Graft Permitting for Eggerthella Lenta Colonization. | Jehangir W, Sanabria F, Singh Z, Enakuaa S, Bedran KH, Raoof N, Yousif A. | J Glob Infect Dis | 10.4103/0974-777x.170506 | 2015 | ||
| Human gut bacteria bioaccumulate per- and polyfluoroalkyl substances. | Lindell AE, Griesshammer A, Michaelis L, Papagiannidis D, Ochner H, Kamrad S, Guan R, Blasche S, Ventimiglia LN, Ramachandran B, Ozgur H, Zelezniak A, Beristain-Covarrubias N, Yam-Puc JC, Roux I, Barron LP, Richardson AK, Martin MG, Benes V, Morone N, Thaventhiran JED, Bharat TAM, Savitski MM, Maier L, Patil KR. | Nat Microbiol | 10.1038/s41564-025-02032-5 | 2025 | ||
| Synthesis of versatile neuromodulatory molecules by a gut microbial glutamate decarboxylase. | Dadi P, Pauling CW, Shrivastava A, Shah DD. | iScience | 10.1016/j.isci.2025.112289 | 2025 | ||
| Personalized modeling of gut microbiome metabolism throughout the first year of life. | Shaaban R, Busi SB, Wilmes P, Gueant JL, Heinken A. | Commun Med (Lond) | 10.1038/s43856-024-00715-4 | 2024 | ||
| Determination of Glycopeptide Resistance Genes and Virulence Factors in Vancomycin-Resistant Enterococci Isolates and the Relationship Between Glycopeptide Resistance Genes and Endogenous/Exogenous Flora. | Orak F, Yalcinkaya KT, Aydin F, Karakaya E, Doganer A, Mustak IB, Aral M, Ipek S. | J Clin Pract Res | 10.14744/cpr.2024.03419 | 2024 | ||
| Characteristics of Intestinal Microbiota in Japanese Patients with Mild Cognitive Impairment and a Risk-Estimating Method for the Disorder. | Hatayama K, Ebara A, Okuma K, Tokuno H, Hasuko K, Masuyama H, Ashikari I, Shirasawa T. | Biomedicines | 10.3390/biomedicines11071789 | 2023 | ||
| Genetics | Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes. | Ren Y, Chen L, Guo R, Ma S, Li S, Zhang Y, Jiang H, Shi H, Zhang P. | J Transl Med | 10.1186/s12967-024-05004-1 | 2024 | |
| Genetics | Changes in Gut Microbiota of Patients with Atopic Dermatitis During Balneotherapy. | Thirion F, Guilly S, Fromentin S, Plaza Onate F, Alvarez AS, Le Chatelier E, Pons N, Levenez F, Quinquis B, Ehrlich S, Dore J, Martin R, Seite S. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s342104 | 2022 | |
| The importance of personalization in high altitude protocols for hematologic and metabolic benefits in sports: A multi-dimensional N-of-1 case study. | Lili L, Meydan C, Rickard N, Zhang B. | Heliyon | 10.1016/j.heliyon.2023.e23159 | 2024 | ||
| Causal effects of the gut microbiome on COVID-19 susceptibility and severity: a two-sample Mendelian randomization study. | Zhong MM, Xie JH, Feng Y, Zhang SH, Xia JN, Tan L, Chen NX, Su XL, Zhang Q, Feng YZ, Guo Y. | Front Immunol | 10.3389/fimmu.2023.1173974 | 2023 | ||
| Metabolism | Systematic identification of secondary bile acid production genes in global microbiome. | Yang Y, Gao W, Zhu R, Tao L, Chen W, Zhu X, Shen M, Xu T, Zhao T, Zhang X, Zhu L, Jiao N. | mSystems | 10.1128/msystems.00817-24 | 2025 | |
| The Possible Preventative Role of Lactate- and Butyrate-Producing Bacteria in Colorectal Carcinogenesis. | Song CH, Kim N, Nam RH, Choi SI, Jang JY, Kim EH, Choi J, Choi Y, Yoon H, Lee SM, Seok YJ. | Gut Liver | 10.5009/gnl230385 | 2024 | ||
| Enzymology | Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope. | Nabeh OA. | Egypt Heart J | 10.1186/s43044-022-00325-2 | 2022 | |
| The gut-kidney axis in high-altitude hypoxia: pathophysiological mechanisms and the central role of hypoxia inducible factor. | Wu P, Li X, Long W, Ma Y, Xue B, Xie W, Ma X. | Ann Med | 10.1080/07853890.2025.2557514 | 2025 | ||
| Urinary Metabolic Profiling During Epileptogenesis in Rat Model of Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy. | Antmen FM, Matpan E, Dongel Dayanc E, Savas EO, Eken Y, Acar D, Ak A, Ozefe B, Sakar D, Canozer U, Sancak SN, Ozdemir O, Sezerman OU, Baykal AT, Serteser M, Suyen G. | Biomedicines | 10.3390/biomedicines13030588 | 2025 | ||
| Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy. | De Vincentis A, Santonico M, Del Chierico F, Altomare A, Marigliano B, Laudisio A, Reddel S, Grasso S, Zompanti A, Pennazza G, Putignani L, Guarino MPL, Cicala M, Antonelli Incalzi R. | Front Med (Lausanne) | 10.3389/fmed.2021.655474 | 2021 | ||
| Metabolism | Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria. | Wegner K, Just S, Gau L, Mueller H, Gerard P, Lepage P, Clavel T, Rohn S. | Anal Bioanal Chem | 10.1007/s00216-016-0048-1 | 2017 | |
| Integrative multiomics analysis reveals association of gut microbiota and its metabolites with susceptibility to keloids. | Li D, Li M, Gao H, Hu K, Xie R, Fan J, Huang M, Liao C, Han C, Guo Z, Chen X, Li M. | Front Microbiol | 10.3389/fmicb.2024.1475984 | 2024 | ||
| Pathogenicity | Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases. | Kumbhari A, Cheng TNH, Ananthakrishnan AN, Kochar B, Burke KE, Shannon K, Lau H, Xavier RJ, Smillie CS. | Cell Host Microbe | 10.1016/j.chom.2024.05.022 | 2024 | |
| Pathogenicity | Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective. | Lohia S, Vlahou A, Zoidakis J. | Toxins (Basel) | 10.3390/toxins14030176 | 2022 | |
| Pathogenicity | Perturbed gut microbiota and serum metabolites are associated with progressive renal fibrosis. | Wang RX, Zhou HB, Gao JX, Li XH, Bai WF, Wang J, Bai YC, Fan LY, Chang H, Shi SL. | Front Med (Lausanne) | 10.3389/fmed.2025.1489100 | 2025 | |
| Enzymology | Dynamics and diversity of the 'Atopobium cluster' in the human faecal microbiota, and phenotypic characterization of 'Atopobium cluster' isolates. | Thorasin T, Hoyles L, McCartney AL. | Microbiology (Reading) | 10.1099/mic.0.000016 | 2015 | |
| Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study. | Ivashkin V, Shifrin O, Maslennikov R, Poluektova E, Korolev A, Kudryavtseva A, Krasnov G, Benuni N, Barbara G. | BMC Gastroenterol | 10.1186/s12876-023-02690-x | 2023 | ||
| Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites. | Zhu J, Bao Z, Hu Z, Wu S, Tian C, Zhou Y, Ding Z, Tan X. | Nutr Diabetes | 10.1038/s41387-024-00268-4 | 2024 | ||
| Advances in understanding the role of gut microbiota in fat deposition and lipid metabolism. | Zhong Y, Lei Y, Jiang S, Chen D, Wang X, Wang K, Liao T, Liao R, Gan M, Niu L, Zhao Y, Chen L, Zhou X, Wang Y, Zhu L, Shen L. | J Anim Sci Biotechnol | 10.1186/s40104-025-01284-9 | 2025 | ||
| Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria. | Shrode RL, Knobbe JE, Cady N, Yadav M, Hoang J, Cherwin C, Curry M, Garje R, Vikas P, Sugg S, Phadke S, Filardo E, Mangalam AK. | Sci Rep | 10.1038/s41598-023-27436-3 | 2023 | ||
| Gut microbiota: a crucial player in the combat against tuberculosis. | Lin J, Chen D, Yan Y, Pi J, Xu J, Chen L, Zheng B. | Front Immunol | 10.3389/fimmu.2024.1442095 | 2024 | ||
| Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model. | Schumacher J, Muller P, Sulzer J, Faber F, Molitor B, Maier L. | Gut Microbes | 10.1080/19490976.2025.2519697 | 2025 | ||
| Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. | Little AS, Younker IT, Schechter MS, Bernardino PN, Meheust R, Stemczynski J, Scorza K, Mullowney MW, Sharan D, Waligurski E, Smith R, Ramaswamy R, Leiter W, Moran D, McMillin M, Odenwald MA, Iavarone AT, Sidebottom AM, Sundararajan A, Pamer EG, Eren AM, Light SH. | Nat Microbiol | 10.1038/s41564-023-01560-2 | 2024 | ||
| Metabolism | Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. | Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, Gao X, Zhu B, Lei XG, Gu Z, Cui W, Xu X, Li Z, Zhu B, Li Y, Chen S, Guo H, Zhang H, Sun J, Zhang M, Hui Y, Zhang X, Liu X, Sun B, Wang L, Qiu Q, Zhang Y, Li X, Liu W, Xue R, Wu H, Shao D, Li J, Zhou Y, Li S, Yang R, Pedersen OB, Yu Z, Ehrlich SD, Ren F. | Gut | 10.1136/gutjnl-2019-319766 | 2020 | |
| Microbiome function and neurodevelopment in Black infants: vitamin B12 emerges as a key factor. | Oliphant K, Cruz Ayala W, Ilyumzhinova R, Mbayiwa K, Sroka A, Xie B, Andrews B, Keenan K, Claud EC. | Gut Microbes | 10.1080/19490976.2023.2298697 | 2024 | ||
| Metagenomic and targeted metabolomic analyses reveal distinct phenotypes of the gut microbiota in patients with colorectal cancer and type 2 diabetes mellitus. | Yang Y, Han Z, Gao Z, Chen J, Song C, Xu J, Wang H, Huang A, Shi J, Gu J. | Chin Med J (Engl) | 10.1097/cm9.0000000000002421 | 2023 | ||
| Associations of fruit, whole grain, and total energy intakes with gut microbiome diversity and composition. | Wang Y, Zhang K, Dai L, Sun F, Wang D, Meng S, Zhao J, Liu Y, Liu W, Li C, Wang Y, Lu W, Zhu Y. | Food Nutr Res | 10.29219/fnr.v67.9725 | 2023 | ||
| Pathogenicity | Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract. | DeFilipp Z, Damania AV, Kim HT, Chang CC, El-Jawahri A, McAfee SL, Bottoms AS, Toncheva V, Smith MM, Dolaher M, Perry L, White M, Diana B, Connolly S, Dey BR, Frigault MJ, Newcomb RA, O'Donnell PV, Spitzer TR, Mansour MK, Weber D, Ajami NJ, Hohmann E, Jenq RR, Chen YB. | Blood Adv | 10.1182/bloodadvances.2024012556 | 2024 | |
| Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections. | Camelena F, Pean de Ponfilly G, Pailhories H, Bonzon L, Alanio A, Poncin T, Lafaurie M, Depret F, Cambau E, Godreuil S, Chenouard R, Le Monnier A, Jacquier H, Bercot B. | Microbiol Spectr | 10.1128/spectrum.02547-22 | 2023 | ||
| Microbiological diagnosis of pleural infections: a comparative evaluation of a novel syndromic real-time PCR panel. | Kommedal O, Eagan TM, Flotten O, Leegaard TM, Siljan W, Fardal H, Bo B, Grovan F, Larssen KW, Kildahl-Andersen A, Hjetland R, Tilseth R, Hareide SKO, Tellevik M, Dyrhovden R. | Microbiol Spectr | 10.1128/spectrum.03510-23 | 2024 | ||
| Genetics | Investigating Multi-Omic Signatures of Ethnicity and Dysglycaemia in Asian Chinese and European Caucasian Adults: Cross-Sectional Analysis of the TOFI_Asia Study at 4-Year Follow-Up. | Faraj S, Joblin-Mills A, Sequeira-Bisson IR, Leiu KH, Tung T, Wallbank JA, Fraser K, Miles-Chan JL, Poppitt SD, Taylor MW. | Metabolites | 10.3390/metabo15080522 | 2025 | |
| Randomised, Placebo-Controlled Investigation of the Impact of Probiotic Consumption on Gut Microbiota Diversity and the Faecal Metabolome in Seniors. | van Zanten GC, Madsen AL, Yde CC, Krych L, Yeung N, Saarinen MT, Kot W, Jensen HM, Rasmussen MA, Ouwehand AC, Nielsen DS. | Microorganisms | 10.3390/microorganisms12040796 | 2024 | ||
| Intestinal Metabolome for Diagnosing and Prognosing Autism Spectrum Disorder in Children: A Systematic Review. | Suarez-Jaramillo A, Cifuentes SG, Baldeon M, Cardenas P. | Metabolites | 10.3390/metabo15040213 | 2025 | ||
| Unraveling the key drivers of bacterial progesterone degradation. | Hernandez-Fernandez G, Ibero J, Garcia JL, Galan B. | mBio | 10.1128/mbio.01077-25 | 2025 | ||
| Application of MALDI-TOF MS to assess clinical characteristics, risk factors, and outcomes associated with anaerobic bloodstream infection: a retrospective observational study. | Watanabe T, Hara Y, Yoshimi Y, Yokoyama-Kokuryo W, Fujita Y, Yokoe M, Noguchi Y. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-021-00449-4 | 2021 | ||
| Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. | Heinken A, Hertel J, Acharya G, Ravcheev DA, Nyga M, Okpala OE, Hogan M, Magnusdottir S, Martinelli F, Nap B, Preciat G, Edirisinghe JN, Henry CS, Fleming RMT, Thiele I. | Nat Biotechnol | 10.1038/s41587-022-01628-0 | 2023 | ||
| Genetics | Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures. | Di Pilato V, Bonaiuto C, Morecchiato F, Antonelli A, Giani T, Rossolini GM. | EBioMedicine | 10.1016/j.ebiom.2025.105633 | 2025 | |
| Genetics | Butyric Acid Supplementation Reduces Changes in the Taxonomic and Functional Composition of Gut Microbiota Caused by H. pylori Eradication Therapy. | Abdulkhakov S, Markelova M, Safina D, Siniagina M, Khusnutdinova D, Abdulkhakov R, Grigoryeva T. | Microorganisms | 10.3390/microorganisms12020319 | 2024 | |
| Enzymology | A metagenome-wide association study of gut microbiota in asthma in UK adults. | Wang Q, Li F, Liang B, Liang Y, Chen S, Mo X, Ju Y, Zhao H, Jia H, Spector TD, Xie H, Guo R. | BMC Microbiol | 10.1186/s12866-018-1257-x | 2018 | |
| Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease. | Cheng G, Hardy M, Hillard CJ, Feix JB, Kalyanaraman B. | Commun Biol | 10.1038/s42003-024-06330-2 | 2024 | ||
| Phylogeny | Host-Microbiome Interactions Mediated by Phenolic Metabolites in Chronically Critically Ill Patients. | Chernevskaya E, Klimenko N, Pautova A, Buyakova I, Tyakht A, Beloborodova N. | Metabolites | 10.3390/metabo11020122 | 2021 | |
| Polyphenol-Rich Cranberry Beverage Positively Affected Skin Health, Skin Lipids, Skin Microbiome, Inflammation, and Oxidative Stress in Women in a Randomized Controlled Trial. | Christman L, De Benedetto A, Johnson E, Khoo C, Gu L. | Nutrients | 10.3390/nu16183126 | 2024 | ||
| Phylogeny | Microbiota profiling reveals alteration of gut microbial neurotransmitters in a mouse model of autism-associated 16p11.2 microduplication. | Fu Z, Yang X, Jiang Y, Mao X, Liu H, Yang Y, Chen J, Chen Z, Li H, Zhang XS, Mao X, Li N, Wang D, Jiang J. | Front Microbiol | 10.3389/fmicb.2024.1331130 | 2024 | |
| Pathogenicity | Causal associations of genetically predicted gut microbiota and blood metabolites with inflammatory states and risk of infections: a Mendelian randomization analysis. | Liu Y, Zhu Q, Guo G, Xie Z, Li S, Lai C, Wu Y, Wang L, Zhong S. | Front Microbiol | 10.3389/fmicb.2024.1342653 | 2024 | |
| Genetics | Framework for exploring the sensory repertoire of the human gut microbiota. | Ross PA, Xu W, Jalomo-Khayrova E, Bange G, Gumerov VM, Bradley PH, Sourjik V, Zhulin IB. | mBio | 10.1128/mbio.01039-24 | 2024 | |
| Pathogenicity | Innovative engineering approaches to model host-microbiome interactions in vitro. | Mancera Azamar KM, Sudi SD, Mohammadalizadeh Z, Coffin C, Parker IK, Porras AM. | Adv Drug Deliv Rev | 10.1016/j.addr.2025.115677 | 2025 | |
| Enzymology | Impact of Physical Exercise on Levodopa Therapy Across Parkinson's Disease Stages. | Figura M, Mrozowicz A, Milanowski L, Szlufik S, Rackowska E, Lypkan H, Friedman A, Koziorowski D, Giebultowicz J. | J Parkinsons Dis | 10.3233/jpd-230384 | 2024 | |
| Comparison of fidaxomicin, thuricin CD, vancomycin and nisin highlights the narrow spectrum nature of thuricin CD. | Walsh L, Lavelle A, O'Connor PM, Hill C, Ross RP. | Gut Microbes | 10.1080/19490976.2024.2342583 | 2024 | ||
| Genetics | Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome. | Crits-Christoph A, Hallowell HA, Koutouvalis K, Suez J. | Gut Microbes | 10.1080/19490976.2022.2055944 | 2022 | |
| Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity. | Jiao B, Ouyang Z, Liu Q, Xu T, Wan M, Ma G, Zhou L, Guo J, Wang J, Tang B, Zhao Z, Shen L. | Gut Microbes | 10.1080/19490976.2024.2331434 | 2024 | ||
| Genetics | Alterations in the gut virome are associated with type 2 diabetes and diabetic nephropathy. | Fan G, Cao F, Kuang T, Yi H, Zhao C, Wang L, Peng J, Zhuang Z, Xu T, Luo Y, Xie Y, Li H, Zhang K, Zeng Y, Zhang X, Peng S, Qiu X, Zhou D, Liang H, Yang B, Kang J, Liu Y, Zhang Y. | Gut Microbes | 10.1080/19490976.2023.2226925 | 2023 | |
| Risk and prognostic factors among patients with bacteremia due to Eggerthella lenta. | Venugopal AA, Szpunar S, Johnson LB. | Anaerobe | 10.1016/j.anaerobe.2012.05.005 | 2012 | ||
| Clinical characteristics of bloodstream infection by Parvimonas micra: retrospective case series and literature review. | Watanabe T, Hara Y, Yoshimi Y, Fujita Y, Yokoe M, Noguchi Y. | BMC Infect Dis | 10.1186/s12879-020-05305-y | 2020 | ||
| Metabolism | The Donor-Dependent and Colon-Region-Dependent Metabolism of (+)-Catechin by Colonic Microbiota in the Simulator of the Human Intestinal Microbial Ecosystem. | Li Q, Van Herreweghen F, De Mey M, Goeminne G, Van de Wiele T. | Molecules | 10.3390/molecules27010073 | 2021 | |
| Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection. | Padilha MDM, Melo FTV, Laurentino RV, da Silva ANMR, Feitosa RNM. | Braz J Infect Dis | 10.1016/j.bjid.2024.104468 | 2025 | ||
| Phylogeny | First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort study. | Rausch P, Ratjen I, Tittmann L, Enderle J, Wacker EM, Jaeger K, Ruhlemann MC, Franzpotter K, Ellul P, Kruse R, Halfvarson J, Roggenbuck D, Ellinghaus D, Jacobs G, Krawczak M, Schreiber S, Bang C, Lieb W, Franke A. | Gut Microbes | 10.1080/19490976.2025.2559119 | 2025 | |
| Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection. | Herrera G, Arboleda JC, Perez-Jaramillo JE, Patarroyo MA, Ramirez JD, Munoz M. | Microbiol Spectr | 10.1128/spectrum.00502-22 | 2022 | ||
| Prevalence of Oral Pathogen Slackia exigua among Clinical Orthodontic and Non-Orthodontic Saliva Samples. | Shen C, Simpson J, Clawson JB, Lam S, Kingsley K. | Microorganisms | 10.3390/microorganisms11040867 | 2023 | ||
| Genetics | Metagenomic analysis reveals distinct changes in the gut microbiome of obese Chinese children. | Li P, Jiang J, Li Y, Lan Y, Yang F, Wang J, Xie Y, Xiong F, Wu J, Liu H, Fan Z. | BMC Genomics | 10.1186/s12864-023-09805-4 | 2023 | |
| Immunoglobulin-coating patterns reveal altered humoral responses to gut bacteria in pediatric cow milk allergies. | Augustine T, Murugesan S, Badri F, Gentilcore G, Grivel JC, Akobeng A, Elawad M, Adeli M, Al Khodor S, van Panhuys N. | J Transl Med | 10.1186/s12967-024-05850-z | 2024 | ||
| Distribution, biosynthesis and therapeutic potential of lignans. | Plaha NS, Awasthi S, Sharma A, Kaushik N. | 3 Biotech | 10.1007/s13205-022-03318-9 | 2022 | ||
| Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy. | Amaro-da-Cruz A, Rubio-Tomas T, Alvarez-Mercado AI. | Clin Transl Oncol | 10.1007/s12094-024-03554-w | 2025 | ||
| Bacteremia caused by Eggerthella lenta in an elderly man with a gastrointestinal malignancy: A case report. | Wong D, Aoki F, Rubinstein E. | Can J Infect Dis Med Microbiol | 10.1155/2014/802481 | 2014 | ||
| The gut microbiome and metabolome in kidney transplant recipients with normal and moderately decreased kidney function. | Lan Y, Wang D, He J, Yang H, Hou Y, Di W, Wang H, Luo X, Wei L. | Ren Fail | 10.1080/0886022x.2023.2228419 | 2023 | ||
| Roles of gut microbiome in epilepsy risk: A Mendelian randomization study. | Zeng Y, Cao S, Yang H. | Front Microbiol | 10.3389/fmicb.2023.1115014 | 2023 | ||
| Bacteriophages targeting Enterococcus faecalis enhance the therapeutic efficacy of levodopa in an MPTP-induced Parkinson's disease mouse model with E. faecalis gut colonization. | Hong JP, Shin S, Chung SH, Song MC, Shim JG, Kim Y, Lee B, Yeom M, Park HJ, Jung KH, Hong J, Hahm DH. | Sci Rep | 10.1038/s41598-024-77038-w | 2024 | ||
| Is Piperacillin-Tazobactam an Appropriate Empirical Agent for Hospital-Acquired Sepsis and Community-Acquired Septic Shock of Unknown Origin in Australia? | Gage-Brown A, George C, Maleki J, Singh KP, Muhi S. | Healthcare (Basel) | 10.3390/healthcare10050851 | 2022 | ||
| Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities. | Xiao F, Gao X, Hu H, Le J, Chen Y, Shu X, Liang Z, Xu Y, Wang Y, Zhang T. | Nutrients | 10.3390/nu14214463 | 2022 | ||
| A New Perspective on the Health Benefits of Moderate Beer Consumption: Involvement of the Gut Microbiota. | Quesada-Molina M, Munoz-Garach A, Tinahones FJ, Moreno-Indias I. | Metabolites | 10.3390/metabo9110272 | 2019 | ||
| Maturation of the oral microbiota during primary teeth eruption: a longitudinal, preliminary study. | Xu H, Tian B, Shi W, Tian J, Wang W, Qin M. | J Oral Microbiol | 10.1080/20002297.2022.2051352 | 2022 | ||
| Pathogenicity | Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. | Faraci M, Bonaretti C, Dell'Orso G, Pierri F, Giardino S, Angiero F, Blasi S, Farronato G, Di Marco E, Trevisiol A, Olcese E, Rufino L, Squillario M, Biassoni R. | Sci Rep | 10.1038/s41598-024-55690-6 | 2024 | |
| Enzymology | Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysis. | Goupil R, Nadeau-Fredette AC, Tennankore KK, Bargman JM. | Perit Dial Int | 10.3747/pdi.2013.00046 | 2014 | |
| Phylogeny | Prediction of delayed graft function by early salivary microbiota following kidney transplantation. | Xiang X, Peng B, Liu K, Wang T, Ding P, Zhu Y, Cheng K, Ming Y, Ming Y. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13236-w | 2024 | |
| Enzymology | Eggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis. | Gardiner BJ, Korman TM, Junckerstorff RK. | J Clin Microbiol | 10.1128/jcm.03158-13 | 2014 | |
| The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications. | Menozzi E, Schapira AHV. | CNS Drugs | 10.1007/s40263-024-01073-4 | 2024 | ||
| Altered gut microbiota-host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern. | Du L, Zhang Z, Zhai L, Xu S, Yang W, Huang C, Lin C, Zhong LLD, Bian Z, Zhao L. | Chin Med | 10.1186/s13020-023-00795-9 | 2023 | ||
| Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure. | Kang Y, Chen S, Chen Y, Tian L, Wu Q, Zheng M, Li Z. | Int J Hyg Environ Health | 10.1016/j.ijheh.2021.113882 | 2022 | ||
| Enzymology | Eggerthella lenta bacteremia in a Crohn's disease patient after ileocecal resection. | Thota VR, Dacha S, Natarajan A, Nerad J. | Future Microbiol | 10.2217/fmb.11.31 | 2011 | |
| Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT). | Claeys KC, Hopkins TL, Schlaffer K, Hitchcock S, Jiang Y, Evans S, Johnson JK, Leekha S. | Antimicrob Agents Chemother | 10.1128/aac.00441-21 | 2021 | ||
| Differences in Gut Microbiome in Hospitalized Immunocompetent vs. Immunocompromised Children, Including Those With Sickle Cell Disease. | Mohandas S, Soma VL, Tran TDB, Sodergren E, Ambooken T, Goldman DL, Weinstock G, Herold BC. | Front Pediatr | 10.3389/fped.2020.583446 | 2020 | ||
| Phylogeny | Effect of Lactobacillus acidophilus D2/CSL (CECT 4529) supplementation in drinking water on chicken crop and caeca microbiome. | De Cesare A, Sala C, Castellani G, Astolfi A, Indio V, Giardini A, Manfreda G. | PLoS One | 10.1371/journal.pone.0228338 | 2020 | |
| Pathogenicity | A rare case of non-clostridial infection in a non-diabetic patient. | Darat HN, Kanodia AK, Yong A, Ram B. | BMJ Case Rep | 10.1136/bcr-2019-233467 | 2020 | |
| Complications of percutaneous nephrostomy in a district general hospital. | Turo R, Horsu S, Broome J, Das S, Gulur DM, Pettersson B, Doyle G, Awsare N. | Turk J Urol | 10.5152/tud.2018.37336 | 2018 | ||
| Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species. | Pidgeon R, Mitchell S, Shamash M, Suleiman L, Dridi L, Maurice CF, Castagner B. | Nat Commun | 10.1038/s41467-025-56266-2 | 2025 | ||
| Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. | Xie N, Wang Z, Shu Q, Liang X, Wang J, Wu K, Nie Y, Shi Y, Fan D, Wu J. | Nutrients | 10.3390/nu15132937 | 2023 | ||
| Distinctive patterns of sulfide- and butyrate-metabolizing bacteria after bariatric surgery: potential implications for colorectal cancer risk. | Hussan H, Clinton SK, Grainger EM, Webb M, Wang C, Webb A, Needleman B, Noria S, Zhu J, Choueiry F, Pietrzak M, Bailey MT. | Gut Microbes | 10.1080/19490976.2023.2255345 | 2023 | ||
| Enzymology | Fecal microbiome profiles of neonatal dairy calves with varying severities of gastrointestinal disease. | Slanzon GS, Ridenhour BJ, Moore DA, Sischo WM, Parrish LM, Trombetta SC, McConnel CS. | PLoS One | 10.1371/journal.pone.0262317 | 2022 | |
| Enzymology | Paediatric splenic and rectovesical pouch abscesses caused by Eggerthella lenta. | Kondo S, Okada H, Shimono R, Kusaka T. | BMJ Case Rep | 10.1136/bcr-2015-209584 | 2015 | |
| Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort. | Gradisteanu Pircalabioru G, Chifiriuc MC, Picu A, Petcu LM, Trandafir M, Savu O. | Int J Mol Sci | 10.3390/ijms232315023 | 2022 | ||
| Pathogenicity | Polyphenols-Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics. | Plamada D, Vodnar DC. | Nutrients | 10.3390/nu14010137 | 2021 | |
| Pathogenicity | Effects of Iron and Zinc Biofortified Foods on Gut Microbiota In Vivo (Gallus gallus): A Systematic Review. | Juste Contin Gomes M, Stampini Duarte Martino H, Tako E. | Nutrients | 10.3390/nu13010189 | 2021 | |
| Metabolism | Intestinal microbiome and digoxin inactivation: meal plan for digoxin users? | Lu L, Wu Y, Zuo L, Luo X, Large PJ. | World J Microbiol Biotechnol | 10.1007/s11274-013-1507-x | 2014 | |
| Oral Cardiac Drug-Gut Microbiota Interaction in Chronic Heart Failure Patients: An Emerging Association. | Paraskevaidis I, Briasoulis A, Tsougos E. | Int J Mol Sci | 10.3390/ijms25031716 | 2024 | ||
| CMV Ileitis: To Treat or Not to Treat? Implications of Initiating Biologic Therapy for Concurrent Crohn's Disease. | Stilwell KT, Estes J, Kurtz MT, Francis JM, Lynch DT, Patel AA. | Case Rep Gastrointest Med | 10.1155/2019/4513795 | 2019 | ||
| Exploring Antimycobacterial Potential: Safety Evaluation and Active Compound Isolation from Gymnopilus junonius. | Didloff J, Boukes GJ, Nyambe MN, Beukes DR, Lerata MS, Vilane V, Lee M, Govender S, van de Venter M. | Antibiotics (Basel) | 10.3390/antibiotics14020179 | 2025 | ||
| Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease. | Liu H, Liu H, Liu C, Shang M, Wei T, Yin P. | Front Mol Biosci | 10.3389/fmolb.2022.841223 | 2022 | ||
| Utility of synovial calprotectin lateral flow test to exclude chronic prosthetic joint infection in periprosthetic fractures: a prospective cohort study. | Lazic I, Burdach A, Pohlig F, von Eisenhart-Rothe R, Suren C. | Sci Rep | 10.1038/s41598-022-22892-9 | 2022 | ||
| Enzymology | High levels of Bifidobacteria are associated with increased levels of anthocyanin microbial metabolites: a randomized clinical trial. | Boto-Ordonez M, Urpi-Sarda M, Queipo-Ortuno MI, Tulipani S, Tinahones FJ, Andres-Lacueva C. | Food Funct | 10.1039/c4fo00029c | 2014 | |
| Microbiome Single Cell Atlases Generated with a Commercial Instrument. | Li X, Xu L, Demaree B, Noecker C, Bisanz JE, Weisgerber DW, Modavi C, Turnbaugh PJ, Abate AR. | Adv Sci (Weinh) | 10.1002/advs.202409338 | 2025 | ||
| Phylogeny | Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome. | Gargari G, Mantegazza G, Cremon C, Taverniti V, Valenza A, Barbaro MR, Marasco G, Duncan R, Fiore W, Ferrari R, De Vitis V, Barbara G, Guglielmetti S. | Gut Microbes | 10.1080/19490976.2023.2298246 | 2024 | |
| Gut microbiome health and dysbiosis: A clinical primer. | Bidell MR, Hobbs ALV, Lodise TP. | Pharmacotherapy | 10.1002/phar.2731 | 2022 | ||
| Longitudinal exposure to antiseizure medications shape gut-derived microbiome, resistome, and metabolome landscape. | Dop C, Auvin S, Mondot S, Lepage P, Ilhan ZE. | ISME Commun | 10.1093/ismeco/ycae123 | 2024 | ||
| Genetics | Pharmacogenomic and Pharmacomicrobiomic Aspects of Drugs of Abuse. | Borrego-Ruiz A, Borrego JJ. | Genes (Basel) | 10.3390/genes16040403 | 2025 | |
| Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients. | Soltys K, Stuchlikova M, Hlavaty T, Gaalova B, Budis J, Gazdarica J, Krajcovicova A, Zelinkova Z, Szemes T, Kuba D, Drahovska H, Turna J, Stuchlik S. | Sci Rep | 10.1038/s41598-020-62811-4 | 2020 | ||
| The first cultivated representatives of the actinobacterial lineage OPB41 isolated from subsurface environments constitute a novel order Anaerosomatales. | Khomyakova MA, Zavarzina DG, Merkel AY, Klyukina AA, Pikhtereva VA, Gavrilov SN, Slobodkin AI. | Front Microbiol | 10.3389/fmicb.2022.1047580 | 2022 | ||
| Metabolism | Metabolism of Soy Isoflavones by Intestinal Bacteria: Genome Analysis of an Adlercreutzia Equolifaciens Strain That Does Not Produce Equol. | Vazquez L, Florez AB, Redruello B, Mayo B. | Biomolecules | 10.3390/biom10060950 | 2020 | |
| Disseminated Infection Caused by Eggerthella lenta in a Previously Healthy Young Man: A Case Report. | Salameh A, Klotz SA, Zangeneh TT. | Case Rep Infect Dis | 10.1155/2012/517637 | 2012 | ||
| Aortic graft infection with enteric organism after embolization of late type II endoleak. | Li B, Tan KT, MacDonald ME, Byrne J. | J Vasc Surg Cases Innov Tech | 10.1016/j.jvscit.2018.10.009 | 2019 | ||
| Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography. | Shuwen H, Yinhang W, Xingming Z, Jing Z, Jinxin L, Wei W, Kefeng D. | Gut Pathog | 10.1186/s13099-022-00524-x | 2022 | ||
| Phylogeny | Comparison of Periodontal Bacteria of Edo and Modern Periods Using Novel Diagnostic Approach for Periodontitis With Micro-CT. | Shiba T, Komatsu K, Sudo T, Sawafuji R, Saso A, Ueda S, Watanabe T, Nemoto T, Kano C, Nagai T, Ohsugi Y, Katagiri S, Takeuchi Y, Kobayashi H, Iwata T. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.723821 | 2021 | |
| Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission. | Pisani A, Rausch P, Bang C, Ellul S, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P. | Microbiol Spectr | 10.1128/spectrum.00616-22 | 2022 | ||
| Structural and functional properties of a plant NRAMP-related aluminum transporter. | Ramanadane K, Liziczai M, Markovic D, Straub MS, Rosalen GT, Udovcic A, Dutzler R, Manatschal C. | Elife | 10.7554/elife.85641 | 2023 | ||
| Characterization of the gut microbiota and fecal and blood metabolomes under various factors in urban children from Northwest China. | Yang Y, Chen J, Gao H, Cui M, Zhu M, Xiang X, Wang Q. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1374544 | 2024 | ||
| Metabolism | Gut bacterial deamination of residual levodopa medication for Parkinson's disease. | van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Permentier H, Keshavarzian A, El Aidy S. | BMC Biol | 10.1186/s12915-020-00876-3 | 2020 | |
| In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections. | Goldstein EJC, Citron DM, Tyrrell KL, Leoncio ES. | Antimicrob Agents Chemother | 10.1128/aac.01401-17 | 2017 | ||
| Small bowel perforation by toothpick. | Lai CMS, Lui TH. | BMJ Case Rep | 10.1136/bcr-2018-225258 | 2018 | ||
| A novel pathway of levodopa metabolism by commensal Bifidobacteria. | Cirstea MS, Creus-Cuadros A, Lo C, Yu AC, Serapio-Palacios A, Neilson S, Appel-Cresswell S, Finlay BB. | Sci Rep | 10.1038/s41598-023-45953-z | 2023 | ||
| Pathogenicity | DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy. | Zaragoza-Garcia O, Castro-Alarcon N, Perez-Rubio G, Guzman-Guzman IP. | Biomolecules | 10.3390/biom10111479 | 2020 | |
| Enzymology | Eggerthella lenta as a cause of anaerobic spondylodiscitis. | Bok CW, Ng YS. | Singapore Med J | 2009 | ||
| Sensitivity and specificity of subgingival bacteria in predicting preterm birth- a pilot cohort study. | Hassan KS, El Tantawi MM, Alagl AS, Alnimr AM, Haseeb YA. | Int J Health Sci (Qassim) | 10.12816/0049657 | 2016 | ||
| Gut microbiome and cardiovascular disease. | Zhao Y, Wang Z. | Curr Opin Cardiol | 10.1097/hco.0000000000000720 | 2020 | ||
| Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis. | Plichta DR, Somani J, Pichaud M, Wallace ZS, Fernandes AD, Perugino CA, Lahdesmaki H, Stone JH, Vlamakis H, Chung DC, Khanna D, Pillai S, Xavier RJ. | Genome Med | 10.1186/s13073-021-00853-7 | 2021 | ||
| Environmental and intrinsic factors shaping gut microbiota composition and diversity and its relation to metabolic health in children and early adolescents: A population-based study. | Moran-Ramos S, Lopez-Contreras BE, Villarruel-Vazquez R, Ocampo-Medina E, Macias-Kauffer L, Martinez-Medina JN, Villamil-Ramirez H, Leon-Mimila P, Del Rio-Navarro BE, Ibarra-Gonzalez I, Vela-Amieva M, Gomez-Perez FJ, Velazquez-Cruz R, Salmeron J, Reyes-Castillo Z, Aguilar-Salinas C, Canizales-Quinteros S. | Gut Microbes | 10.1080/19490976.2020.1712985 | 2020 | ||
| Osteoimmunology in periodontitis; a paradigm for Th17/IL-17 inflammatory bone loss. | Ikeuchi T, Moutsopoulos NM. | Bone | 10.1016/j.bone.2022.116500 | 2022 | ||
| Transcriptome | Engraftment of essential functions through multiple fecal microbiota transplants in chronic antibiotic-resistant pouchitis-a case study using metatranscriptomics. | Deng ZL, Pieper DH, Stallmach A, Steube A, Vital M, Reck M, Wagner-Dobler I. | Microbiome | 10.1186/s40168-023-01713-9 | 2023 | |
| A microbial causal mediation analytic tool for health disparity and applications in body mass index. | Wang C, Ahn J, Tarpey T, Yi SS, Hayes RB, Li H. | Microbiome | 10.1186/s40168-023-01608-9 | 2023 | ||
| Enzymology | Isolation of catechin-converting human intestinal bacteria. | Kutschera M, Engst W, Blaut M, Braune A. | J Appl Microbiol | 10.1111/j.1365-2672.2011.05025.x | 2011 | |
| Metabolism | Fucose ameliorates the proinflammatory property of Fusobacterium nucleatum in colitis via altering its metabolism. | Duan C, Hou L, Deng X, Wu J, Qian W, Han C, Hou X. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1190602 | 2023 | |
| Metabolism | Therapeutic Potential of Metabolites from Lactobacillus rhamnosus and Mare's Milk in the Treatment of Dysbiosis. | Kozhakhmetov S, Babenko D, Kozhakhmetova S, Tuyakova A, Nurgaziyev M, Nurgozhina A, Muhanbetganov N, Chulenbayeva L, Sergazy S, Gulyayev A, Aljofan M, Kushugulova A. | Biomed Res Int | 10.1155/2022/3851478 | 2022 | |
| Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation With Response to Neoadjuvant Therapy. | White MG, Damania A, Alshenaifi J, Sahasrabhojane P, Peacock O, Losh J, Wong MC, Lutter-Berkova Z, Chang GJ, Futreal A, Wargo JA, Ajami NJ, Kopetz S, You YN. | Ann Surg | 10.1097/sla.0000000000006015 | 2023 | ||
| A decade of insight: bibliometric analysis of gut microbiota's role in osteoporosis (2014-2024). | Luo ZQ, Huang YJ, Chen ZH, Lu CY, Zhou B, Gong XH, Shen Z, Wang T. | Front Med (Lausanne) | 10.3389/fmed.2024.1409534 | 2024 | ||
| Feeding Practice and Delivery Mode Are Determinants of Vitamin K in the Infant Gut: An Exploratory Analysis. | Ellis JL, Wang M, Fu X, Fields CJ, Donovan SM, Booth SL. | Curr Dev Nutr | 10.1093/cdn/nzac019 | 2022 | ||
| Metabolism | Colonic microflora and plasma metabolite-based comparative analysis of unilateral ureteral obstruction-induced chronic kidney disease after treatment with the Chinese medicine FuZhengHuaYuJiangZhuTongLuo and AST-120. | Chen Z, Wu S, Huang L, Li J, Li X, Zeng Y, Chen Z, Chen M. | Heliyon | 10.1016/j.heliyon.2024.e24987 | 2024 | |
| Nutrition, hydration and supplementation considerations for mountaineers in high-altitude conditions: a narrative review. | Karpecka-Galka E, Fraczek B. | Front Sports Act Living | 10.3389/fspor.2024.1435494 | 2024 | ||
| Emerging Targets and Treatments for Sarcopenia: A Narrative Review. | Cacciatore S, Calvani R, Esposito I, Massaro C, Gava G, Picca A, Tosato M, Marzetti E, Landi F. | Nutrients | 10.3390/nu16193271 | 2024 | ||
| Chronic Ulcers and Malnutrition in an African Patient. | Singer TG, Bray MA, Chan A, Ikeda S, Walters B, Fuller MY, Falco C. | Pediatrics | 10.1542/peds.2020-1717 | 2020 | ||
| Phytochemicals From Vicia faba Beans as Ligands of the Aryl Hydrocarbon Receptor to Regulate Autoimmune Diseases. | Mendez-Lopez LF, Sosa de Leon D, Lopez-Cabanillas Lomeli M, Gonzalez-Martinez BE, Vazquez-Rodriguez JA. | Front Nutr | 10.3389/fnut.2022.790440 | 2022 | ||
| Phylogeny | Machine learning-causal inference based on multi-omics data reveals the association of altered gut bacteria and bile acid metabolism with neonatal jaundice. | Chen W, Zhang P, Zhang X, Xiao T, Zeng J, Guo K, Qiu H, Cheng G, Wang Z, Zhou W, Zeng S, Wang M. | Gut Microbes | 10.1080/19490976.2024.2388805 | 2024 | |
| A maltose-regulated large genomic region is activated by the transcriptional regulator MalT in Actinoplanes sp. SE50/110. | Droste J, Kulisch M, Wolf T, Schaffert L, Schneiker-Bekel S, Puhler A, Kalinowski J. | Appl Microbiol Biotechnol | 10.1007/s00253-020-10923-2 | 2020 | ||
| NNAN: Nearest Neighbor Attention Network to Predict Drug-Microbe Associations. | Zhu B, Xu Y, Zhao P, Yiu SM, Yu H, Shi JY. | Front Microbiol | 10.3389/fmicb.2022.846915 | 2022 | ||
| Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome. | Kawano Y, Edwards M, Huang Y, Bilate AM, Araujo LP, Tanoue T, Atarashi K, Ladinsky MS, Reiner SL, Wang HH, Mucida D, Honda K, Ivanov II. | Cell | 10.1016/j.cell.2022.08.005 | 2022 | ||
| Enzymology | [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents - Special references to bacteria isolated between April 2011 and March 2012]. | Shinagawa N, Taniguchi M, Hirata K, Furuhata T, Mizuguchi T, Osanai H, Yanai Y, Hata F, Kihara C, Sasaki K, Oono K, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Watabe K, Hoshikawa T, Oshima H, Aikawa N, Sasaki J, Suzuki M, Sekine K, Abe S, Takeyama H, Wakasugi T, Mashita K, Tanaka M, Mizuno A, Ishikawa M, Iwai A, Saito T, Muramoto M, Kubo S, Lee S, Fukuhara K, Kobayashi Y, Yamaue H, Hirono S, Takesue Y, Fujiwara T, Shinoura S, Kimura H, Iwagaki H, Tokunaga N, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Tsumura H, Kanehiro T, Takeuchi H, Tanakaya K, Iwasaki M. | Jpn J Antibiot | 2014 | ||
| Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview. | Li G, Hou Y, Zhang C, Zhou X, Bao F, Yang Y, Chen L, Yu D. | Cell Mol Gastroenterol Hepatol | 10.1016/j.jcmgh.2024.05.003 | 2024 | ||
| Pathogenicity | CRISPR-Cas spacer acquisition is a rare event in human gut microbiome. | Zhang AN, Gaston JM, Cardenas P, Zhao S, Gu X, Alm EJ. | Cell Genom | 10.1016/j.xgen.2024.100725 | 2025 | |
| A Scoping Review of Gut Microbiome and Bifidobacterium Research in Zimbabwe: Implications for Future Studies. | Zhou DT, Mudhluli TE, Hall LJ, Manasa J, Munyati S. | Pediatric Health Med Ther | 10.2147/phmt.s414766 | 2023 | ||
| Metabolism | Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria. | Bess EN, Bisanz JE, Yarza F, Bustion A, Rich BE, Li X, Kitamura S, Waligurski E, Ang QY, Alba DL, Spanogiannopoulos P, Nayfach S, Koliwad SK, Wolan DW, Franke AA, Turnbaugh PJ. | Nat Microbiol | 10.1038/s41564-019-0596-1 | 2020 | |
| Identification of the Microbial Transformation Products of Secoisolariciresinol Using an Untargeted Metabolomics Approach and Evaluation of the Osteogenic Activities of the Metabolites. | Yu WX, Tang HH, Ye JJ, Xiao HH, Lam CY, Shum TF, Sun ZK, Li YZ, Zang XY, Du WC, Zhang JP, Kong TH, Zhou LP, Chiou JC, Kung CF, Mok KW, Hu J, Wong MS. | Molecules | 10.3390/molecules28155742 | 2023 | ||
| Multiple Pyogenic Liver Abscesses Caused by Eggerthella lenta Treated with Ertapenem: A Case Report. | Elias RM, Khoo SY, Pupaibool J, Nienaber JH, Cummins NW. | Case Rep Med | 10.1155/2012/718130 | 2012 | ||
| Genetics | Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. | Zhang Y, Han S, Xiao X, Zheng L, Chen Y, Zhang Z, Gao X, Zhou S, Yu K, Huang L, Fu J, Hong Y, Jiang J, Qian W, Yang H, Shen J. | Front Immunol | 10.3389/fimmu.2023.1146861 | 2023 | |
| Enzymology | [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2010 and March 2011]. | Shinagawa N, Taniguchi M, Hirata K, Furuhata T, Fukuhara K, Mizugucwi T, Osanai H, Yanai Y, Hata F, Kihara C, Sasaki K, Oono K, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Watabe K, Kobayashi Y, Yamaue H, Hirono S, Takesue Y, Fujiwara T, Shinoura S, Kimura H, Hoshikawa T, Oshima H, Aikawa N, Sasaki J, Suzuki M, Sekine K, Abe S, Takeyama H, Wakasugi T, Mashita K, Tanaka M, Mizuno A, Ishikawa M, Iwai A, Saito T, Muramoto M, Kubo S, Lee S, Fukuhara K, Iwagaki H, Tokunaga N, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Tsumura H, Kanehiro T, Takeuchi H, Tanakaya K, Iwasaki M. | Jpn J Antibiot | 2014 | ||
| Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours | Ruiz-Saavedra S, Zapico A, Gonzalez S, Salazar N, de los Reyes-Gavilan C. | Microbiome Res Rep | 2023 | |||
| Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population. | Iadsee N, Chuaypen N, Techawiwattanaboon T, Jinato T, Patcharatrakul T, Malakorn S, Petchlorlian A, Praditpornsilpa K, Patarakul K. | Sci Rep | 10.1038/s41598-023-33794-9 | 2023 | ||
| Lactobacillus Intestinalis Primes Epithelial Cells to Suppress Colitis-Related Th17 Response by Host-Microbe Retinoic Acid Biosynthesis. | Wang QW, Jia DJ, He JM, Sun Y, Qian Y, Ge QW, Qi YD, Wang QY, Hu YY, Wang L, Fang YF, He HQ, Luo M, Feng LJ, Si JM, Song ZF, Wang LJ, Chen SJ. | Adv Sci (Weinh) | 10.1002/advs.202303457 | 2023 | ||
| Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort. | Neri-Rosario D, Martinez-Lopez YE, Esquivel-Hernandez DA, Sanchez-Castaneda JP, Padron-Manrique C, Vazquez-Jimenez A, Giron-Villalobos D, Resendis-Antonio O. | Front Endocrinol (Lausanne) | 10.3389/fendo.2023.1170459 | 2023 | ||
| Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant. | Wang YZ, Zhou JG, Lu YM, Hu H, Xiao FF, Ge T, Wang X, Zheng L, Yu LH, Le J, Yu H, Yu GJ, Xia Q, Zhang T, Zhou WH. | World J Pediatr | 10.1007/s12519-022-00659-6 | 2023 | ||
| The Implication of the Gut Microbiome in Heart Failure. | Lupu VV, Adam Raileanu A, Mihai CM, Morariu ID, Lupu A, Starcea IM, Frasinariu OE, Mocanu A, Dragan F, Fotea S. | Cells | 10.3390/cells12081158 | 2023 | ||
| Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). | Peters BA, Qi Q, Usyk M, Daviglus ML, Cai J, Franceschini N, Lash JP, Gellman MD, Yu B, Boerwinkle E, Knight R, Burk RD, Kaplan RC. | Gut Microbes | 10.1080/19490976.2023.2186685 | 2023 | ||
| Metabolism | Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. | Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. | Science | 10.1126/science.aau6323 | 2019 | |
| Pathogenicity | Characterizing the Effects of Calcium and Prebiotic Fiber on Human Gut Microbiota Composition and Function Using a Randomized Crossover Design-A Feasibility Study. | Yoon LS, Michels KB. | Nutrients | 10.3390/nu13061937 | 2021 | |
| Genetics | Characterization and Spatial Mapping of the Human Gut Metasecretome. | Velez-Cortes F, Wang H. | mSystems | 10.1128/msystems.00717-22 | 2022 | |
| Pathogenicity | Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome. | Hamrefors V, Kahn F, Holmqvist M, Carlson K, Varjus R, Gudjonsson A, Fedorowski A, Ohlsson B. | Sci Rep | 10.1038/s41598-024-53784-9 | 2024 | |
| Metabolism | Bacterial species involved in the conversion of dietary flavonoids in the human gut. | Braune A, Blaut M. | Gut Microbes | 10.1080/19490976.2016.1158395 | 2016 | |
| Metabolism | Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease. | Denburg MR, Koepsell K, Lee JJ, Gerber J, Bittinger K, Tasian GE. | J Am Soc Nephrol | 10.1681/asn.2019101131 | 2020 | |
| Seasonal restructuring facilitates compositional convergence of gut microbiota in free-ranging rodents. | Klure DM, Dearing MD. | FEMS Microbiol Ecol | 10.1093/femsec/fiad127 | 2023 | ||
| Enzymology | Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats. | Zhou J, Zhang R, Guo P, Li P, Huang X, Wei Y, Yang C, Zhou J, Yang T, Liu Y, Shi S. | Front Microbiol | 10.3389/fmicb.2022.1032290 | 2022 | |
| Accelerometer-based physical activity is associated with the gut microbiota in 8416 individuals in SCAPIS. | Baldanzi G, Sayols-Baixeras S, Ekblom-Bak E, Ekblom O, Dekkers KF, Hammar U, Nguyen D, Ahmad S, Ericson U, Arvidsson D, Borjesson M, Johanson PJ, Smith JG, Bergstrom G, Lind L, Engstrom G, Arnlov J, Kennedy B, Orho-Melander M, Fall T. | EBioMedicine | 10.1016/j.ebiom.2024.104989 | 2024 | ||
| Influence of Bifidobacterium breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial. | Chaiyasut C, Sivamaruthi BS, Lailerd N, Sirilun S, Thangaleela S, Khongtan S, Bharathi M, Kesika P, Saelee M, Choeisoongnern T, Fukngoen P, Peerajan S, Sittiprapaporn P. | Pharmaceuticals (Basel) | 10.3390/ph16050695 | 2023 | ||
| Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease. | Margiotta E, Miragoli F, Callegari ML, Vettoretti S, Caldiroli L, Meneghini M, Zanoni F, Messa P. | PLoS One | 10.1371/journal.pone.0228530 | 2020 | ||
| Metabolism | Identification of Human Gut Microbiome Associated with Enterolignan Production. | Sawane K, Hosomi K, Park J, Ookoshi K, Nanri H, Nakagata T, Chen YA, Mohsen A, Kawashima H, Mizuguchi K, Miyachi M, Kunisawa J. | Microorganisms | 10.3390/microorganisms10112169 | 2022 | |
| Pathogenicity | An exploration of alginate oligosaccharides modulating intestinal inflammatory networks via gut microbiota. | Zhang Z, Wang X, Li F. | Front Microbiol | 10.3389/fmicb.2023.1072151 | 2023 | |
| Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality. | Molinaro A, Nemet I, Bel Lassen P, Chakaroun R, Nielsen T, Aron-Wisnewsky J, Bergh PO, Li L, Henricsson M, Kober L, Isnard R, Helft G, Stumvoll M, Pedersen O, Smith JG, Tang WHW, Clement K, Hazen SL, Backhed F, MetaCardis Consortium. | JACC Heart Fail | 10.1016/j.jchf.2023.03.008 | 2023 | ||
| Pathogenicity | Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease. | Lindner S, Miltiadous O, Ramos RJF, Paredes J, Kousa AI, Dai A, Fei T, Lauder E, Frame J, Waters NR, Sadeghi K, Armijo GK, Ghale R, Victor K, Gipson B, Monette S, Russo MV, Nguyen CL, Slingerland J, Taur Y, Markey KA, Andrlova H, Giralt S, Perales MA, Reddy P, Peled JU, Smith M, Cross JR, Burgos da Silva M, Campbell C, van den Brink MRM. | Nat Microbiol | 10.1038/s41564-024-01617-w | 2024 | |
| Characterization of the Interindividual Variability Associated with the Microbial Metabolism of (-)-Epicatechin. | Lessard-Lord J, Roussel C, Guay V, Desjardins Y. | J Agric Food Chem | 10.1021/acs.jafc.3c05491 | 2023 | ||
| Pathogenicity | Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. | Queipo-Ortuno MI, Boto-Ordonez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andres-Lacueva C, Tinahones FJ. | Am J Clin Nutr | 10.3945/ajcn.111.027847 | 2012 | |
| Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. | Qin Y, Tong X, Mei WJ, Cheng Y, Zou Y, Han K, Yu J, Jie Z, Zhang T, Zhu S, Jin X, Wang J, Yang H, Xu X, Zhong H, Xiao L, Ding PR. | Nat Commun | 10.1038/s41467-024-47523-x | 2024 | ||
| The microbial-derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota. | Kisthardt SC, Thanissery R, Pike CM, Foley MH, Theriot CM. | J Bacteriol | 10.1128/jb.00180-23 | 2023 | ||
| Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study. | Bermingham KM, Linenberg I, Hall WL, Kade K, Franks PW, Davies R, Wolf J, Hadjigeorgiou G, Asnicar F, Segata N, Manson JE, Newson LR, Delahanty LM, Ordovas JM, Chan AT, Spector TD, Valdes AM, Berry SE. | EBioMedicine | 10.1016/j.ebiom.2022.104303 | 2022 | ||
| Phylogeny | Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients. | Dangtakot R, Intuyod K, Ahooja A, Wongwiwatchai J, Hanpanich P, Lulitanond A, Chamgramol Y, Pinlaor S, Pinlaor P. | Asian Pac J Cancer Prev | 10.31557/apjcp.2021.22.1.233 | 2021 | |
| Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma. | Chen Y, Ma J, Dong Y, Yang Z, Zhao N, Liu Q, Zhai W, Zheng J. | Front Microbiol | 10.3389/fmicb.2022.913718 | 2022 | ||
| Metabolism | A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols. | Maini Rekdal V, Nol Bernadino P, Luescher MU, Kiamehr S, Le C, Bisanz JE, Turnbaugh PJ, Bess EN, Balskus EP. | Elife | 10.7554/elife.50845 | 2020 | |
| Metabolism | Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. | Mabrok HB, Klopfleisch R, Ghanem KZ, Clavel T, Blaut M, Loh G. | Carcinogenesis | 10.1093/carcin/bgr256 | 2012 | |
| Metabolism | Bacterial conversion of secoisolariciresinol and anhydrosecoisolariciresinol. | Struijs K, Vincken JP, Gruppen H. | J Appl Microbiol | 10.1111/j.1365-2672.2009.04209.x | 2009 | |
| Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial. | Gao P, Rinott E, Dong D, Mei Z, Wang F, Liu Y, Kamer O, Yaskolka Meir A, Tuohy KM, Bluher M, Stumvoll M, Stampfer MJ, Shai I, Wang DD. | Gut Microbes | 10.1080/19490976.2024.2426610 | 2024 | ||
| Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity. | Kunika, Frey N, Rangrez AY. | Int J Mol Sci | 10.3390/ijms24087261 | 2023 | ||
| Alteration of Skin Microbiome in CKD Patients Is Associated With Pruritus and Renal Function. | Tian Y, Gu C, Yan F, Gu Y, Feng Y, Chen J, Sheng J, Hu L, Jiang P, Guo W, Feng N. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.923581 | 2022 | ||
| Strain diversity in the microbiome: Lessons from Bacteroides fragilis. | Carrow HC, Batachari LE, Chu H. | PLoS Pathog | 10.1371/journal.ppat.1009056 | 2020 | ||
| Frailty and Age-Associated Assessments Associated with Chronic Kidney Disease and Transplantation Outcomes. | Fulinara CP, Huynh A, Goldwater D, Abdalla B, Schaenman J. | J Transplant | 10.1155/2023/1510259 | 2023 | ||
| Anaerobes in diabetic foot infections: pathophysiology, epidemiology, virulence, and management. | Villa F, Marchandin H, Lavigne J-P, Schuldiner S, Cellier N, Sotto A, Loubet P. | Clin Microbiol Rev | 10.1128/cmr.00143-23 | 2024 | ||
| Genetics | Making Millennial Medicine More Meta. | Turnbaugh PJ. | mSystems | 10.1128/msystems.00154-17 | 2018 | |
| Diet-microbiota associations in gastrointestinal research: a systematic review. | Duncanson K, Williams G, Hoedt EC, Collins CE, Keely S, Talley NJ. | Gut Microbes | 10.1080/19490976.2024.2350785 | 2024 | ||
| Gut Microbiota Exceeds Cervical Microbiota for Early Diagnosis of Endometriosis. | Huang L, Liu B, Liu Z, Feng W, Liu M, Wang Y, Peng D, Fu X, Zhu H, Cui Z, Xie L, Ma Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.788836 | 2021 | ||
| Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis. | Hua Z, Xu L, Zhu J, Xiao L, Lu B, Wu J, Wu Z, Zhou Q, Zhang J. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1221433 | 2023 | ||
| A genome-wide association study for gut metagenome in Chinese adults illuminates complex diseases. | Liu X, Tang S, Zhong H, Tong X, Jie Z, Ding Q, Wang D, Guo R, Xiao L, Xu X, Yang H, Wang J, Zong Y, Liu W, Liu X, Zhang Y, Brix S, Kristiansen K, Hou Y, Jia H, Zhang T. | Cell Discov | 10.1038/s41421-020-00239-w | 2021 | ||
| Pathogenicity | Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species. | Byun JH, Kim M, Lee Y, Lee K, Chong Y. | Ann Lab Med | 10.3343/alm.2019.39.2.190 | 2019 | |
| Enzymology | Effect of Gut Microbiota on the Pharmacokinetics of Nifedipine in Spontaneously Hypertensive Rats. | Zhou R, Yang H, Zhu P, Liu Y, Zhang Y, Zhang W, Zhou H, Li X, Li Q. | Pharmaceutics | 10.3390/pharmaceutics15082085 | 2023 | |
| Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. | Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, Vuyisich M, Naliboff BD, Lackner JM, Gupta A, Tillisch K, Mayer EA. | Microbiome | 10.1186/s40168-022-01450-5 | 2023 | ||
| Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes. | Bao L, Zhang Y, Zhang G, Jiang D, Yan D. | Commun Biol | 10.1038/s42003-023-04591-x | 2023 | ||
| Compliance with Nutritional Recommendations and Gut Microbiota Profile in Galician Overweight/Obese and Normal-Weight Individuals. | Sinisterra-Loaiza L, Alonso-Lovera P, Cardelle-Cobas A, Miranda JM, Vazquez BI, Cepeda A. | Nutrients | 10.3390/nu15153418 | 2023 | ||
| Genetics | Iron Biofortified Carioca Bean (Phaseolus vulgaris L.)-Based Brazilian Diet Delivers More Absorbable Iron and Affects the Gut Microbiota In Vivo (Gallus gallus). | Dias DM, Kolba N, Binyamin D, Ziv O, Regini Nutti M, Martino HSD, Glahn RP, Koren O, Tako E. | Nutrients | 10.3390/nu10121970 | 2018 | |
| Genetics | The Depletion of Carbohydrate Metabolic Genes in the Gut Microbiome Contributes to the Transition From Central Obesity to Type 2 Diabetes. | Jia R, Huang M, Qian L, Yan X, Lv Q, Ye H, Ye L, Wu X, Chen W, Chen Y, Jia Y, Huang Y, Wu H. | Front Endocrinol (Lausanne) | 10.3389/fendo.2021.747646 | 2021 | |
| Periodontal status and the incidence of selected bacterial pathogens in periodontal pockets and vascular walls in patients with atherosclerosis and abdominal aortic aneurysms. | Kregielczak A, Dorocka-Bobkowska B, Slomski R, Oszkinis G, Krasinski Z. | PLoS One | 10.1371/journal.pone.0270177 | 2022 | ||
| Enzymology | Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans. | Liderot K, Larsson M, Borang S, Ozenci V. | J Clin Microbiol | 10.1128/jcm.02481-09 | 2010 | |
| Pathogenicity | Impact of Variations in Test Method Parameters on In Vitro Activity of Surotomycin against Clostridium difficile and Surotomycin Quality Control Limits for Broth Microdilution and Agar Dilution Susceptibility Testing. | Traczewski MM, Deane J, Sahm D, Brown SD, Chesnel L. | J Clin Microbiol | 10.1128/jcm.02881-15 | 2016 | |
| Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency. | Marcos-Kovandzic L, Avagliano M, Ben Khelil M, Srikanthan J, Abdallah R, Petrocelli V, Rengassamy J, Alfaro A, Bied M, Fidelle M, Ferrere G, Daillere R, Arbab A, Amine-Hneineh R, Pages A, Dartigues P, Ly P, Simon S, Durand S, Gottschlich A, Ginhoux F, Bleriot C, Liu P, Zhao L, Creusot L, Rolhion N, Derosa L, Kroemer G, Menger L, Kobold S, Castilla-Llorente C, Sokol H, Casola S, Pasolli E, Zitvogel L, Bigenwald C. | Cancer Discov | 10.1158/2159-8290.cd-24-1230 | 2025 | ||
| Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data. | Chen H, Ou R, Tang N, Su W, Yang R, Yu X, Zhang G, Jiao J, Zhou X. | J Transl Med | 10.1186/s12967-023-03953-7 | 2023 | ||
| Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. | Lindell AE, Zimmermann-Kogadeeva M, Patil KR. | Nat Rev Microbiol | 10.1038/s41579-022-00681-5 | 2022 | ||
| Adjuvant Injections Altered the Ileal and Fecal Microbiota Differently with Changes in Immunoglobulin Isotypes and Antimycobacterial Antibody Responses. | Khadka S, Omura S, Sato F, Tsunoda I. | Int J Mol Sci | 10.3390/ijms24032818 | 2023 | ||
| Genetics | Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease. | Hacker D, Siebert K, Smith BJ, Kohler N, Riva A, Mahapatra A, Heimes H, Nie J, Metwaly A, Holz H, Manz Q, De Zen F, Heetmeyer J, Socas K, Le Thi G, Meng C, Kleigrewe K, Pauling JK, Neuhaus K, List M, Pollard KS, Schwerd T, Haller D. | Cell Host Microbe | 10.1016/j.chom.2024.10.001 | 2024 | |
| Metabolism | Heterogeneity in gut microbiota drive polyphenol metabolism that influences alpha-synuclein misfolding and toxicity. | Ho L, Zhao D, Ono K, Ruan K, Mogno I, Tsuji M, Carry E, Brathwaite J, Sims S, Frolinger T, Westfall S, Mazzola P, Wu Q, Hao K, Lloyd TE, Simon JE, Faith J, Pasinetti GM. | J Nutr Biochem | 10.1016/j.jnutbio.2018.10.019 | 2019 | |
| Grape seed and skin extract, a potential prebiotic with anti-obesity effect through gut microbiota modulation. | Mokrani M, Charradi K, Limam F, Aouani E, Urdaci MC. | Gut Pathog | 10.1186/s13099-022-00505-0 | 2022 | ||
| Enzymology | Clinical and microbiological characteristics of Eggerthella lenta bacteremia. | Gardiner BJ, Tai AY, Kotsanas D, Francis MJ, Roberts SA, Ballard SA, Junckerstorff RK, Korman TM. | J Clin Microbiol | 10.1128/jcm.02926-14 | 2015 | |
| Metabolism | Bacterial transformation of dietary lignans in gnotobiotic rats. | Woting A, Clavel T, Loh G, Blaut M. | FEMS Microbiol Ecol | 10.1111/j.1574-6941.2010.00863.x | 2010 | |
| Key bacterial taxa determine longitudinal dynamics of aromatic amino acid catabolism in infants' gut. | Laursen MF, Sinha AK, Sinha AK, Pedersen M, Roager HM. | Gut Microbes | 10.1080/19490976.2023.2221426 | 2023 | ||
| Metabolism | Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. | Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. | Gut Microbes | 10.4161/gmic.27915 | 2014 | |
| Enzymology | Reconstruction of Acinetobacter johnsonii ICE_NC genome using hybrid de novo genome assemblies and identification of the 12alpha-hydroxysteroid dehydrogenase gene. | Favale N, Costa S, Scapoli C, Carrieri A, Sabbioni S, Tamburini E, Benazzo A, Bernacchia G. | J Appl Microbiol | 10.1111/jam.15657 | 2022 | |
| Metabolism | Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. | Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ. | Science | 10.1126/science.1235872 | 2013 | |
| Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis | You Y, Xiang T, Yang C, Xiao S, Tang Y, Luo G, Ling Z, Luo F, Chen Y. | Gut microbes | 2025 | |||
| Dysbiosis in Children With Neurological Impairment and Long-Term Enteral Nutrition. | Panelli S, Calcaterra V, Verduci E, Comandatore F, Pelizzo G, Borghi E, Bandi C, Zuccotti G. | Front Nutr | 10.3389/fnut.2022.895046 | 2022 | ||
| Pathogenicity | The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson's Disease Animal Models-A Systematic Review. | Panaitescu PS, Razniceanu V, Mocrei-Rebrean SM, Neculicioiu VS, Dragos HM, Costache C, Filip GA. | Curr Issues Mol Biol | 10.3390/cimb46050244 | 2024 | |
| Methanogenic patterns in the gut microbiome are associated with survival in a population of feral horses. | Stothart MR, McLoughlin PD, Medill SA, Greuel RJ, Wilson AJ, Poissant J. | Nat Commun | 10.1038/s41467-024-49963-x | 2024 | ||
| Phylogeny | A prebiotic intervention study in children with autism spectrum disorders (ASDs). | Grimaldi R, Gibson GR, Gibson GR, Vulevic J, Giallourou N, Castro-Mejia JL, Hansen LH, Leigh Gibson E, Nielsen DS, Costabile A. | Microbiome | 10.1186/s40168-018-0523-3 | 2018 | |
| Enzymology | Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010. | Lee MR, Huang YT, Liao CH, Chuang TY, Wang WJ, Lee SW, Lee LN, Hsueh PR. | J Clin Microbiol | 10.1128/jcm.00548-12 | 2012 | |
| Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. | Lee JWJ, Plichta D, Hogstrom L, Borren NZ, Lau H, Gregory SM, Tan W, Khalili H, Clish C, Vlamakis H, Xavier RJ, Ananthakrishnan AN. | Cell Host Microbe | 10.1016/j.chom.2021.06.019 | 2021 | ||
| Metabolism | Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport. | Zheng S, Wang H, Han J, Dai X, Lv Y, Sun T, Liu H. | iScience | 10.1016/j.isci.2023.108092 | 2023 | |
| Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis. | Dahal RH, Kim S, Kim YK, Kim ES, Kim J. | Front Microbiol | 10.3389/fmicb.2023.1174832 | 2023 | ||
| Metabolism | Gut Microbiota as a Source of Uremic Toxins. | Popkov VA, Zharikova AA, Demchenko EA, Andrianova NV, Zorov DB, Plotnikov EY. | Int J Mol Sci | 10.3390/ijms23010483 | 2022 | |
| Scanning Electron Microscope: A New Potential Tool to Replace Gram Staining for Microbe Identification in Blood Cultures. | Haddad G, Bellali S, Takakura T, Fontanini A, Ominami Y, Bou Khalil J, Raoult D. | Microorganisms | 10.3390/microorganisms9061170 | 2021 | ||
| Genetics | OperomeDB: A Database of Condition-Specific Transcription Units in Prokaryotic Genomes. | Chetal K, Janga SC. | Biomed Res Int | 10.1155/2015/318217 | 2015 | |
| Metabolism | INTEDE: interactome of drug-metabolizing enzymes. | Yin J, Li F, Zhou Y, Mou M, Lu Y, Chen K, Xue J, Luo Y, Fu J, He X, Gao J, Zeng S, Yu L, Zhu F. | Nucleic Acids Res | 10.1093/nar/gkaa755 | 2021 | |
| A cross-sectional study identifying disparities in serum metabolic profiles among hypertensive patients with ISH, IDH and SDH subtypes. | Shen Y, Wang P, Yang X, Chen M, Dong Y, Li J. | Front Cardiovasc Med | 10.3389/fcvm.2023.1102754 | 2023 | ||
| Altered Gut Microbiota as a Potential Risk Factor for Coronary Artery Disease in Diabetes: A Two-Sample Bi-Directional Mendelian Randomization Study. | Zeng Z, Qiu J, Chen Y, Liang D, Wei F, Fu Y, Zhang J, Wei X, Zhang X, Tao J, Lin L, Zheng J. | Int J Med Sci | 10.7150/ijms.92131 | 2024 | ||
| Pathogenicity | Immunometabolic Analysis of Mobiluncus mulieris and Eggerthella sp. Reveals Novel Insights Into Their Pathogenic Contributions to the Hallmarks of Bacterial Vaginosis. | McKenzie R, Maarsingh JD, Laniewski P, Herbst-Kralovetz MM. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.759697 | 2021 | |
| Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis. | Cheng M, Zhao Y, Cui Y, Zhong C, Zha Y, Li S, Cao G, Li M, Zhang L, Ning K, Han J. | Ann Rheum Dis | 10.1136/ard-2022-222871 | 2022 | ||
| The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease. | Connors J, Dunn KA, Allott J, Bandsma R, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. | ISME J | 10.1038/s41396-019-0560-3 | 2020 | ||
| Gut-resident microorganisms and their genes are associated with cognition and neuroanatomy in children. | Bonham KS, Fahur Bottino G, McCann SH, Beauchemin J, Weisse E, Barry F, Cano Lorente R, RESONANCE Consortium, Huttenhower C, Bruchhage M, D'Sa V, Deoni S, Klepac-Ceraj V. | Sci Adv | 10.1126/sciadv.adi0497 | 2023 | ||
| Impact of the microbiota on solid organ transplant rejection. | Sepulveda M, Pirozzolo I, Alegre ML. | Curr Opin Organ Transplant | 10.1097/mot.0000000000000702 | 2019 | ||
| Delayed gut microbiota maturation in the first year of life is a hallmark of pediatric allergic disease. | Hoskinson C, Dai DLY, Del Bel KL, Becker AB, Moraes TJ, Mandhane PJ, Finlay BB, Simons E, Kozyrskyj AL, Azad MB, Subbarao P, Petersen C, Turvey SE. | Nat Commun | 10.1038/s41467-023-40336-4 | 2023 | ||
| "Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction. | Zheng H, Zhang C, Zhang J, Duan L. | Protein Cell | 10.1093/procel/pwad020 | 2023 | ||
| Enzymology | Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype. | Vernocchi P, Del Chierico F, Russo A, Majo F, Rossitto M, Valerio M, Casadei L, La Storia A, De Filippis F, Rizzo C, Manetti C, Paci P, Ercolini D, Marini F, Fiscarelli EV, Dallapiccola B, Lucidi V, Miccheli A, Putignani L. | PLoS One | 10.1371/journal.pone.0208171 | 2018 | |
| Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline. | Liu X, Wu J, Tang J, Xu Z, Zhou B, Liu Y, Hu F, Zhang G, Cheng R, Xia X, Chen Y, Wu H, Wang D, Yue J, Dong B, Fu J, Yu H, Dong B. | J Cachexia Sarcopenia Muscle | 10.1002/jcsm.13313 | 2023 | ||
| Implementing a multidisciplinary care bundle to reduce colon surgical site infections. | Park CM, Ha TS, Lee WY, Chung DR, Park YA, Choi JR, Jeong NY. | Ann Surg Treat Res | 10.4174/astr.2020.99.5.285 | 2020 | ||
| Metabolism | Completion of the gut microbial epi-bile acid pathway. | Doden HL, Wolf PG, Gaskins HR, Anantharaman K, Alves JMP, Ridlon JM. | Gut Microbes | 10.1080/19490976.2021.1907271 | 2021 | |
| Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. | Gao W, Gao X, Zhu L, Gao S, Sun R, Feng Z, Wu D, Liu Z, Zhu R, Jiao N. | Gut Microbes | 10.1080/19490976.2023.2245562 | 2023 | ||
| Phocaeicola vulgatus shapes the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile. | Sulaiman JE, Thompson J, Cheung PLK, Qian Y, Mill J, James I, Im H, Vivas EI, Simcox J, Venturelli OS. | Cell Host Microbe | 10.1016/j.chom.2024.12.001 | 2025 | ||
| Enzymology | The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome. | Enright EF, Gahan CG, Joyce SA, Griffin BT. | Yale J Biol Med | 2016 | ||
| Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. | Maeda Y, Motooka D, Kawasaki T, Oki H, Noda Y, Adachi Y, Niitsu T, Okamoto S, Tanaka K, Fukushima K, Amiya S, Hara R, Oguro-Igashira E, Matsuki T, Hirata H, Takeda Y, Kida H, Kumanogoh A, Nakamura S, Takeda K. | BMC Infect Dis | 10.1186/s12879-022-07358-7 | 2022 | ||
| Pathogenicity | Microbiota, IgA and Multiple Sclerosis. | Boussamet L, Rajoka MSR, Berthelot L. | Microorganisms | 10.3390/microorganisms10030617 | 2022 | |
| Pathogenicity | Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress. | Margiotta E, Caldiroli L, Callegari ML, Miragoli F, Zanoni F, Armelloni S, Rizzo V, Messa P, Vettoretti S. | Toxins (Basel) | 10.3390/toxins13070472 | 2021 | |
| Metabolism | Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis. | Probstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish G, Liesche-Starnecker F, Ramaglia V, Singh S, Tran EB, Barba P, Zorn K, Oechtering J, Forsberg K, Shiow LR, Henry RG, Graves J, Cree BAC, Hauser SL, Kuhle J, Gelfand JM, Andersen PM, Schlegel J, Turnbaugh PJ, Seeberger PH, Gommerman JL, Wilson MR, Schirmer L, Baranzini SE. | Sci Immunol | 10.1126/sciimmunol.abc7191 | 2020 | |
| Metabolism | Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria. | Jin JS, Nishihata T, Kakiuchi N, Hattori M. | Biol Pharm Bull | 10.1248/bpb.31.1621 | 2008 | |
| Pathogenicity | Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates. | Goldstein EJ, Citron DM, Tyrrell KL, Merriam CV. | Antimicrob Agents Chemother | 10.1128/aac.01136-13 | 2013 | |
| Phylogeny | Combining 16S rRNA gene variable regions enables high-resolution microbial community profiling. | Fuks G, Elgart M, Amir A, Zeisel A, Turnbaugh PJ, Soen Y, Shental N. | Microbiome | 10.1186/s40168-017-0396-x | 2018 | |
| Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans. | Halldin E, Eriksen AK, Brunius C, da Silva AB, Bronze M, Hanhineva K, Aura AM, Landberg R. | Mol Nutr Food Res | 10.1002/mnfr.201801159 | 2019 | ||
| Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review. | Ser HL, Au Yong SJ, Shafiee MN, Mokhtar NM, Ali RAR. | Microorganisms | 10.3390/microorganisms11020360 | 2023 | ||
| Towards geospatially-resolved public-health surveillance via wastewater sequencing. | Tierney BT, Foox J, Ryon KA, Butler D, Damle N, Young BG, Mozsary C, Babler KM, Yin X, Carattini Y, Andrews D, Lucaci AG, Solle NS, Kumar N, Shukla B, Vidovic D, Currall B, Williams SL, Schurer SC, Stevenson M, Amirali A, Beaver CC, Kobetz E, Boone MM, Reding B, Laine J, Comerford S, Lamar WE, Tallon JJ, Wain Hirschberg J, Proszynski J, Al Ghalith G, Can Kurt K, Sharkey ME, Church GM, Grills GS, Solo-Gabriele HM, Mason CE. | Nat Commun | 10.1038/s41467-024-52427-x | 2024 | ||
| Metabolism | Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice. | Belik J, Shifrin Y, Arning E, Bottiglieri T, Pan J, Daigneault MC, Allen-Vercoe E. | Sci Rep | 10.1038/srep39854 | 2017 | |
| The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control. | Choo JM, Martin AM, Taylor SL, Sun E, Mobegi FM, Kanno T, Richard A, Burr LD, Lingman S, Martin M, Keating DJ, Mason AJ, Rogers GB. | Microbiol Spectr | 10.1128/spectrum.00831-23 | 2023 | ||
| Toward an improved definition of a healthy microbiome for healthy aging. | Ghosh TS, Shanahan F, O'Toole PW. | Nat Aging | 10.1038/s43587-022-00306-9 | 2022 | ||
| Tutorial: Microbiome studies in drug metabolism. | Dodd D, Cann I. | Clin Transl Sci | 10.1111/cts.13416 | 2022 | ||
| Succinate-producing microbiota drives tuft cell hyperplasia to protect against Clostridioides difficile. | Kellogg TD, Ceglia S, Mortzfeld BM, Tanna TM, Zeamer AL, Mancini MR, Foley SE, Ward DV, Bhattarai SK, McCormick BA, Reboldi A, Bucci V. | J Exp Med | 10.1084/jem.20232055 | 2025 | ||
| Infant gut microbiota and environment associate with juvenile idiopathic arthritis many years prior to disease onset, especially in genetically vulnerable children. | Kindgren E, Ahrens AP, Triplett EW, Ludvigsson J. | EBioMedicine | 10.1016/j.ebiom.2023.104654 | 2023 | ||
| Comparative study of different liquid diets for dairy calves and the impact on performance and the bacterial community during diarrhea. | Coelho MG, Virginio Junior GF, Tomaluski CR, de Toledo AF, Reis ME, Donde SC, Mendes LW, Coutinho LL, Bittar CMM. | Sci Rep | 10.1038/s41598-022-17613-1 | 2022 | ||
| Breast Cancer Survivors and Healthy Women: Could Gut Microbiota Make a Difference?-"BiotaCancerSurvivors": A Case-Control Study. | Caleca T, Ribeiro P, Vitorino M, Menezes M, Sampaio-Alves M, Mendes AD, Vicente R, Negreiros I, Faria A, Costa DA. | Cancers (Basel) | 10.3390/cancers15030594 | 2023 | ||
| Effects of Alternative Administration Programs of a Synbiotic Supplement on Broiler Performance, Foot Pad Dermatitis, Caecal Microbiota, and Blood Metabolites. | Brugaletta G, De Cesare A, Zampiga M, Laghi L, Oliveri C, Zhu C, Manfreda G, Syed B, Valenzuela L, Sirri F. | Animals (Basel) | 10.3390/ani10030522 | 2020 | ||
| A grape seed and bilberry extract reduces blood pressure in individuals at risk of developing type 2 diabetes: the PRECISE study, a double-blind placebo-controlled cross-over intervention study. | Grohmann T, Walker AW, Russell WR, Hoggard N, Zhang X, Horgan G, de Roos B. | Front Nutr | 10.3389/fnut.2023.1139880 | 2023 | ||
| Butterflies in the gut: the interplay between intestinal microbiota and stress. | Lai TT, Liou CW, Tsai YH, Lin YY, Wu WL. | J Biomed Sci | 10.1186/s12929-023-00984-6 | 2023 | ||
| Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa. | Leon LM, Park AE, Borges AL, Zhang JY, Bondy-Denomy J. | Nucleic Acids Res | 10.1093/nar/gkab006 | 2021 | ||
| Pathogenicity | The Effects of High-Salt Gastric Intake on the Composition of the Intestinal Microbiota in Wistar Rats. | Dong Z, Liu Y, Pan H, Wang H, Wang X, Xu X, Xiao K, Liu M, Xu Z, Li L, Zhang Y. | Med Sci Monit | 10.12659/msm.922160 | 2020 | |
| Pathogenicity | Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions. | Bundgaard-Nielsen C, Lauritsen MB, Knudsen JK, Rold LS, Larsen MH, Hindersson P, Villadsen AB, Leutscher PDC, Hagstrom S, Nyegaard M, Sorensen S. | Gut Microbes | 10.1080/19490976.2023.2211923 | 2023 | |
| Phylogeny | DNA-DNA relatedness and phylogenetic positions of Slackia exigua, Slackia heliotrinireducens, Eggerthella lenta, and other related bacteria. | Nakazawa F, Hoshino E. | Oral Microbiol Immunol | 10.1111/j.1399-302x.2004.00162.x | 2004 | |
| Plant-Derived Nutraceuticals in Mental Health and Brain Function: Mechanisms of Action and Therapeutic Potential. | Borrego-Ruiz A, Borrego JJ. | Int J Mol Sci | 10.3390/ijms26188849 | 2025 | ||
| Genetics | The gut microbiome is a significant risk factor for future chronic lung disease. | Liu Y, Teo SM, Meric G, Tang HHF, Zhu Q, Sanders JG, Vazquez-Baeza Y, Verspoor K, Vartiainen VA, Jousilahti P, Lahti L, Niiranen T, Havulinna AS, Knight R, Salomaa V, Inouye M. | J Allergy Clin Immunol | 10.1016/j.jaci.2022.12.810 | 2023 | |
| Pathogenicity | Ridinilazole, a narrow spectrum antibiotic for treatment of Clostridioides difficile infection, enhances preservation of microbiota-dependent bile acids. | Qian X, Yanagi K, Kane AV, Alden N, Lei M, Snydman DR, Vickers RJ, Lee K, Thorpe CM. | Am J Physiol Gastrointest Liver Physiol | 10.1152/ajpgi.00046.2020 | 2020 | |
| Enzymology | Targeted Synthesis and Characterization of a Gene Cluster Encoding NAD(P)H-Dependent 3alpha-, 3beta-, and 12alpha-Hydroxysteroid Dehydrogenases from Eggerthella CAG:298, a Gut Metagenomic Sequence. | Mythen SM, Devendran S, Mendez-Garcia C, Cann I, Ridlon JM. | Appl Environ Microbiol | 10.1128/aem.02475-17 | 2018 | |
| Modulation of gut microbiota with Ayurveda diet and lifestyle: A review on its possible way to treat type 2 diabetes. | Chauhan A, Semwal DK, Semwal RB, Joshi SK, Adhana RK, Goswami MS. | Ayu | 10.4103/ayu.ayu_7_20 | 2022 | ||
| Methyl halide transferase-based gas reporters for quantification of filamentous bacteria in microdroplet emulsions. | Song X, Kong SJ, Seo S, Prabhakar RG, Shamoo Y. | Appl Environ Microbiol | 10.1128/aem.00764-23 | 2023 | ||
| The gut microbiome in microscopic polyangiitis with kidney involvement: common and unique alterations, clinical association and values for disease diagnosis and outcome prediction. | Yu B, Jin L, Chen Z, Nie W, Chen L, Ma Y, Chen H, Wu Y, Ma Y, Chen J, Han F. | Ann Transl Med | 10.21037/atm-21-1315 | 2021 | ||
| Gut microbiota and the prevalence and incidence of renal stones. | Kim HN, Kim JH, Chang Y, Yang D, Joo KJ, Cho YS, Park HJ, Kim HL, Ryu S. | Sci Rep | 10.1038/s41598-022-07796-y | 2022 | ||
| Phylogeny | Key Technologies for Progressing Discovery of Microbiome-Based Medicines. | Young RB, Marcelino VR, Chonwerawong M, Gulliver EL, Forster SC. | Front Microbiol | 10.3389/fmicb.2021.685935 | 2021 | |
| Enzymology | First report of Gordonibacter pamelaeae bacteremia. | Woo PC, Teng JL, Lam KK, Tse CW, Leung KW, Leung AW, Lau SK, Yuen KY. | J Clin Microbiol | 10.1128/jcm.01459-09 | 2010 | |
| Pathogenicity | Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites. | Jang WY, Kim MY, Cho JY. | Int J Mol Sci | 10.3390/ijms232415482 | 2022 | |
| Electroacupuncture modulates the intestinal microecology to improve intestinal motility in spinal cord injury rats. | Cheng J, Li W, Wang Y, Cao Q, Ni Y, Zhang W, Guo J, Chen B, Zang Y, Zhu Y. | Microb Biotechnol | 10.1111/1751-7915.13968 | 2022 | ||
| Pathogenicity | Role of Dietary Flavonoid Compounds in Driving Patterns of Microbial Community Assembly. | Ivey KL, Chan AT, Izard J, Cassidy A, Rogers GB, Rimm EB. | mBio | 10.1128/mbio.01205-19 | 2019 | |
| Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis. | Strauss JC, Haskey N, Ramay HR, Ghosh TS, Taylor LM, Yousuf M, Ohland C, McCoy KD, Ingram RJM, Ghosh S, Panaccione R, Raman M. | Int J Mol Sci | 10.3390/ijms24087323 | 2023 | ||
| Beyond Metabolism: The Complex Interplay Between Dietary Phytoestrogens, Gut Bacteria, and Cells of Nervous and Immune Systems. | Cady N, Peterson SR, Freedman SN, Mangalam AK. | Front Neurol | 10.3389/fneur.2020.00150 | 2020 | ||
| Metabolism | Complex influences of gut microbiome metabolism on various drug responses. | Chae S, Kim DJ, Cho JY. | Transl Clin Pharmacol | 10.12793/tcp.2020.28.e3 | 2020 | |
| Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders. | Proffitt C, Bidkhori G, Lee S, Tebani A, Mardinoglu A, Uhlen M, Moyes DL, Shoaie S. | iScience | 10.1016/j.isci.2022.104513 | 2022 | ||
| The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery. | Louca P, Meijnikman AS, Nogal A, Asnicar F, Attaye I, Vijay A, Kouraki A, Visconti A, Wong K, Berry SE, Leeming ER, Mompeo O, Tettamanzi F, Baleanu AF, Falchi M, Hadjigeorgiou G, Wolf J, Acherman YIZ, Van de Laar AW, Gerdes VEA, Michelotti GA, Franks PW, Segata N, Mangino M, Spector TD, Bulsiewicz WJ, Nieuwdorp M, Valdes AM, Menni C. | Cell Rep Med | 10.1016/j.xcrm.2023.100993 | 2023 | ||
| A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data. | Han W, Ye Y. | Pac Symp Biocomput | 10.1142/9789813279827_0022 | 2019 | ||
| Genetics | Shotgun Metagenomics of Gut Microbiota in Humans with up to Extreme Longevity and the Increasing Role of Xenobiotic Degradation. | Rampelli S, Soverini M, D'Amico F, Barone M, Tavella T, Monti D, Capri M, Astolfi A, Brigidi P, Biagi E, Franceschi C, Turroni S, Candela M. | mSystems | 10.1128/msystems.00124-20 | 2020 | |
| Pathogenicity | [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2009 and March 2010]. | Shinagawa N, Osanai H, Hirata K, Furuhata T, Mizukuchi T, Yanai Y, Hata F, Taniguchi M, Sasaki K, Someya T, Sasaki K, Oono K, Mizuno I, Shamoto T, Fukui T, Tokita S, Nakamura M, Mashita K, Shibuya H, Tanaka M, Hasegawa I, Kimura M, Oshima H, Maeda H, Ishikawa S, Mukaiya M, Kihara C, Mizuno A, Watabe K, Iwai A, Saito T, Hoshikawa T, Kimura H, Moori N, Sumita N, Jae-Hoon Y, Kubo S, Lee S, Aikawa N, Sekine K, Abe S, Oomura T, Takeyama H, Wakasugi T, Kobayashi Y, Tsuji T, Yamaue H, Ozawa S, Takesue Y, Fujiwara T, Tsumura H, Kimura H, Yokoyama T, Iwagaki H, Takeuchi H, Tanakaya K, Sueda T, Hiyama E, Murakami Y, Ohge H, Uemura K, Yasunami Y, Sasaki T. | Jpn J Antibiot | 2011 | ||
| Implication of Gut Microbiota in Cardiovascular Diseases. | Zhou W, Cheng Y, Zhu P, Nasser MI, Nasser MI, Zhang X, Zhao M. | Oxid Med Cell Longev | 10.1155/2020/5394096 | 2020 | ||
| Metabolism | Impact of outdoor nature-related activities on gut microbiota, fecal serotonin, and perceived stress in preschool children: the Play&Grow randomized controlled trial. | Sobko T, Liang S, Cheng WHG, Tun HM. | Sci Rep | 10.1038/s41598-020-78642-2 | 2020 | |
| Association between Gut Microbiome Composition and Rotavirus Vaccine Response among Nicaraguan Infants. | Fix J, Chandrashekhar K, Perez J, Bucardo F, Hudgens MG, Yuan L, Twitchell E, Azcarate-Peril MA, Vilchez S, Becker-Dreps S. | Am J Trop Med Hyg | 10.4269/ajtmh.19-0355 | 2020 | ||
| Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism. | Daniel SL, Ridlon JM. | FEMS Microbiol Rev | 10.1093/femsre/fuaf016 | 2025 | ||
| Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease. | Zhang P, Wang X, Li S, Cao X, Zou J, Fang Y, Shi Y, Xiang F, Shen B, Li Y, Fang B, Zhang Y, Guo R, Lv Q, Zhang L, Lu Y, Wang Y, Yu J, Xie Y, Wang R, Chen X, Yu J, Zhang Z, He J, Zhan J, Lv W, Nie Y, Cai J, Xu X, Hu J, Zhang Q, Gao T, Jiang X, Tan X, Xue N, Wang Y, Ren Y, Wang L, Zhang H, Ning Y, Chen J, Zhang L, Jin S, Ren F, Ehrlich SD, Zhao L, Ding X. | Genome Biol | 10.1186/s13059-023-03056-y | 2023 | ||
| Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray. | Ny P, Ozaki A, Pallares J, Nieberg P, Wong-Beringer A. | J Clin Microbiol | 10.1128/jcm.01941-18 | 2019 | ||
| An Inductive Logistic Matrix Factorization Model for Predicting Drug-Metabolite Association With Vicus Regularization. | Ma Y, Liu L, Chen Q, Ma Y. | Front Microbiol | 10.3389/fmicb.2021.650366 | 2021 | ||
| Dietary Modulation of the Human Gut Microbiota and Metabolome with Flaxseed Preparations. | Kleigrewe K, Haack M, Baudin M, Menabreaz T, Crovadore J, Masri M, Beyrer M, Andlauer W, Lefort F, Dawid C, Bruck TB, Bruck WM. | Int J Mol Sci | 10.3390/ijms231810473 | 2022 | ||
| Metabolism | Colonic Bacteria-Transformed Catechin Metabolite Response to Cytokine Production by Human Peripheral Blood Mononuclear Cells. | Krishnamoorthy R, Adisa AR, Periasamy VS, Athinarayanan J, Pandurangan SB, Alshatwi AA. | Biomolecules | 10.3390/biom9120830 | 2019 | |
| Dual Regulation Mechanism of Obesity: DNA Methylation and Intestinal Flora. | Ren Y, Huang P, Zhang L, Tang YF, Luo SL, She Z, Peng H, Chen YQ, Luo JW, Duan WX, Liu LJ, Liu LQ. | Biomedicines | 10.3390/biomedicines12081633 | 2024 | ||
| A Novel Trimethylamine Oxide-Induced Model Implicates Gut Microbiota-Related Mechanisms in Frailty. | Chen SY, Rong XY, Sun XY, Zou YR, Zhao C, Wang HJ. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.803082 | 2022 | ||
| Genetics | Dysbiosis and relapse-related microbiome in inflammatory bowel disease: A shotgun metagenomic approach. | Serrano-Gomez G, Mayorga L, Oyarzun I, Roca J, Borruel N, Casellas F, Varela E, Pozuelo M, Machiels K, Guarner F, Vermeire S, Manichanh C. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.11.037 | 2021 | |
| Cultivation of gastrointestinal microbiota in a new growth system revealed dysbiosis and metabolic disruptions in carcinoma-bearing rats. | Pena-Ocana BA, Hoshiko Y, Silva-Flores M, Maeda T, Perez-Torres I, Garcia-Contreras R, Gutierrez-Sarmiento W, Hernandez-Esquivel L, Marin-Hernandez A, Sanchez-Thomas R, Saavedra E, Rodriguez-Zavala JS, Jasso-Chavez R. | Front Microbiol | 10.3389/fmicb.2022.949272 | 2022 | ||
| Pathogenicity | Enterolignan Production in a Flaxseed Intervention Study in Postmenopausal US Women of African Ancestry and European Ancestry. | McCann SE, Hullar MAJ, Tritchler DL, Cortes-Gomez E, Yao S, Davis W, O'Connor T, Erwin D, Thompson LU, Yan L, Lampe JW. | Nutrients | 10.3390/nu13030919 | 2021 | |
| Phylogeny | Gut Microbial Characteristics of Adult Patients With Epilepsy. | Dong L, Zheng Q, Cheng Y, Zhou M, Wang M, Xu J, Xu Z, Wu G, Yu Y, Ye L, Feng Z. | Front Neurosci | 10.3389/fnins.2022.803538 | 2022 | |
| Benefits of Fermented Papaya in Human Health. | Leitao M, Ribeiro T, Garcia PA, Barreiros L, Correia P. | Foods | 10.3390/foods11040563 | 2022 | ||
| A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes. | Radwan S, Gilfillan D, Eklund B, Radwan HM, El Menofy NG, Lee J, Kapuscinski M, Abdo Z. | PLoS One | 10.1371/journal.pone.0238764 | 2020 | ||
| Genetics | Characterization of the gut microbiome and resistome of Galapagos marine iguanas (Amblyrhynchus cristatus) from uninhabited islands. | Vasco K, Guevara N, Mosquera J, Zapata S, Zhang L. | Anim Microbiome | 10.1186/s42523-022-00218-4 | 2022 | |
| Zinc Deficiency During Pregnancy Leads to Altered Microbiome and Elevated Inflammatory Markers in Mice. | Sauer AK, Grabrucker AM. | Front Neurosci | 10.3389/fnins.2019.01295 | 2019 | ||
| Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies | Favari C, Rinaldi de Alvarenga J, Sanchez-Martinez L, Tosi N, Mignogna C, Cremonini E, Manach C, Bresciani L, Del Rio D, Mena P. | Redox Biol | 2024 | |||
| Abundance and prevalence of ESBL coding genes in patients undergoing first line eradication therapy for Helicobacter pylori. | Gudra D, Silamikelis I, Pjalkovskis J, Danenberga I, Pupola D, Skenders G, Ustinova M, Megnis K, Leja M, Vangravs R, Fridmanis D. | PLoS One | 10.1371/journal.pone.0289879 | 2023 | ||
| Metabolism | Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. | Clavel T, Henderson G, Engst W, Dore J, Blaut M. | FEMS Microbiol Ecol | 10.1111/j.1574-6941.2005.00057.x | 2006 | |
| Kombuchas from Green and Black Tea Modulate the Gut Microbiota and Improve the Intestinal Health of Wistar Rats Fed a High-Fat High-Fructose Diet. | Costa MAC, Dias Moreira LP, Duarte VDS, Cardoso RR, Sao Jose VPB, Silva BPD, Grancieri M, Corich V, Giacomini A, Bressan J, Martino HSD, Barros FAR. | Nutrients | 10.3390/nu14245234 | 2022 | ||
| Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility. | Dinakaran V, Mandape SN, Shuba K, Pratap S, Sakhare SS, Tabatabai MA, Smoot DT, Farmer-Dixon CM, Kesavalu LN, Adunyah SE, Southerland JH, Gangula PR. | Front Microbiol | 10.3389/fmicb.2018.03220 | 2018 | ||
| Phylogeny | Anaerobic, non-sporulating, Gram-positive bacilli bacteraemia characterized by 16S rRNA gene sequencing. | Lau SK, Woo PC, Fung AM, Chan KM, Woo GK, Yuen KY. | J Med Microbiol | 10.1099/jmm.0.45803-0 | 2004 | |
| Pathogenicity | [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009]. | Shinagawa N, Hasegawa M, Hirata K, Furuhata T, Mizukuchi T, Osanai H, Yanai Y, Hata F, Sasaki K, Someya T, Harada K, Oono K, Tokita S, Nakamura M, Shibuya H, Hasegawa I, Kimura M, Oshima H, Maeda H, Mukaiya M, Kihara C, Kosho W, Hoshikawa T, Kimura H, Ushijima Y, Yae-Hoon Y, Aikawa N, Abe S, Yura J, Takeyama H, Wakasugi T, Taniguchi M, Mizuno I, Fukui T, Mashita K, Ishikawa S, Mizuno A, Moori N, Sumita N, Kubo S, Lee S, Oomura T, Kobayashi Y, Tsuji T, Yamaue H, Kawai M, Takesue Y, Tanaka N, Kimura H, Iwagaki H, Sueda T, Hiyama E, Murakami Y, Ooge H, Uemura K, Tsumura H, Yokoyama T, Takeuchi H, Tanakaya K, Yasunami Y, Ryu S. | Jpn J Antibiot | 2010 | ||
| Metabolism | Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. | Clavel T, Borrmann D, Braune A, Dore J, Blaut M. | Anaerobe | 10.1016/j.anaerobe.2005.11.002 | 2006 | |
| Metabolism | Structural and Functional Characterization of the Gut Microbiota in Elderly Women With Migraine. | Chen J, Wang Q, Wang A, Lin Z. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00470 | 2019 | |
| Phylogeny | Application of rrs gene sequencing to elucidate the clinical significance of Eggerthela lenta infection. | Landais C, Doudier B, Imbert G, Fenollar F, Brouqui P. | J Clin Microbiol | 10.1128/jcm.01805-06 | 2007 | |
| Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine. | Wyatt NJ, Watson H, Anderson CA, Kennedy NA, Raine T, Ahmad T, Allerton D, Bardgett M, Clark E, Clewes D, Cotobal Martin C, Doona M, Doyle JA, Frith K, Hancock HC, Hart AL, Hildreth V, Irving PM, Iqbal S, Kennedy C, King A, Lawrence S, Lees CW, Lees R, Letchford L, Liddle T, Lindsay JO, Maier RH, Mansfield JC, Marchesi JR, McGregor N, McIntyre RE, Ostermayer J, Osunnuyi T, Powell N, Prescott NJ, Satsangi J, Sharma S, Shrestha T, Speight A, Strickland M, Wason JM, Whelan K, Wood R, Young GR, Zhang X, Parkes M, Stewart CJ, Jostins-Dean L, Lamb CA. | BMJ Open | 10.1136/bmjopen-2023-073639 | 2024 | ||
| Genetics | A Catalog of over 5,000 Metagenome-Assembled Microbial Genomes from the Caprinae Gut Microbiota. | Zhang XX, Lv QB, Yan QL, Zhang Y, Guo RC, Meng JX, Ma H, Qin SY, Zhu QH, Li CQ, Liu R, Liu G, Li SH, Sun DB, Ni HB. | Microbiol Spectr | 10.1128/spectrum.02211-22 | 2022 | |
| Interactions between Gut Microbiota and Polyphenols: New Insights into the Treatment of Fatigue. | Luo C, Wei X, Song J, Xu X, Huang H, Fan S, Zhang D, Han L, Lin J. | Molecules | 10.3390/molecules27217377 | 2022 | ||
| Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective. | Valles-Colomer M, Menni C, Berry SE, Valdes AM, Spector TD, Segata N. | Nat Med | 10.1038/s41591-023-02260-4 | 2023 | ||
| Pathogenicity | FuZhengHuaYuJiangZhuTongLuoFang Prescription Modulates Gut Microbiota and Gut-Derived Metabolites in UUO Rats. | Chen Z, Wu S, Zeng Y, Chen Z, Li X, Li J, He L, Chen M. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.837205 | 2022 | |
| Fermented Papaya Preparation Restores Age-Related Reductions in Peripheral Blood Mononuclear Cell Cytolytic Activity in Tube-Fed Patients. | Fujita Y, Tsuno H, Nakayama J. | PLoS One | 10.1371/journal.pone.0169240 | 2017 | ||
| Insights in the Complex DegU, DegS, and Spo0A Regulation System of Paenibacillus polymyxa by CRISPR-Cas9-Based Targeted Point Mutations. | Meliawati M, May T, Eckerlin J, Heinrich D, Herold A, Schmid J. | Appl Environ Microbiol | 10.1128/aem.00164-22 | 2022 | ||
| Polyphenols-Gut-Heart: An Impactful Relationship to Improve Cardiovascular Diseases. | Bianchi F, Cappella A, Gagliano N, Sfondrini L, Stacchiotti A. | Antioxidants (Basel) | 10.3390/antiox11091700 | 2022 | ||
| Sex-specific relationships of the infant microbiome and early-childhood behavioral outcomes. | Laue HE, Karagas MR, Coker MO, Bellinger DC, Baker ER, Korrick SA, Madan JC. | Pediatr Res | 10.1038/s41390-021-01785-z | 2022 | ||
| Impacts of dietary exposure to pesticides on faecal microbiome metabolism in adult twins. | Mesnage R, Bowyer RCE, El Balkhi S, Saint-Marcoux F, Gardere A, Ducarmon QR, Geelen AR, Zwittink RD, Tsoukalas D, Sarandi E, Paramera EI, Spector T, Steves CJ, Antoniou MN. | Environ Health | 10.1186/s12940-022-00860-0 | 2022 | ||
| Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis. | Dong Y, Yao J, Deng Q, Li X, He Y, Ren X, Zheng Y, Song R, Zhong X, Ma J, Shan D, Lv F, Wang X, Yuan R, She G. | Front Immunol | 10.3389/fimmu.2023.1131933 | 2023 | ||
| Genetics | Catabolic Machinery of the Human Gut Microbes Bestow Resilience Against Vanillin Antimicrobial Nature. | Yadav M, Pandey R, Chauhan NS. | Front Microbiol | 10.3389/fmicb.2020.588545 | 2020 | |
| mEnrich-seq: methylation-guided enrichment sequencing of bacterial taxa of interest from microbiome. | Cao L, Kong Y, Fan Y, Ni M, Tourancheau A, Ksiezarek M, Mead EA, Koo T, Gitman M, Zhang XS, Fang G. | Nat Methods | 10.1038/s41592-023-02125-1 | 2024 | ||
| Thiostrepton alleviates experimental colitis by promoting RORgammat ubiquitination and modulating dysbiosis. | Luo Y, Liu C, Luo Y, Zhang X, Li J, Hu C, Yang S. | Cell Mol Immunol | 10.1038/s41423-023-01085-y | 2023 | ||
| The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. | Forkosh E, Ilan Y. | Open Heart | 10.1136/openhrt-2018-000993 | 2019 | ||
| Dietary lignans, plasma enterolactone levels, and metabolic risk in men: exploring the role of the gut microbiome. | Li Y, Wang F, Li J, Ivey KL, Wilkinson JE, Wang DD, Li R, Liu G, Eliassen HA, Chan AT, Clish CB, Huttenhower C, Hu FB, Sun Q, Rimm EB. | BMC Microbiol | 10.1186/s12866-022-02495-0 | 2022 | ||
| Plasma quercetin metabolites are affected by intestinal microbiota of human microbiota-associated mice fed with a quercetin-containing diet. | Tamura M, Nakagawa H, Hori S, Suzuki T, Hirayama K. | J Clin Biochem Nutr | 10.3164/jcbn.19-45 | 2019 | ||
| Effects of Rare Microbiome Taxa Filtering on Statistical Analysis. | Cao Q, Sun X, Rajesh K, Chalasani N, Gelow K, Katz B, Shah VH, Sanyal AJ, Smirnova E. | Front Microbiol | 10.3389/fmicb.2020.607325 | 2020 | ||
| Metabolism | Structural and biochemical characterization of 20beta-hydroxysteroid dehydrogenase from Bifidobacterium adolescentis strain L2-32. | Doden HL, Pollet RM, Mythen SM, Wawrzak Z, Devendran S, Cann I, Koropatkin NM, Ridlon JM. | J Biol Chem | 10.1074/jbc.ra119.009390 | 2019 | |
| Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside. | Ma YY, Li X, Yu JT, Wang YJ. | Transl Neurodegener | 10.1186/s40035-024-00404-1 | 2024 | ||
| Distinct colon mucosa microbiomes associated with tubular adenomas and serrated polyps. | Avelar-Barragan J, DeDecker L, Lu ZN, Coppedge B, Karnes WE, Whiteson KL. | NPJ Biofilms Microbiomes | 10.1038/s41522-022-00328-6 | 2022 | ||
| Phylogeny | Signatures of early frailty in the gut microbiota. | Jackson MA, Jeffery IB, Jeffery IB, Beaumont M, Bell JT, Clark AG, Ley RE, O'Toole PW, Spector TD, Steves CJ. | Genome Med | 10.1186/s13073-016-0262-7 | 2016 | |
| Phylogeny | Reanalysis of the Mars500 experiment reveals common gut microbiome alterations in astronauts induced by long-duration confinement. | Brereton NJB, Pitre FE, Gonzalez E. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.03.040 | 2021 | |
| Robust cross-cohort gut microbiome associations with COVID-19 severity. | Li J, Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, Horgan M, O'Mahony L, O'Toole PW. | Gut Microbes | 10.1080/19490976.2023.2242615 | 2023 | ||
| A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders. | Ligezka AN, Sonmez AI, Corral-Frias MP, Golebiowski R, Lynch B, Croarkin PE, Romanowicz M. | Prog Neuropsychopharmacol Biol Psychiatry | 10.1016/j.pnpbp.2020.110187 | 2021 | ||
| Phylogeny | Evolutionary and Comparative Analysis of Bacterial Nonhomologous End Joining Repair. | Sharda M, Badrinarayanan A, Seshasayee ASN. | Genome Biol Evol | 10.1093/gbe/evaa223 | 2020 | |
| Pathogenicity | Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. | Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G, Fidelle M, Christodoulidis S, Segata N, Thomas AM, Martin AL, Sirven A, Everhard S, Aprahamian F, Nirmalathasan N, Aarnoutse R, Smidt M, Ziemons J, Caldas C, Loibl S, Denkert C, Durand S, Iglesias C, Pietrantonio F, Routy B, Andre F, Pasolli E, Delaloge S, Zitvogel L. | Cell Death Differ | 10.1038/s41418-021-00784-1 | 2021 | |
| Gut microbiota and metabolic health among overweight and obese individuals. | Kim MH, Yun KE, Kim J, Park E, Chang Y, Ryu S, Kim HL, Kim HN. | Sci Rep | 10.1038/s41598-020-76474-8 | 2020 | ||
| Metabolism | Diversification of host bile acids by members of the gut microbiota. | Winston JA, Theriot CM. | Gut Microbes | 10.1080/19490976.2019.1674124 | 2020 | |
| Non-antibiotics disrupt colonization resistance against enteropathogens. | Griesshammer A, de la Cuesta-Zuluaga J, Muller P, Gekeler C, Homolak J, Chang H, Schmitt K, Planker C, Schmidtchen V, Gallage S, Bohn E, Nguyen TH, Hetzer J, Heikenwalder M, Huang KC, Zahir T, Maier L. | Nature | 10.1038/s41586-025-09217-2 | 2025 | ||
| Microbial and immunological responses relative to high-altitude exposure in mountaineers. | Kleessen B, Schroedl W, Stueck M, Richter A, Rieck O, Krueger M. | Med Sci Sports Exerc | 10.1249/01.mss.0000174888.22930.e0 | 2005 | ||
| Intra- and Inter-individual Differences in the Human Intestinal Microbial Conversion of (-)-Epicatechin and Bioactivity of Its Major Colonic Metabolite 5-(3',4'-Dihydroxy-Phenyl)-gamma-Valerolactone in Regulating Nrf2-Mediated Gene Expression. | Liu C, Boeren S, Rietjens IMCM. | Front Nutr | 10.3389/fnut.2022.910785 | 2022 | ||
| Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. | Moran CJ, Huang H, Rivas M, Kaplan JL, Daly MJ, Winter HS. | PLoS One | 10.1371/journal.pone.0192806 | 2018 | ||
| Gut Microbiota Features in Young Children With Autism Spectrum Disorders. | Coretti L, Paparo L, Riccio MP, Amato F, Cuomo M, Natale A, Borrelli L, Corrado G, Comegna M, Buommino E, Castaldo G, Bravaccio C, Chiariotti L, Berni Canani R, Lembo F. | Front Microbiol | 10.3389/fmicb.2018.03146 | 2018 | ||
| Metabolism | Droplet-based microfluidic platform for high-throughput screening of Streptomyces. | Tu R, Zhang Y, Hua E, Bai L, Huang H, Yun K, Wang M. | Commun Biol | 10.1038/s42003-021-02186-y | 2021 | |
| Enzymology | The Performance of the Four Anaerobic Blood Culture Bottles BacT/ALERT-FN, -FN Plus, BACTEC-Plus and -Lytic in Detection of Anaerobic Bacteria and Identification by Direct MALDI-TOF MS. | Almuhayawi M, Altun O, Abdulmajeed AD, Ullberg M, Ozenci V. | PLoS One | 10.1371/journal.pone.0142398 | 2015 | |
| Enzymology | Rapid detection of human fecal Eubacterium species and related genera by nested PCR method. | Kageyama A, Benno Y. | Microbiol Immunol | 10.1111/j.1348-0421.2001.tb02624.x | 2001 | |
| Genetics | Assessing Gut Microbiota in an Infant with Congenital Propionic Acidemia before and after Probiotic Supplementation. | Bordugo A, Salvetti E, Rodella G, Piazza M, Dianin A, Amoruso A, Piacentini G, Pane M, Torriani S, Vitulo N, Felis GE. | Microorganisms | 10.3390/microorganisms9122599 | 2021 | |
| Enzymology | Fungemia due to Lachancea fermentati: a case report. | Leuck AM, Rothenberger MK, Green JS. | BMC Infect Dis | 10.1186/1471-2334-14-250 | 2014 | |
| Compositional and genetic alterations in Graves' disease gut microbiome reveal specific diagnostic biomarkers. | Zhu Q, Hou Q, Huang S, Ou Q, Huo D, Vazquez-Baeza Y, Cen C, Cantu V, Estaki M, Chang H, Belda-Ferre P, Kim HC, Chen K, Knight R, Zhang J. | ISME J | 10.1038/s41396-021-01016-7 | 2021 | ||
| Pathogenicity | Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time? | Ren J, Li H, Zeng G, Pang B, Wang Q, Wei J. | Front Pharmacol | 10.3389/fphar.2023.1178596 | 2023 | |
| Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients. | Ma TK, Chow KM, Choy AS, Kwan BC, Szeto CC, Li PK. | Clin Kidney J | 10.1093/ckj/sfu098 | 2014 | ||
| Polyphenols as Drivers of a Homeostatic Gut Microecology and Immuno-Metabolic Traits of Akkermansia muciniphila: From Mouse to Man. | Rodriguez-Daza MC, de Vos WM. | Int J Mol Sci | 10.3390/ijms24010045 | 2022 | ||
| Effects of a high-gamma-polyglutamic acid-containing natto diet on liver lipids and cecal microbiota of adult female mice. | Tamura M, Watanabe J, Hori S, Inose A, Kubo Y, Noguchi T, Nishikawa T, Ikezawa M, Araki R, Kobori M. | Biosci Microbiota Food Health | 10.12938/bmfh.2020-061 | 2021 | ||
| Genetics | Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome. | Yang Z, Fu H, Su H, Cai X, Wang Y, Hong Y, Hu J, Xie Z, Wang X. | Front Microbiol | 10.3389/fmicb.2022.1017147 | 2022 | |
| Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men. | Li J, Li Y, Ivey KL, Wang DD, Wilkinson JE, Franke A, Lee KH, Chan A, Huttenhower C, Hu FB, Rimm EB, Sun Q. | Gut | 10.1136/gutjnl-2020-322473 | 2022 | ||
| Nutraceuticals and Herbal Food Supplements for Weight Loss: Is There a Prebiotic Role in the Mechanism of Action? | Bertuccioli A, Cardinali M, Biagi M, Moricoli S, Morganti I, Zonzini GB, Rigillo G. | Microorganisms | 10.3390/microorganisms9122427 | 2021 | ||
| Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease. | Shapiro JM, de Zoete MR, Palm NW, Laenen Y, Bright R, Mallette M, Bu K, Bielecka AA, Xu F, Hurtado-Lorenzo A, Shah SA, Cho JH, LeLeiko NS, Sands BE, Flavell RA, Clemente JC. | Cell Host Microbe | 10.1016/j.chom.2020.12.003 | 2021 | ||
| Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. | Zhou Y, Zhang D, Cheng H, Wu J, Liu J, Feng W, Peng C. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1389925 | 2024 | ||
| Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. | Abouelela ME, Helmy YA. | Microorganisms | 10.3390/microorganisms12030430 | 2024 | ||
| Genetics | Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture. | Reddel S, Del Chierico F, Quagliariello A, Giancristoforo S, Vernocchi P, Russo A, Fiocchi A, Rossi P, Putignani L, El Hachem M. | Sci Rep | 10.1038/s41598-019-41149-6 | 2019 | |
| Pathogenicity | Effects of Anthocyanin on Intestinal Health: A Systematic Review. | Verediano TA, Stampini Duarte Martino H, Dias Paes MC, Tako E. | Nutrients | 10.3390/nu13041331 | 2021 | |
| Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization. | Pi Y, Wu Y, Zhang X, Lu D, Han D, Zhao J, Zheng X, Zhang S, Ye H, Lian S, Bai Y, Wang Z, Tao S, Ni D, Zou X, Jia W, Zhang G, Li D, Wang J. | Microbiome | 10.1186/s40168-022-01458-x | 2023 | ||
| Metabolism | A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. | Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. | Sci Rep | 10.1038/s41598-017-10203-6 | 2017 | |
| Beneficial metabolic transformations and prebiotic potential of hemp bran and its alcalase hydrolysate, after colonic fermentation in a gut model. | Nissen L, Casciano F, Babini E, Gianotti A. | Sci Rep | 10.1038/s41598-023-27726-w | 2023 | ||
| Metabolism | The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice. | Streidl T, Karkossa I, Segura Munoz RR, Eberl C, Zaufel A, Plagge J, Schmaltz R, Schubert K, Basic M, Schneider KM, Afify M, Trautwein C, Tolba R, Stecher B, Doden HL, Ridlon JM, Ecker J, Moustafa T, von Bergen M, Ramer-Tait AE, Clavel T. | Gut Microbes | 10.1080/19490976.2020.1854008 | 2021 | |
| Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life. | Jackson CL, Frank DN, Robertson CE, Ir D, Kofonow JM, Montlha MP, Mutsaerts EAML, Nunes MC, Madhi SA, Ghosh D, Weinberg A. | mBio | 10.1128/mbio.01229-22 | 2022 | ||
| Enzymology | Multiple bacteria in aortic aneurysms. | Marques da Silva R, Lingaas PS, Geiran O, Tronstad L, Olsen I. | J Vasc Surg | 10.1016/s0741-5214(03)00926-1 | 2003 | |
| Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial. | Chong CYL, Vatanen T, Alexander T, Bloomfield FH, O'Sullivan JM. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.595323 | 2021 | ||
| Pathogenicity | Advancing functional and translational microbiome research using meta-omics approaches. | Zhang X, Li L, Butcher J, Stintzi A, Figeys D. | Microbiome | 10.1186/s40168-019-0767-6 | 2019 | |
| Maternal and food microbial sources shape the infant microbiome of a rural Ethiopian population. | Manara S, Selma-Royo M, Huang KD, Asnicar F, Armanini F, Blanco-Miguez A, Cumbo F, Golzato D, Manghi P, Pinto F, Valles-Colomer M, Amoroso L, Corrias MV, Ponzoni M, Raffaeta R, Cabrera-Rubio R, Olcina M, Pasolli E, Collado MC, Segata N. | Curr Biol | 10.1016/j.cub.2023.04.011 | 2023 | ||
| Stewed Rhubarb Decoction Ameliorates Adenine-Induced Chronic Renal Failure in Mice by Regulating Gut Microbiota Dysbiosis. | Wang R, Hu B, Ye C, Zhang Z, Yin M, Cao Q, Ba Y, Liu H. | Front Pharmacol | 10.3389/fphar.2022.842720 | 2022 | ||
| Reverse Microbiomics: A New Reverse Dysbiosis Analysis Strategy and Its Usage in Prediction of Autoantigens and Virulent Factors in Dysbiotic Gut Microbiomes From Rheumatoid Arthritis Patients. | Wang H, Ong E, Kao JY, Sun D, He Y. | Front Microbiol | 10.3389/fmicb.2021.633732 | 2021 | ||
| Phylogeny | The family Coriobacteriaceae: reclassification of Eubacterium exiguum (Poco et al. 1996) and Peptostreptococcus heliotrinreducens (Lanigan 1976) as Slackia exigua gen. nov., comb. nov. and Slackia heliotrinireducens gen. nov., comb. nov., and Eubacterium lentum (Prevot 1938) as Eggerthella lenta gen. nov., comb. nov. | Wade WG, Downes J, Dymock D, Hiom SJ, Weightman AJ, Dewhirst FE, Paster BJ, Tzellas N, Coleman B. | Int J Syst Bacteriol | 10.1099/00207713-49-2-595 | 1999 | |
| Genetics | Consistency across multi-omics layers in a drug-perturbed gut microbial community. | Wuyts S, Alves R, Zimmermann-Kogadeeva M, Nishijima S, Blasche S, Driessen M, Geyer PE, Hercog R, Kartal E, Maier L, Muller JB, Garcia Santamarina S, Schmidt TSB, Sevin DC, Telzerow A, Treit PV, Wenzel T, Typas A, Patil KR, Mann M, Kuhn M, Bork P. | Mol Syst Biol | 10.15252/msb.202311525 | 2023 | |
| Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy. | Aarnoutse R, Ziemons J, Hillege LE, de Vos-Geelen J, de Boer M, Bisschop SMP, Vriens BEPJ, Vincent J, van de Wouw AJ, Le GN, Venema K, Rensen SS, Penders J, Smidt ML. | NPJ Breast Cancer | 10.1038/s41523-022-00455-5 | 2022 | ||
| Genetics | Finegoldia magna Isolated from Orthopedic Joint Implant-Associated Infections. | Soderquist B, Bjorklund S, Hellmark B, Jensen A, Bruggemann H. | J Clin Microbiol | 10.1128/jcm.00866-17 | 2017 | |
| Pathogenicity | Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences. | Salem F, Kindt N, Marchesi JR, Netter P, Lopez A, Kokten T, Danese S, Jouzeau JY, Peyrin-Biroulet L, Moulin D. | United European Gastroenterol J | 10.1177/2050640619867555 | 2019 | |
| Isolation of Human Intestinal Bacteria Capable of Producing the Bioactive Metabolite Isourolithin A from Ellagic Acid. | Selma MV, Beltran D, Luna MC, Romo-Vaquero M, Garcia-Villalba R, Mira A, Espin JC, Tomas-Barberan FA. | Front Microbiol | 10.3389/fmicb.2017.01521 | 2017 | ||
| Gut microbiome sheds light on the development and treatment of abdominal aortic aneurysm. | Ling X, Jie W, Qin X, Zhang S, Shi K, Li T, Guo J. | Front Cardiovasc Med | 10.3389/fcvm.2022.1063683 | 2022 | ||
| Metabolism | Quantitative systems pharmacology and the personalized drug-microbiota-diet axis. | Thiele I, Clancy CM, Heinken A, Fleming RMT. | Curr Opin Syst Biol | 10.1016/j.coisb.2017.06.001 | 2017 | |
| Pathogenicity | Insight into Polyphenol and Gut Microbiota Crosstalk: Are Their Metabolites the Key to Understand Protective Effects against Metabolic Disorders? | Koudoufio M, Desjardins Y, Feldman F, Spahis S, Delvin E, Levy E. | Antioxidants (Basel) | 10.3390/antiox9100982 | 2020 | |
| Hippuric Acid Promotes Renal Fibrosis by Disrupting Redox Homeostasis via Facilitation of NRF2-KEAP1-CUL3 Interactions in Chronic Kidney Disease. | Sun B, Wang X, Liu X, Wang L, Ren F, Wang X, Leng X. | Antioxidants (Basel) | 10.3390/antiox9090783 | 2020 | ||
| The Influence of Polyphenols on Atherosclerosis Development. | Ziolkiewicz A, Kasprzak-Drozd K, Rusinek R, Markut-Miotla E, Oniszczuk A. | Int J Mol Sci | 10.3390/ijms24087146 | 2023 | ||
| Control points for design of taxonomic composition in synthetic human gut communities. | Connors BM, Thompson J, Ertmer S, Clark RL, Pfleger BF, Venturelli OS. | Cell Syst | 10.1016/j.cels.2023.11.007 | 2023 | ||
| Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. | Thomas AM, Fidelle M, Routy B, Kroemer G, Wargo JA, Segata N, Zitvogel L. | Nat Rev Clin Oncol | 10.1038/s41571-023-00785-8 | 2023 | ||
| Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1/Sirt1 axis. | Li HL, Wei YY, Li XH, Zhang SS, Zhang RT, Li JH, Ma BW, Shao SB, Lv ZW, Ruan H, Zhou HG, Yang C. | Acta Pharmacol Sin | 10.1038/s41401-021-00726-0 | 2022 | ||
| Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice. | Ben-Amram H, Bashi T, Werbner N, Neuman H, Fridkin M, Blank M, Shoenfeld Y, Koren O. | Front Microbiol | 10.3389/fmicb.2017.01222 | 2017 | ||
| Pathogenicity | Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer. | Hamamah S, Lobiuc A, Covasa M. | Int J Mol Sci | 10.3390/ijms25169026 | 2024 | |
| The gut microbiota and its interactions with cardiovascular disease. | Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. | Microb Biotechnol | 10.1111/1751-7915.13524 | 2020 | ||
| Antidiabetic Function of Lactobacillus fermentum MF423-Fermented Rice Bran and Its Effect on Gut Microbiota Structure in Type 2 Diabetic Mice. | Ai X, Wu C, Yin T, Zhur O, Liu C, Yan X, Yi C, Liu D, Xiao L, Li W, Xie B, He H. | Front Microbiol | 10.3389/fmicb.2021.682290 | 2021 | ||
| Metabolism | Chemical reaction vector embeddings: towards predicting drug metabolism in the human gut microbiome. | Mallory EK, Acharya A, Rensi SE, Turnbaugh PJ, Bright RA, Altman RB. | Pac Symp Biocomput | 10.1142/9789813235533_0006 | 2018 | |
| Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: A pilot study. | Al Bataineh MT, Dash NR, Bel Lassen P, Banimfreg BH, Nada AM, Belda E, Clement K. | Sci Rep | 10.1038/s41598-020-66598-2 | 2020 | ||
| Phylogeny | Does entry to center-based childcare affect gut microbial colonization in young infants? | Hermes GDA, Eckermann HA, de Vos WM, de Weerth C. | Sci Rep | 10.1038/s41598-020-66404-z | 2020 | |
| Pathogenicity | Early-life gut dysbiosis linked to juvenile mortality in ostriches. | Videvall E, Song SJ, Bensch HM, Strandh M, Engelbrecht A, Serfontein N, Hellgren O, Olivier A, Cloete S, Knight R, Cornwallis CK. | Microbiome | 10.1186/s40168-020-00925-7 | 2020 | |
| Metabolism | Gut microbiota determines the fate of dietary fiber-targeted interventions in host health. | Wang W, Fan Z, Yan Q, Pan T, Luo J, Wei Y, Li B, Fang Z, Lu W. | Gut Microbes | 10.1080/19490976.2024.2416915 | 2024 | |
| From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade. | Abdel Sater AH, Bouferraa Y, Amhaz G, Haibe Y, Lakkiss AE, Shamseddine A. | Front Oncol | 10.3389/fonc.2022.804983 | 2022 | ||
| Pathogenicity | Quinones are growth factors for the human gut microbiota. | Fenn K, Strandwitz P, Stewart EJ, Dimise E, Rubin S, Gurubacharya S, Clardy J, Lewis K. | Microbiome | 10.1186/s40168-017-0380-5 | 2017 | |
| Phylogeny | Genotypic diversity of anaerobic isolates from bloodstream infections. | Simmon KE, Mirrett S, Reller LB, Petti CA. | J Clin Microbiol | 10.1128/jcm.02469-07 | 2008 | |
| Dysbiosis of human gut microbiome in young-onset colorectal cancer. | Yang Y, Du L, Shi D, Kong C, Liu J, Liu G, Li X, Ma Y. | Nat Commun | 10.1038/s41467-021-27112-y | 2021 | ||
| Genetics | A metagenome-wide association study of gut microbiome and visceral fat accumulation. | Nie X, Chen J, Ma X, Ni Y, Shen Y, Yu H, Panagiotou G, Bao Y. | Comput Struct Biotechnol J | 10.1016/j.csbj.2020.09.026 | 2020 | |
| Metabolism | Metagenomic analysis of bile salt biotransformation in the human gut microbiome. | Das P, Marcisauskas S, Ji B, Nielsen J. | BMC Genomics | 10.1186/s12864-019-5899-3 | 2019 | |
| Pathogenicity | Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. | Wybo I, Van den Bossche D, Soetens O, Vekens E, Vandoorslaer K, Claeys G, Glupczynski Y, Ieven M, Melin P, Nonhoff C, Rodriguez-Villalobos H, Verhaegen J, Pierard D. | J Antimicrob Chemother | 10.1093/jac/dkt344 | 2014 | |
| Resveratrol affects in vitro rumen fermentation, methane production and prokaryotic community composition in a time- and diet-specific manner. | Ma T, Wu W, Tu Y, Zhang N, Diao Q. | Microb Biotechnol | 10.1111/1751-7915.13566 | 2020 | ||
| Pathogenicity | The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. | Lv Y, Zhao X, Guo W, Gao Y, Yang S, Li Z, Wang G. | J Diabetes Res | 10.1155/2018/1890978 | 2018 | |
| Enzymology | Cystathionine beta-Synthase (CBS) Domain-containing Pyrophosphatase as a Target for Diadenosine Polyphosphates in Bacteria. | Anashkin VA, Salminen A, Tuominen HK, Orlov VN, Lahti R, Baykov AA. | J Biol Chem | 10.1074/jbc.m115.680272 | 2015 | |
| Pathogenicity | Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome. | Liu A, Ma T, Xu N, Jin H, Zhao F, Kwok LY, Zhang H, Zhang S, Sun Z. | Microbiol Spectr | 10.1128/spectrum.00859-21 | 2021 | |
| Engineering probiotics as living diagnostics and therapeutics for improving human health. | Zhou Z, Chen X, Sheng H, Shen X, Sun X, Yan Y, Wang J, Yuan Q. | Microb Cell Fact | 10.1186/s12934-020-01318-z | 2020 | ||
| Pathogenicity | The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease. | Dogra N, Mani RJ, Katare DP. | Cell Mol Neurobiol | 10.1007/s10571-021-01066-7 | 2022 | |
| Social and psychological adversity are associated with distinct mother and infant gut microbiome variations. | Warner BB, Rosa BA, Ndao IM, Tarr PI, Miller JP, England SK, Luby JL, Rogers CE, Hall-Moore C, Bryant RE, Wang JD, Linneman LA, Smyser TA, Smyser CD, Barch DM, Miller GE, Chen E, Martin J, Mitreva M. | Nat Commun | 10.1038/s41467-023-41421-4 | 2023 | ||
| Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis. | Yang Y, Liu S, Wang Y, Wang Z, Ding W, Sun X, He K, Feng Q, Zhang X. | Aging (Albany NY) | 10.18632/aging.103399 | 2020 | ||
| Phylogeny | Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. | Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Makivuokko H, Kajander K, Palva A. | BMC Gastroenterol | 10.1186/1471-230x-9-95 | 2009 | |
| Role of the gut microbiome in three major psychiatric disorders. | Borkent J, Ioannou M, Laman JD, Haarman BCM, Sommer IEC, Sommer IEC. | Psychol Med | 10.1017/s0033291722000897 | 2022 | ||
| Metabolism | A Novel Heme Transporter from the Energy Coupling Factor Family Is Vital for Group A Streptococcus Colonization and Infections. | Chatterjee N, Cook LCC, Lyles KV, Nguyen HAT, Devlin DJ, Thomas LS, Eichenbaum Z. | J Bacteriol | 10.1128/jb.00205-20 | 2020 | |
| The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts. | Liwinski T, Heinemann M, Schramm C. | Semin Immunopathol | 10.1007/s00281-022-00936-6 | 2022 | ||
| Metabolism | Effect of a Flaxseed Lignan Intervention on Circulating Bile Acids in a Placebo-Controlled Randomized, Crossover Trial. | Navarro SL, Levy L, Curtis KR, Elkon I, Kahsai OJ, Ammar HS, Randolph TW, Hong NN, Carnevale Neto F, Raftery D, Chapkin RS, Lampe JW, Hullar MAJ. | Nutrients | 10.3390/nu12061837 | 2020 | |
| Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study. | Clooney AG, Eckenberger J, Laserna-Mendieta E, Sexton KA, Bernstein MT, Vagianos K, Sargent M, Ryan FJ, Moran C, Sheehan D, Sleator RD, Targownik LE, Bernstein CN, Shanahan F, Claesson MJ. | Gut | 10.1136/gutjnl-2020-321106 | 2021 | ||
| Metabolism | 5-(3',4'-Dihydroxyphenyl-gamma-valerolactone), a Major Microbial Metabolite of Proanthocyanidin, Attenuates THP-1 Monocyte-Endothelial Adhesion. | Lee CC, Kim JH, Kim JS, Oh YS, Han SM, Park JHY, Lee KW, Lee CY. | Int J Mol Sci | 10.3390/ijms18071363 | 2017 | |
| Pathogenicity | The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2. | Sarkar A, Harty S, Moeller AH, Klein SL, Erdman SE, Friston KJ, Carmody RN. | Trends Mol Med | 10.1016/j.molmed.2021.09.009 | 2021 | |
| Phylogeny | Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. | Martinez I, Perdicaro DJ, Brown AW, Hammons S, Carden TJ, Carr TP, Eskridge KM, Walter J. | Appl Environ Microbiol | 10.1128/aem.03046-12 | 2013 | |
| Pathogenicity | Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria. | Citron DM, Tyrrell KL, Merriam CV, Goldstein EJ. | Antimicrob Agents Chemother | 10.1128/aac.06305-11 | 2012 | |
| Phylogeny | Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. | Zhang Y, Yu X, Yu E, Wang N, Cai Q, Shuai Q, Yan F, Jiang L, Wang H, Liu J, Chen Y, Li Z, Jiang Q. | BMC Microbiol | 10.1186/s12866-018-1232-6 | 2018 | |
| Gut-Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. | Suganya K, Koo BS. | Int J Mol Sci | 10.3390/ijms21207551 | 2020 | ||
| 2017 NIH-wide workshop report on "The Human Microbiome: Emerging Themes at the Horizon of the 21st Century". | 2017 NIH-wide microbiome workshop writing team. | Microbiome | 10.1186/s40168-019-0627-4 | 2019 | ||
| Enteric Phageome Alterations in Patients With Type 2 Diabetes. | Chen Q, Ma X, Li C, Shen Y, Zhu W, Zhang Y, Guo X, Zhou J, Liu C. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.575084 | 2020 | ||
| Pathogenicity | B Cells and Microbiota in Autoimmunity. | Botia-Sanchez M, Alarcon-Riquelme ME, Galicia G. | Int J Mol Sci | 10.3390/ijms22094846 | 2021 | |
| Enzymology | Bacteriology of histopathologically defined appendicitis in children. | Rautio M, Saxen H, Siitonen A, Nikku R, Jousimies-Somer H. | Pediatr Infect Dis J | 10.1097/00006454-200011000-00010 | 2000 | |
| Meta-Analysis Reveals Reproducible Gut Microbiome Alterations in Response to a High-Fat Diet. | Bisanz JE, Upadhyay V, Turnbaugh JA, Ly K, Turnbaugh PJ. | Cell Host Microbe | 10.1016/j.chom.2019.06.013 | 2019 | ||
| Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review. | Mamic P, Chaikijurajai T, Tang WHW. | J Mol Cell Cardiol | 10.1016/j.yjmcc.2020.12.001 | 2021 | ||
| Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study. | Wang S, Ren H, Zhong H, Zhao X, Li C, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Zou Y, Shi Z, Li X, Li T, Yang H, Lai S, Xu G, Li J, Zhang Y, Gu Y, Wang W. | Gut Microbes | 10.1080/19490976.2021.2003176 | 2022 | ||
| Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease. | Pavan S, Prabhu AN, Prasad Gorthi S, Das B, Mutreja A, Shetty V, Ramamurthy T, Ballal M. | Folia Microbiol (Praha) | 10.1007/s12223-022-00977-2 | 2022 | ||
| Metabolism | Interindividual Differences in Human Intestinal Microbial Conversion of (-)-Epicatechin to Bioactive Phenolic Compounds. | Liu C, Vervoort J, Beekmann K, Baccaro M, Kamelia L, Wesseling S, Rietjens IMCM. | J Agric Food Chem | 10.1021/acs.jafc.0c05890 | 2020 | |
| Mammalian gut metabolomes mirror microbiome composition and host phylogeny. | Gregor R, Probst M, Eyal S, Aksenov A, Sasson G, Horovitz I, Dorrestein PC, Meijler MM, Mizrahi I. | ISME J | 10.1038/s41396-021-01152-0 | 2022 | ||
| Drivers and determinants of strain dynamics following fecal microbiota transplantation. | Schmidt TSB, Li SS, Maistrenko OM, Akanni W, Coelho LP, Dolai S, Fullam A, Glazek AM, Hercog R, Herrema H, Jung F, Kandels S, Orakov A, Thielemann R, von Stetten M, Van Rossum T, Benes V, Borody TJ, de Vos WM, Ponsioen CY, Nieuwdorp M, Bork P. | Nat Med | 10.1038/s41591-022-01913-0 | 2022 | ||
| Pathogenicity | Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population. | Silveira-Nunes G, Durso DF, Jr LRAO, Cunha EHM, Maioli TU, Vieira AT, Speziali E, Correa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Franceschi C, Rampelli S, Turroni S, Brigidi P, Faria AMC. | Front Pharmacol | 10.3389/fphar.2020.00258 | 2020 | |
| The secret social lives of African crested rats, Lophiomys imhausi. | Weinstein SB, Malanga KN, Agwanda B, Maldonado JE, Dearing MD. | J Mammal | 10.1093/jmammal/gyaa127 | 2020 | ||
| Metabotypes of flavan-3-ol colonic metabolites after cranberry intake: elucidation and statistical approaches. | Mena P, Favari C, Acharjee A, Chernbumroong S, Bresciani L, Curti C, Brighenti F, Heiss C, Rodriguez-Mateos A, Del Rio D. | Eur J Nutr | 10.1007/s00394-021-02692-z | 2022 | ||
| Phylogeny | Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans. | Doumatey AP, Adeyemo A, Zhou J, Lei L, Adebamowo SN, Adebamowo C, Rotimi CN. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00063 | 2020 | |
| Pathogenicity | Effects of beta-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. | Knecht H, Neulinger SC, Heinsen FA, Knecht C, Schilhabel A, Schmitz RA, Zimmermann A, dos Santos VM, Ferrer M, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ. | PLoS One | 10.1371/journal.pone.0089417 | 2014 | |
| Harnessing phosphonate antibiotics argolaphos biosynthesis enables a synthetic biology-based green synthesis of glyphosate. | Chu L, Luo X, Zhu T, Cao Y, Zhang L, Deng Z, Gao J. | Nat Commun | 10.1038/s41467-022-29188-6 | 2022 | ||
| Prebiotic Potential of Herbal Medicines Used in Digestive Health and Disease. | Peterson CT, Sharma V, Uchitel S, Denniston K, Chopra D, Mills PJ, Peterson SN. | J Altern Complement Med | 10.1089/acm.2017.0422 | 2018 | ||
| The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer. | Yu I, Wu R, Tokumaru Y, Terracina KP, Takabe K. | Cancers (Basel) | 10.3390/cancers14225685 | 2022 | ||
| The changing epidemiology of VanB Enterococcus faecium in Poland. | Sadowy E, Gawryszewska I, Kuch A, Zabicka D, Hryniewicz W. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-018-3209-7 | 2018 | ||
| Pathogenicity | In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. | Liebetrau A, Rodloff AC, Behra-Miellet J, Dubreuil L. | Antimicrob Agents Chemother | 10.1128/aac.47.11.3667-3671.2003 | 2003 | |
| Metabolism | Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis. | Yang L, Wang T, Zhang X, Zhang H, Yan N, Zhang G, Yan R, Li Y, Yu J, He J, Jia S, Wang H. | BMC Cardiovasc Disord | 10.1186/s12872-022-02508-w | 2022 | |
| The Potential Role of Phytonutrients Flavonoids Influencing Gut Microbiota in the Prophylaxis and Treatment of Inflammatory Bowel Disease. | Wang L, Gao M, Kang G, Huang H. | Front Nutr | 10.3389/fnut.2021.798038 | 2021 | ||
| Pathogenicity | Convergent and Divergent Age Patterning of Gut Microbiota Diversity in Humans and Nonhuman Primates. | Sang J, Zhuang D, Zhang T, Wu Q, Yu J, Zhang Z. | mSystems | 10.1128/msystems.01512-21 | 2022 | |
| Disordered development of gut microbiome interferes with the establishment of the gut ecosystem during early childhood with atopic dermatitis. | Lee MJ, Park YM, Kim B, Tae IH, Kim NE, Pranata M, Kim T, Won S, Kang NJ, Lee YK, Lee DW, Nam MH, Hong SJ, Kim BS. | Gut Microbes | 10.1080/19490976.2022.2068366 | 2022 | ||
| Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. | van Dijkhuizen EHP, Del Chierico F, Malattia C, Russo A, Pires Marafon D, Ter Haar NM, Magni-Manzoni S, Vastert SJ, Dallapiccola B, Prakken B, Martini A, De Benedetti F, Putignani L, Model Driven Paediatric European Digital Repository Consortium. | Arthritis Rheumatol | 10.1002/art.40827 | 2019 | ||
| Integrated gut virome and bacteriome dynamics in COVID-19 patients. | Cao J, Wang C, Zhang Y, Lei G, Xu K, Zhao N, Lu J, Meng F, Yu L, Yan J, Bai C, Zhang S, Zhang N, Gong Y, Bi Y, Shi Y, Chen Z, Dai L, Wang J, Yang P. | Gut Microbes | 10.1080/19490976.2021.1887722 | 2021 | ||
| Genetics | OrthoReD: a rapid and accurate orthology prediction tool with low computational requirement. | Battenberg K, Lee EK, Chiu JC, Berry AM, Potter D. | BMC Bioinformatics | 10.1186/s12859-017-1726-5 | 2017 | |
| New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota. | Lorente-Picon M, Laguna A. | Biomolecules | 10.3390/biom11030433 | 2021 | ||
| Metabolism | Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. | Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, McCormick BA. | mBio | 10.1128/mbio.00632-19 | 2019 | |
| Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. | Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P. | Biomedicines | 10.3390/biomedicines11020294 | 2023 | ||
| Metabolism | Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. | Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T. | PLoS One | 10.1371/journal.pone.0137429 | 2015 | |
| An untargeted fecal and urine metabolomics analysis of the interplay between the gut microbiome, diet and human metabolism in Indian and Chinese adults. | Jain A, Li XH, Chen WN. | Sci Rep | 10.1038/s41598-019-45640-y | 2019 | ||
| Enzymology | Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeasts from positive blood culture bottles. | Altun O, Almuhayawi M, Ullberg M, Ozenci V. | J Clin Microbiol | 10.1128/jcm.01835-13 | 2013 | |
| Metabolism | An atypical phosphodiesterase capable of degrading haloalkyl phosphate diesters from Sphingobium sp. strain TCM1. | Abe K, Mukai N, Morooka Y, Makino T, Oshima K, Takahashi S, Kera Y. | Sci Rep | 10.1038/s41598-017-03142-9 | 2017 | |
| Molecular characterization of vanB elements in naturally occurring gut anaerobes. | Ballard SA, Pertile KK, Lim M, Johnson PD, Grayson ML. | Antimicrob Agents Chemother | 10.1128/aac.49.5.1688-1694.2005 | 2005 | ||
| Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis. | Di Vincenzo F, Puca P, Lopetuso LR, Petito V, Masi L, Bartocci B, Murgiano M, De Felice M, Petronio L, Gasbarrini A, Scaldaferri F. | Nutrients | 10.3390/nu14132664 | 2022 | ||
| Metabolism | Nanaerobic growth enables direct visualization of dynamic cellular processes in human gut symbionts. | Garcia-Bayona L, Coyne MJ, Hantman N, Montero-Llopis P, Von SS, Ito T, Malamy MH, Basler M, Barquera B, Comstock LE. | Proc Natl Acad Sci U S A | 10.1073/pnas.2009556117 | 2020 | |
| Major Traditional Probiotics: Comparative Genomic Analyses and Roles in Gut Microbiome of Eight Cohorts. | Luo G, Li B, Yang C, Wang Y, Bian X, Li W, Liu F, Huo G. | Front Microbiol | 10.3389/fmicb.2019.00712 | 2019 | ||
| Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis. | Colquhoun C, Duncan M, Grant G. | Diseases | 10.3390/diseases8020013 | 2020 | ||
| Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants. | Kim AH, Armah G, Dennis F, Wang L, Rodgers R, Droit L, Baldridge MT, Handley SA, Harris VC. | Cell Host Microbe | 10.1016/j.chom.2021.12.002 | 2022 | ||
| DNA sequence repeats identify numerous Type I restriction-modification systems that are potential epigenetic regulators controlling phase-variable regulons; phasevarions. | Atack JM, Guo C, Yang L, Zhou Y, Jennings MP. | FASEB J | 10.1096/fj.201901536rr | 2020 | ||
| Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. | Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Sand IK, Gacias M, Zhu Y, Casaccia P, Cree BAC, Knight R, Mazmanian SK, Baranzini SE. | Proc Natl Acad Sci U S A | 10.1073/pnas.1711235114 | 2017 | ||
| Phylogeny | Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. | Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, Klimas NG, Komaroff AL, Levine S, Montoya JG, Peterson DL, Ramanan D, Jain K, Eddy ML, Hornig M, Lipkin WI. | Microbiome | 10.1186/s40168-017-0261-y | 2017 | |
| Metabolism | Biogeography of microbial bile acid transformations along the murine gut. | Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S, Bernier-Latmani R. | J Lipid Res | 10.1194/jlr.ra120001021 | 2020 | |
| Metabolism | Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. | Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Gasbarrini A, Flore R. | World J Gastroenterol | 10.3748/wjg.v23.i7.1241 | 2017 | |
| Pathogenicity | Triclosan and prescription antibiotic exposures and enterolactone production in adults. | Adgent MA, Rogan WJ. | Environ Res | 10.1016/j.envres.2015.06.017 | 2015 | |
| Gut Microbiome of Patients With Breast Cancer in Vietnam. | Nguyen SM, Tran HTT, Long J, Shrubsole MJ, Cai H, Yang Y, Nguyen LM, Nguyen GH, Nguyen CV, Ta TV, Wu J, Cai Q, Zheng W, Tran TV, Shu XO. | JCO Glob Oncol | 10.1200/go.23.00234 | 2024 | ||
| Metabolism | Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites. | Guo Y, Crnkovic CM, Won KJ, Yang X, Lee JR, Orjala J, Lee H, Jeong H. | Drug Metab Dispos | 10.1124/dmd.118.084772 | 2019 | |
| Human gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope? | Horvath A, Zukauskaite K, Hazia O, Balazs I, Stadlbauer V. | Endocrinol Diabetes Metab | 10.1002/edm2.436 | 2024 | ||
| Negative interactions determine Clostridioides difficile growth in synthetic human gut communities. | Hromada S, Qian Y, Jacobson TB, Clark RL, Watson L, Safdar N, Amador-Noguez D, Venturelli OS. | Mol Syst Biol | 10.15252/msb.202110355 | 2021 | ||
| MALDI-TOF identification of the human Gut microbiome in people with and without diarrhea in Senegal. | Samb-Ba B, Mazenot C, Gassama-Sow A, Dubourg G, Richet H, Hugon P, Lagier JC, Raoult D, Fenollar F. | PLoS One | 10.1371/journal.pone.0087419 | 2014 | ||
| Enzymology | Antibiotics may increase triazine herbicide exposure risk via disturbing gut microbiota. | Zhan J, Liang Y, Liu D, Ma X, Li P, Liu C, Liu X, Wang P, Zhou Z. | Microbiome | 10.1186/s40168-018-0602-5 | 2018 | |
| Pathogenicity | The impact of Bacillus subtilis DSM 32315 on the pathology, performance, and intestinal microbiome of broiler chickens in a necrotic enteritis challenge. | Whelan RA, Doranalli K, Rinttila T, Vienola K, Jurgens G, Apajalahti J. | Poult Sci | 10.3382/ps/pey500 | 2019 | |
| Metabolism | Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease. | Baloni P, Funk CC, Yan J, Yurkovich JT, Kueider-Paisley A, Nho K, Heinken A, Jia W, Mahmoudiandehkordi S, Louie G, Saykin AJ, Arnold M, Kastenmuller G, Griffiths WJ, Thiele I, Alzheimer's Disease Metabolomics Consortium, Kaddurah-Daouk R, Price ND. | Cell Rep Med | 10.1016/j.xcrm.2020.100138 | 2020 | |
| Planktonic and Sessile Artificial Colonic Microbiota Harbor Distinct Composition and Reestablish Differently upon Frozen and Freeze-Dried Long-Term Storage. | Bircher L, Schwab C, Geirnaert A, Greppi A, Lacroix C. | mSystems | 10.1128/msystems.00521-19 | 2020 | ||
| Pathogenicity | Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. | Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. | Nutrients | 10.3390/nu12020381 | 2020 | |
| A P4 Medicine Perspective of Gut Microbiota and Prediabetes: Systems Analysis and Personalized Intervention. | Huang Q, Fang Q, Hu Z. | J Transl Int Med | 10.2478/jtim-2020-0020 | 2020 | ||
| Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies. | Blauvelt A, Paul C, van de Kerkhof P, Warren RB, Gottlieb AB, Langley RG, Brock F, Arendt C, Boehnlein M, Lebwohl M, Reich K. | Br J Dermatol | 10.1111/bjd.19314 | 2021 | ||
| Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100). | Miyoshi J, Nobutani K, Musch MW, Ringus DL, Hubert NA, Yamamoto M, Kase Y, Nishiyama M, Chang EB. | Evid Based Complement Alternat Med | 10.1155/2018/7415975 | 2018 | ||
| Enzymology | Cystathionine beta-synthase (CBS) domains confer multiple forms of Mg2+-dependent cooperativity to family II pyrophosphatases. | Salminen A, Anashkin VA, Lahti M, Tuominen HK, Lahti R, Baykov AA. | J Biol Chem | 10.1074/jbc.m114.589473 | 2014 | |
| Pathogenicity | Dysbiosis of the gut microbiota in disease. | Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. | Microb Ecol Health Dis | 10.3402/mehd.v26.26191 | 2015 | |
| Phylogeny | The role of the gut microbiome in the association between habitual anthocyanin intake and visceral abdominal fat in population-level analysis. | Jennings A, Koch M, Jensen MK, Bang C, Kassubek J, Muller HP, Nothlings U, Franke A, Lieb W, Cassidy A. | Am J Clin Nutr | 10.1093/ajcn/nqz299 | 2020 | |
| Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine. | Alpuim Costa D, Nobre JG, Batista MV, Ribeiro C, Calle C, Cortes A, Marhold M, Negreiros I, Borralho P, Brito M, Cortes J, Braga SA, Costa L. | Front Microbiol | 10.3389/fmicb.2021.584332 | 2021 | ||
| Genetics | Microbe-Metabolite Associations Linked to the Rebounding Murine Gut Microbiome Postcolonization with Vancomycin-Resistant Enterococcus faecium. | Mu A, Carter GP, Li L, Isles NS, Vrbanac AF, Morton JT, Jarmusch AK, De Souza DP, Narayana VK, Kanojia K, Nijagal B, McConville MJ, Knight R, Howden BP, Stinear TP. | mSystems | 10.1128/msystems.00452-20 | 2020 | |
| Genetics | Metatranscriptome of human faecal microbial communities in a cohort of adult men. | Abu-Ali GS, Mehta RS, Lloyd-Price J, Mallick H, Branck T, Ivey KL, Drew DA, DuLong C, Rimm E, Izard J, Chan AT, Huttenhower C. | Nat Microbiol | 10.1038/s41564-017-0084-4 | 2018 | |
| Metabolism | Use of Shotgun Metagenomics and Metabolomics to Evaluate the Impact of Glyphosate or Roundup MON 52276 on the Gut Microbiota and Serum Metabolome of Sprague-Dawley Rats. | Mesnage R, Teixeira M, Mandrioli D, Falcioni L, Ducarmon QR, Zwittink RD, Mazzacuva F, Caldwell A, Halket J, Amiel C, Panoff JM, Belpoggi F, Antoniou MN. | Environ Health Perspect | 10.1289/ehp6990 | 2021 | |
| Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. | Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M, Musiime V, Lutaakome J, Kekitiinwa A, Mutasa K, Szubert AJ, Spyer MJ, Deayton JR, Glass M, Geum HM, Pardieu C, Gibb DM, Klein N, Edens TJ, Walker AS, Manges AR, Prendergast AJ. | Sci Transl Med | 10.1126/scitranslmed.aav0537 | 2019 | ||
| Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases. | Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ. | Cell Host Microbe | 10.1016/j.chom.2017.04.010 | 2017 | ||
| 'RA and the microbiome: do host genetic factors provide the link? | Wells PM, Williams FMK, Matey-Hernandez ML, Menni C, Steves CJ. | J Autoimmun | 10.1016/j.jaut.2019.02.004 | 2019 | ||
| Metabolism | Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire. | Zhang C, Bjorkman A, Cai K, Liu G, Wang C, Li Y, Xia H, Sun L, Kristiansen K, Wang J, Han J, Hammarstrom L, Pan-Hammarstrom Q. | Front Immunol | 10.3389/fimmu.2018.00908 | 2018 | |
| Strains of the Propionibacterium acnes type III lineage are associated with the skin condition progressive macular hypomelanosis. | Barnard E, Liu J, Yankova E, Cavalcanti SM, Magalhaes M, Li H, Patrick S, McDowell A. | Sci Rep | 10.1038/srep31968 | 2016 | ||
| Pathogenicity | The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. | Lindefeldt M, Eng A, Darban H, Bjerkner A, Zetterstrom CK, Allander T, Andersson B, Borenstein E, Dahlin M, Prast-Nielsen S. | NPJ Biofilms Microbiomes | 10.1038/s41522-018-0073-2 | 2019 | |
| Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota. | Shimizu H, Benno Y. | Microbiol Immunol | 10.1111/1348-0421.12332 | 2015 | ||
| Gestational Diabetes Mellitus Is Associated with Reduced Dynamics of Gut Microbiota during the First Half of Pregnancy. | Zheng W, Xu Q, Huang W, Yan Q, Chen Y, Zhang L, Tian Z, Liu T, Yuan X, Liu C, Luo J, Guo C, Song W, Zhang L, Liang X, Qin H, Li G. | mSystems | 10.1128/msystems.00109-20 | 2020 | ||
| Metabolism | A microbial transporter of the dietary antioxidant ergothioneine. | Dumitrescu DG, Gordon EM, Kovalyova Y, Seminara AB, Duncan-Lowey B, Forster ER, Zhou W, Booth CJ, Shen A, Kranzusch PJ, Hatzios SK. | Cell | 10.1016/j.cell.2022.10.008 | 2022 | |
| Metabolism | Short-chain ketone production by engineered polyketide synthases in Streptomyces albus. | Yuzawa S, Mirsiaghi M, Jocic R, Fujii T, Masson F, Benites VT, Baidoo EEK, Sundstrom E, Tanjore D, Pray TR, George A, Davis RW, Gladden JM, Simmons BA, Katz L, Keasling JD. | Nat Commun | 10.1038/s41467-018-07040-0 | 2018 | |
| Pathogenicity | Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. | Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, Rufo P, Baker SS, Sauer C, Markowitz J, Pfefferkorn M, Oliva-Hemker M, Rosh J, Otley A, Boyle B, Mack D, Baldassano R, Keljo D, LeLeiko N, Heyman M, Griffiths A, Patel AS, Noe J, Kugathasan S, Walters T, Huttenhower C, Hyams J, Xavier RJ. | Cell Host Microbe | 10.1016/j.chom.2018.09.009 | 2018 | |
| Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. | Ianiro G, Puncochar M, Karcher N, Porcari S, Armanini F, Asnicar F, Beghini F, Blanco-Miguez A, Cumbo F, Manghi P, Pinto F, Pinto F, Masucci L, Quaranta G, De Giorgi S, Sciume GD, Bibbo S, Del Chierico F, Putignani L, Sanguinetti M, Gasbarrini A, Valles-Colomer M, Cammarota G, Segata N. | Nat Med | 10.1038/s41591-022-01964-3 | 2022 | ||
| From obesity through gut microbiota to cardiovascular diseases: a dangerous journey. | Marzullo P, Di Renzo L, Pugliese G, De Siena M, Barrea L, Muscogiuri G, Colao A, Savastano S, Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group. | Int J Obes Suppl | 10.1038/s41367-020-0017-1 | 2020 | ||
| Biological Aging and the Human Gut Microbiota. | Maffei VJ, Kim S, Blanchard E, Luo M, Jazwinski SM, Taylor CM, Welsh DA. | J Gerontol A Biol Sci Med Sci | 10.1093/gerona/glx042 | 2017 | ||
| Enzymology | Identification and characterization of a 20beta-HSDH from the anaerobic gut bacterium Butyricicoccus desmolans ATCC 43058. | Devendran S, Mendez-Garcia C, Ridlon JM. | J Lipid Res | 10.1194/jlr.m074914 | 2017 | |
| Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. | Africa CW, Nel J, Stemmet M. | Int J Environ Res Public Health | 10.3390/ijerph110706979 | 2014 | ||
| Genetics | Re-evaluation of Diadenosine Tetraphosphate (Ap4A) From a Stress Metabolite to Bona Fide Secondary Messenger. | Ferguson F, McLennan AG, Urbaniak MD, Jones NJ, Copeland NA. | Front Mol Biosci | 10.3389/fmolb.2020.606807 | 2020 | |
| Phylogeny | Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria. | Lee EH, Degener JE, Welling GW, Veloo AC. | J Clin Microbiol | 10.1128/jcm.02166-10 | 2011 | |
| Environmental toxicants in breast milk of Norwegian mothers and gut bacteria composition and metabolites in their infants at 1 month. | Iszatt N, Janssen S, Lenters V, Dahl C, Stigum H, Knight R, Mandal S, Peddada S, Gonzalez A, Midtvedt T, Eggesbo M. | Microbiome | 10.1186/s40168-019-0645-2 | 2019 | ||
| Enzymology | Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis. | Tecer D, Gogus F, Kalkanci A, Erdogan M, Hasanreisoglu M, Ergin C, Karakan T, Kozan R, Coban S, Diker KS. | PLoS One | 10.1371/journal.pone.0241691 | 2020 | |
| Metabolism | Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. | Carmody RN, Turnbaugh PJ. | J Clin Invest | 10.1172/jci72335 | 2014 | |
| Enzymology | Local bacteria affect the efficacy of chemotherapeutic drugs. | Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. | Sci Rep | 10.1038/srep14554 | 2015 | |
| Metabolism | Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States. | Hullar MA, Lancaster SM, Li F, Tseng E, Beer K, Atkinson C, Wahala K, Copeland WK, Randolph TW, Newton KM, Lampe JW. | Cancer Epidemiol Biomarkers Prev | 10.1158/1055-9965.epi-14-0262 | 2015 | |
| Enzymology | Isolation of Genetically Tractable Most-Wanted Bacteria by Metaparental Mating. | Cuiv PO, Smith WJ, Pottenger S, Burman S, Shanahan ER, Morrison M. | Sci Rep | 10.1038/srep13282 | 2015 | |
| Enzymology | Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. | Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. | Appl Environ Microbiol | 10.1128/aem.70.12.7220-7228.2004 | 2004 | |
| Gut microbiota interspecies interactions shape the response of Clostridioides difficile to clinically relevant antibiotics. | Hromada S, Venturelli OS. | PLoS Biol | 10.1371/journal.pbio.3002100 | 2023 | ||
| Metabolism | Gut microbial carbohydrate metabolism contributes to insulin resistance. | Takeuchi T, Kubota T, Nakanishi Y, Tsugawa H, Suda W, Kwon AT, Yazaki J, Ikeda K, Nemoto S, Mochizuki Y, Kitami T, Yugi K, Mizuno Y, Yamamichi N, Yamazaki T, Takamoto I, Kubota N, Kadowaki T, Arner E, Carninci P, Ohara O, Arita M, Hattori M, Koyasu S, Ohno H. | Nature | 10.1038/s41586-023-06466-x | 2023 | |
| Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis. | Evans-Marin H, Rogier R, Koralov SB, Manasson J, Roeleveld D, van der Kraan PM, Scher JU, Koenders MI, Abdollahi-Roodsaz S. | Arthritis Rheumatol | 10.1002/art.40657 | 2018 | ||
| Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia. | Liu F, Ling Z, Xiao Y, Yang Q, Wang B, Zheng L, Jiang P, Li L, Wang W. | Front Physiol | 10.3389/fphys.2017.00126 | 2017 | ||
| A microbial signature for Crohn's disease. | Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C. | Gut | 10.1136/gutjnl-2016-313235 | 2017 | ||
| Helicobacter pylori antibiotic eradication coupled with a chemically defined diet in INS-GAS mice triggers dysbiosis and vitamin K deficiency resulting in gastric hemorrhage. | Quinn L, Sheh A, Ellis JL, Smith DE, Booth SL, Fu X, Muthupalani S, Ge Z, Puglisi DA, Wang TC, Gonda TA, Holcombe H, Fox JG. | Gut Microbes | 10.1080/19490976.2019.1710092 | 2020 | ||
| Pathogenicity | Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. | Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. | Microbiome | 10.1186/s40168-016-0171-4 | 2016 | |
| Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. | Rogier R, Evans-Marin H, Manasson J, van der Kraan PM, Walgreen B, Helsen MM, van den Bersselaar LA, van de Loo FA, van Lent PL, Abramson SB, van den Berg WB, Koenders MI, Scher JU, Abdollahi-Roodsaz S. | Sci Rep | 10.1038/s41598-017-15802-x | 2017 | ||
| Enzymology | Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency. | Jacobs JP, Lin L, Goudarzi M, Ruegger P, McGovern DP, Fornace AJ, Borneman J, Xia L, Braun J. | Gut Microbes | 10.1080/19490976.2016.1257469 | 2017 | |
| Metabolism | 16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics. | Peterson CT, Sharma V, Iablokov SN, Albayrak L, Khanipov K, Uchitel S, Chopra D, Mills PJ, Fofanov Y, Rodionov DA, Peterson SN. | PLoS One | 10.1371/journal.pone.0213869 | 2019 | |
| Phylogeny | High mortality associated with Catabacter hongkongensis bacteremia. | Lau SK, Fan RY, Lo HW, Ng RH, Wong SS, Li IW, Wu AK, Ng KH, Tseung S, Lee RA, Fung KS, Que TL, Yuen KY, Woo PC. | J Clin Microbiol | 10.1128/jcm.00128-12 | 2012 | |
| Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. | Launay A, Ballard SA, Johnson PD, Grayson ML, Lambert T. | Antimicrob Agents Chemother | 10.1128/aac.50.3.1054-1062.2006 | 2006 | ||
| Multivariate Analysis of Fecal Metabolites from Children with Autism Spectrum Disorder and Gastrointestinal Symptoms before and after Microbiota Transfer Therapy. | Qureshi F, Adams J, Hanagan K, Kang DW, Krajmalnik-Brown R, Hahn J. | J Pers Med | 10.3390/jpm10040152 | 2020 | ||
| Gut Microbiota, Blood Metabolites, and Spleen Immunity in Broiler Chickens Fed Berry Pomaces and Phenolic-Enriched Extractives. | Das Q, Islam MR, Lepp D, Tang J, Yin X, Mats L, Liu H, Ross K, Kennes YM, Yacini H, Warriner K, Marcone MF, Diarra MS. | Front Vet Sci | 10.3389/fvets.2020.00150 | 2020 | ||
| Metabolism | Genomic insights into diverse bacterial taxa that degrade extracellular DNA in marine sediments. | Wasmund K, Pelikan C, Schintlmeister A, Wagner M, Watzka M, Richter A, Bhatnagar S, Noel A, Hubert CRJ, Rattei T, Hofmann T, Hausmann B, Herbold CW, Loy A. | Nat Microbiol | 10.1038/s41564-021-00917-9 | 2021 | |
| Pathogenicity | First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species. | Rennie RP, Turnbull L, Brosnikoff C, Cloke J. | J Clin Microbiol | 10.1128/jcm.05397-11 | 2012 | |
| Metabolism | Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids. | Richardson AJ, McKain N, Wallace RJ. | BMC Microbiol | 10.1186/1471-2180-13-6 | 2013 | |
| Pathogenicity | Drug-gut microbiota interactions: implications for neuropharmacology. | Walsh J, Griffin BT, Clarke G, Hyland NP. | Br J Pharmacol | 10.1111/bph.14366 | 2018 | |
| Metabolism | Design of synthetic human gut microbiome assembly and butyrate production. | Clark RL, Connors BM, Stevenson DM, Hromada SE, Hamilton JJ, Amador-Noguez D, Venturelli OS. | Nat Commun | 10.1038/s41467-021-22938-y | 2021 | |
| Phylogeny | Accurate genome relative abundance estimation for closely related species in a metagenomic sample. | Sohn MB, An L, Pookhao N, Li Q. | BMC Bioinformatics | 10.1186/1471-2105-15-242 | 2014 | |
| Metabolism | l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. | Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, Copeland MF, Bartlett D, Cody DB, Dai HJ, Culley MK, Li XS, Fu X, Wu Y, Li L, DiDonato JA, Tang WHW, Garcia-Garcia JC, Hazen SL. | J Clin Invest | 10.1172/jci94601 | 2019 | |
| Studies on Modulation of Gut Microbiota by Wine Polyphenols: From Isolated Cultures to Omic Approaches. | Duenas M, Cueva C, Munoz-Gonzalez I, Jimenez-Giron A, Sanchez-Patan F, Santos-Buelga C, Moreno-Arribas MV, Bartolome B. | Antioxidants (Basel) | 10.3390/antiox4010001 | 2015 | ||
| Metabolism | Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. | Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD. | Clin Transl Sci | 10.1111/cts.12131 | 2014 | |
| Genetics | The gut microbiome in atherosclerotic cardiovascular disease. | Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K. | Nat Commun | 10.1038/s41467-017-00900-1 | 2017 | |
| Metabolism | RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. | Fu ZD, Selwyn FP, Cui JY, Klaassen CD. | Drug Metab Dispos | 10.1124/dmd.117.077313 | 2017 | |
| Shotgun Metagenomics of 250 Adult Twins Reveals Genetic and Environmental Impacts on the Gut Microbiome. | Xie H, Guo R, Zhong H, Feng Q, Lan Z, Qin B, Ward KJ, Jackson MA, Xia Y, Chen X, Chen B, Xia H, Xu C, Li F, Xu X, Al-Aama JY, Yang H, Wang J, Kristiansen K, Wang J, Steves CJ, Bell JT, Li J, Spector TD, Jia H. | Cell Syst | 10.1016/j.cels.2016.10.004 | 2016 | ||
| Metabolism | Chemical transformation of xenobiotics by the human gut microbiota. | Koppel N, Maini Rekdal V, Balskus EP. | Science | 10.1126/science.aag2770 | 2017 | |
| RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice. | Selwyn FP, Cui JY, Klaassen CD. | Drug Metab Dispos | 10.1124/dmd.115.063545 | 2015 | ||
| Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis. | Cruciani F, Biagi E, Severgnini M, Consolandi C, Calanni F, Donders G, Brigidi P, Vitali B. | Antimicrob Agents Chemother | 10.1128/aac.00225-15 | 2015 | ||
| Genetics | Probabilistic model based on circular statistics for quantifying coverage depth dynamics originating from DNA replication. | Suzuki S, Yamada T. | PeerJ | 10.7717/peerj.8722 | 2020 | |
| Phylogeny | Cooking shapes the structure and function of the gut microbiome. | Carmody RN, Bisanz JE, Bowen BP, Maurice CF, Lyalina S, Louie KB, Treen D, Chadaideh KS, Maini Rekdal V, Bess EN, Spanogiannopoulos P, Ang QY, Bauer KC, Balon TW, Pollard KS, Northen TR, Turnbaugh PJ. | Nat Microbiol | 10.1038/s41564-019-0569-4 | 2019 | |
| Metagenomic profiling of known and unknown microbes with microbeGPS. | Lindner MS, Renard BY. | PLoS One | 10.1371/journal.pone.0117711 | 2015 | ||
| Pathogenicity | Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens. | Sutcliffe JA, O'Brien W, Fyfe C, Grossman TH. | Antimicrob Agents Chemother | 10.1128/aac.01288-13 | 2013 | |
| Enzymology | A roadmap for metagenomic enzyme discovery. | Robinson SL, Piel J, Sunagawa S. | Nat Prod Rep | 10.1039/d1np00006c | 2021 | |
| The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials. | Schepici G, Silvestro S, Bramanti P, Mazzon E. | Cell Transplant | 10.1177/0963689719873890 | 2019 | ||
| Metabolism | Ruminal Prevotella spp. may play an important role in the conversion of plant lignans into human health beneficial antioxidants. | Schogor AL, Huws SA, Santos GT, Scollan ND, Hauck BD, Winters AL, Kim EJ, Petit HV. | PLoS One | 10.1371/journal.pone.0087949 | 2014 | |
| Metabolism | In vitro and in vivo characterization of Clostridium scindens bile acid transformations. | Marion S, Studer N, Desharnais L, Menin L, Escrig S, Meibom A, Hapfelmeier S, Bernier-Latmani R. | Gut Microbes | 10.1080/19490976.2018.1549420 | 2019 | |
| An insight into gut microbiota and its functionalities. | Adak A, Khan MR. | Cell Mol Life Sci | 10.1007/s00018-018-2943-4 | 2019 | ||
| Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. | Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA. | Cell | 10.1016/j.cell.2014.08.006 | 2014 | ||
| Phylogeny | High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray. | Paliy O, Kenche H, Abernathy F, Michail S. | Appl Environ Microbiol | 10.1128/aem.02764-08 | 2009 | |
| Alignment-free visualization of metagenomic data by nonlinear dimension reduction. | Laczny CC, Pinel N, Vlassis N, Wilmes P. | Sci Rep | 10.1038/srep04516 | 2014 | ||
| Metabolism | Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. | Lecomte V, Kaakoush NO, Maloney CA, Raipuria M, Huinao KD, Mitchell HM, Morris MJ. | PLoS One | 10.1371/journal.pone.0126931 | 2015 | |
| Metabolism | A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont. | Liou CS, Sirk SJ, Diaz CAC, Klein AP, Fischer CR, Higginbottom SK, Erez A, Donia MS, Sonnenburg JL, Sattely ES. | Cell | 10.1016/j.cell.2020.01.023 | 2020 | |
| The Association Between Intestinal Bacteria and Allergic Diseases-Cause or Consequence? | Han P, Gu JQ, Li LS, Wang XY, Wang HT, Wang Y, Chang C, Sun JL. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.650893 | 2021 | ||
| Metabolism | Mapping human microbiome drug metabolism by gut bacteria and their genes. | Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. | Nature | 10.1038/s41586-019-1291-3 | 2019 | |
| Phylogeny | Distribution and phylogenetic analysis of family 19 chitinases in Actinobacteria. | Kawase T, Saito A, Sato T, Kanai R, Fujii T, Nikaidou N, Miyashita K, Watanabe T. | Appl Environ Microbiol | 10.1128/aem.70.2.1135-1144.2004 | 2004 | |
| Metabolism | Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. | Clavel T, Henderson G, Alpert CA, Philippe C, Rigottier-Gois L, Dore J, Blaut M. | Appl Environ Microbiol | 10.1128/aem.71.10.6077-6085.2005 | 2005 | |
| Pathogenicity | Microbiota and Colorectal Cancer: From Gut to Bedside. | Silva M, Brunner V, Tschurtschenthaler M. | Front Pharmacol | 10.3389/fphar.2021.760280 | 2021 | |
| High-resolution structures with bound Mn2+ and Cd2+ map the metal import pathway in an Nramp transporter. | Ray S, Berry SP, Wilson EA, Zhang CH, Shekhar M, Singharoy A, Gaudet R. | Elife | 10.7554/elife.84006 | 2023 | ||
| Metabolism | Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. | Feng W, Liu J, Ao H, Yue S, Peng C. | Theranostics | 10.7150/thno.47289 | 2020 | |
| Pathogenicity | In vitro susceptibility testing of Dientamoeba fragilis. | Nagata N, Marriott D, Harkness J, Ellis JT, Stark D. | Antimicrob Agents Chemother | 10.1128/aac.05125-11 | 2012 | |
| Genetics | Experimental design and quantitative analysis of microbial community multiomics. | Mallick H, Ma S, Franzosa EA, Vatanen T, Morgan XC, Huttenhower C. | Genome Biol | 10.1186/s13059-017-1359-z | 2017 | |
| Metabolism | The variable subdomain of Escherichia coli SecA functions to regulate SecA ATPase activity and ADP release. | Das S, Grady LM, Michtavy J, Zhou Y, Cohan FM, Hingorani MM, Oliver DB. | J Bacteriol | 10.1128/jb.00039-12 | 2012 | |
| Enzymology | Stool metatranscriptomics: A technical guideline for mRNA stabilisation and isolation. | Reck M, Tomasch J, Deng Z, Jarek M, Husemann P, Wagner-Dobler I, COMBACTE Consortium. | BMC Genomics | 10.1186/s12864-015-1694-y | 2015 | |
| Pathogenicity | Personalized Mapping of Drug Metabolism by the Human Gut Microbiome. | Javdan B, Lopez JG, Chankhamjon P, Lee YJ, Hull R, Wu Q, Wang X, Chatterjee S, Donia MS. | Cell | 10.1016/j.cell.2020.05.001 | 2020 | |
| Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. | Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M, Kitzweger E, Ruckser R, Haslberger AG. | PLoS One | 10.1371/journal.pone.0028654 | 2011 | ||
| Metabolism | Colonization-induced host-gut microbial metabolic interaction. | Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J, Paris A, Want EJ, de Waziers I, Cloarec O, Richards SE, Wang Y, Dumas ME, Ross A, Rezzi S, Kochhar S, Van Bladeren P, Lindon JC, Holmes E, Nicholson JK. | mBio | 10.1128/mbio.00271-10 | 2011 | |
| Metabolism | Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas. | Pereyre S, Sirand-Pugnet P, Beven L, Charron A, Renaudin H, Barre A, Avenaud P, Jacob D, Couloux A, Barbe V, de Daruvar A, Blanchard A, Bebear C. | PLoS Genet | 10.1371/journal.pgen.1000677 | 2009 | |
| Enzymology | Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. | Stamper PD, Cai M, Lema C, Eskey K, Carroll KC. | J Clin Microbiol | 10.1128/jcm.01458-07 | 2007 | |
| Phylogeny | The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. | Bian G, Gloor GB, Gong A, Jia C, Zhang W, Hu J, Zhang H, Zhang Y, Zhou Z, Zhang J, Burton JP, Reid G, Xiao Y, Zeng Q, Yang K, Li J. | mSphere | 10.1128/msphere.00327-17 | 2017 | |
| Enzymology | Diet rapidly and reproducibly alters the human gut microbiome. | David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. | Nature | 10.1038/nature12820 | 2014 | |
| Metabolism | Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. | Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, Bogatyrev SR, Ismagilov RF, Pamer EG, Turnbaugh PJ, Chervonsky AV. | Nature | 10.1038/nature13823 | 2014 | |
| The gut microbiota and host health: a new clinical frontier. | Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM, Thomas LV, Zoetendal EG, Hart A. | Gut | 10.1136/gutjnl-2015-309990 | 2016 | ||
| Metabolism | First insights into the syntrophic acetate-oxidizing bacteria--a genetic study. | Muller B, Sun L, Schnurer A. | Microbiologyopen | 10.1002/mbo3.50 | 2013 | |
| Metabolism | Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. | Turroni F, Foroni E, O'Connell Motherway M, Bottacini F, Giubellini V, Zomer A, Ferrarini A, Delledonne M, Zhang Z, van Sinderen D, Ventura M. | Appl Environ Microbiol | 10.1128/aem.02938-09 | 2010 | |
| Systems biology of host-microbe metabolomics. | Heinken A, Thiele I. | Wiley Interdiscip Rev Syst Biol Med | 10.1002/wsbm.1301 | 2015 | ||
| Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. | Noce A, Marrone G, Di Daniele F, Ottaviani E, Wilson Jones G, Bernini R, Romani A, Rovella V. | Nutrients | 10.3390/nu11051073 | 2019 | ||
| Metabolism | Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes. | Turroni S, Bendazzoli C, Dipalo SC, Candela M, Vitali B, Gotti R, Brigidi P. | Appl Environ Microbiol | 10.1128/aem.00844-10 | 2010 | |
| Phylogeny | Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes. | Schwiertz A, Le Blay G, Blaut M. | Appl Environ Microbiol | 10.1128/aem.66.1.375-382.2000 | 2000 | |
| Metabolism | Bidirectional interactions between indomethacin and the murine intestinal microbiota. | Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA. | Elife | 10.7554/elife.08973 | 2015 | |
| The first 1000 cultured species of the human gastrointestinal microbiota. | Rajilic-Stojanovic M, de Vos WM. | FEMS Microbiol Rev | 10.1111/1574-6976.12075 | 2014 | ||
| Mediterranean Diet: Prevention of Colorectal Cancer. | Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. | Front Nutr | 10.3389/fnut.2017.00059 | 2017 | ||
| Phylogeny | Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. | Leser TD, Amenuvor JZ, Jensen TK, Lindecrona RH, Boye M, Moller K. | Appl Environ Microbiol | 10.1128/aem.68.2.673-690.2002 | 2002 | |
| Genetics | Genome-Based Taxonomic Classification of the Phylum Actinobacteria. | Nouioui I, Carro L, Garcia-Lopez M, Meier-Kolthoff JP, Woyke T, Kyrpides NC, Pukall R, Klenk HP, Goodfellow M, Goker M. | Front Microbiol | 10.3389/fmicb.2018.02007 | 2018 | |
| Pathogenicity | The Gut Microbiota Links Dietary Polyphenols With Management of Psychiatric Mood Disorders. | Westfall S, Pasinetti GM. | Front Neurosci | 10.3389/fnins.2019.01196 | 2019 | |
| Bidirectional Interactions between Green Tea (GT) Polyphenols and Human Gut Bacteria. | Choi SR, Lee H, Singh D, Singh D, Cho D, Chung JO, Roh JH, Kim WG, Lee CH. | J Microbiol Biotechnol | 10.4014/jmb.2306.06014 | 2023 | ||
| Phylogeny | Eggerthella timonensis sp. nov, a new species isolated from the stool sample of a pygmy female. | Bilen M, Fonkou MDM, Tomei E, Armstrong N, Bittar F, Lagier JC, Daoud Z, Fournier PE, Raoult D, Cadoret F | Microbiologyopen | 10.1002/mbo3.575 | 2018 | |
| Metabolism | Bile acid oxidation by Eggerthella lenta strains C592 and DSM 2243(T). | Harris SC, Devendran S, Mendez-Garcia C, Mythen SM, Wright CL, Fields CJ, Hernandez AG, Cann I, Hylemon PB, Ridlon JM | Gut Microbes | 10.1080/19490976.2018.1458180 | 2018 | |
| Metabolism | Mechanistic and structural insight into promiscuity based metabolism of cardiac drug digoxin by gut microbial enzyme. | Kumar K, Jaiswal SK, Dhoke GV, Srivastava GN, Sharma AK, Sharma VK | J Cell Biochem | 10.1002/jcb.26638 | 2018 | |
| Metabolism | Bioconversion of (-)-epicatechin, (+)-epicatechin, (-)-catechin, and (+)-catechin by (-)-epigallocatechin-metabolizing bacteria. | Takagaki A, Nanjo F | Biol Pharm Bull | 10.1248/bpb.b14-00813 | 2015 | |
| Phylogeny | Isolation and characterization of rat intestinal bacteria involved in biotransformation of (-)-epigallocatechin. | Takagaki A, Kato Y, Nanjo F | Arch Microbiol | 10.1007/s00203-014-1006-y | 2014 | |
| Phylogeny | Isolation and characterization of novel S-equol-producing bacteria from brines of stinky tofu, a traditional fermented soy food in Taiwan. | Abiru Y, Ueno T, Uchiyama S | Int J Food Sci Nutr | 10.3109/09637486.2013.816936 | 2013 | |
| Genetics | Complete genome sequence of Eggerthella lenta type strain (IPP VPI 0255). | Saunders E, Pukall R, Abt B, Lapidus A, Glavina Del Rio T, Copeland A, Tice H, Cheng JF, Lucas S, Chen F, Nolan M, Bruce D, Goodwin L, Pitluck S, Ivanova N, Mavromatis K, Ovchinnikova G, Pati A, Chen A, Palaniappan K, Land M, Hauser L, Chang YJ, Jeffries CD, Chain P, Meincke L, Sims D, Brettin T, Detter JC, Goker M, Bristow J, Eisen JA, Markowitz V, Hugenholtz P, Kyrpides NC, Klenk HP, Han C | Stand Genomic Sci | 10.4056/sigs.33592 | 2009 | |
| Cultivation | Production of antagonistic substance by Eikenella corrodens isolated from the oral cavity of human beings with and without periodontal disease. | Apolonio AC, Carvalho MA, Ribas RN, Sousa-Gaia LG, Santos KV, Lana MA, Nicoli JR, Farias LM | J Appl Microbiol | 10.1111/j.1365-2672.2006.03211.x | 2007 | |
| Phylogeny | Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. | Minamida K, Tanaka M, Abe A, Sone T, Tomita F, Hara H, Asano K | J Biosci Bioeng | 10.1263/jbb.102.247 | 2006 | |
| Phylogeny | Phylogenetic evidence for the transfer of Eubacterium lentum to the genus Eggerthella as Eggerthella lenta gen. nov., comb. nov. | Kageyama A, Benno Y, Nakase T | Int J Syst Bacteriol | 10.1099/00207713-49-4-1725 | 1999 | |
| Metabolism | Experimental root canal infections in conventional and germ-free mice. | Sobrinho AP, Barros MH, Nicoli JR, Carvalho MA, Farias LM, Bambirra EA, Bahia MG, Vieira EC | J Endod | 10.1016/S0099-2399(98)80021-6 | 1998 | |
| Metabolism | Reduction of digoxin to 20R-dihydrodigoxin by cultures of Eubacterium lentum. | Robertson LW, Chandrasekaran A, Reuning RH, Hui J, Rawal BD | Appl Environ Microbiol | 10.1128/aem.51.6.1300-1303.1986 | 1986 | |
| Metabolism | Bile salt 3 alpha- and 12 alpha-hydroxysteroid dehydrogenases from Eubacterium lentum and related organisms. | MacDonald IA, Jellett JF, Mahony DE, Holdeman LV | Appl Environ Microbiol | 10.1128/aem.37.5.992-1000.1979 | 1979 | |
| Pathogenicity | Immuno-electron microscopic localization of a choriogonadotropin-like antigen in cancer-associated bacteria. | Slifkin M, Pardo M, Pouchet-Melvin GR, Acevedo HF | Oncology | 10.1159/000225343 | 1979 | |
| Stress | Eggerthella lenta DSM 2243 Alleviates Bile Acid Stress Response in Clostridium ramosum and Anaerostipes caccae by Transformation of Bile Acids. | Pedersen KJ, Haange SB, Zizalova K, Viehof A, Clavel T, Lenicek M, Engelmann B, Wick LY, Schaap FG, Jehmlich N, Rolle-Kampczyk U, von Bergen M | Microorganisms | 10.3390/microorganisms10102025 | 2022 | |
| Phylogeny | Umbribacter vaginalis gen. nov., sp. nov.: novel bacterium isolated from the human vagina. | Srinivasan S, Strenk SM, Beamer MA, Fiedler TL, Proll S, Acevedo-Oquendo GR, Bonura GM, Nagana Gowda GA, Raftery D, Hillier SL, Fredricks DN. | Int J Syst Evol Microbiol | 10.1099/ijsem.0.006931 | 2025 | |
| Genetics | Noncontiguous finished genome sequence and description of Raoultibacter massiliensis gen. nov., sp. nov. and Raoultibacter timonensis sp. nov, two new bacterial species isolated from the human gut. | Traore SI, Bilen M, Beye M, Diop A, Mbogning Fonkou MD, Tall ML, Michelle C, Yasir M, Ibraheem Azhar E, Bibi F, Bittar F, Jiman-Fatani AA, Daoud Z, Cadoret F, Fournier PE, Edouard S. | Microbiologyopen | 10.1002/mbo3.758 | 2019 | |
| Genetics | Non-contiguous finished genome sequence and description of Collinsella massiliensis sp. nov. | Padmanabhan R, Dubourg G, Jean-Christophe lagier, Nguyen TT, Couderc C, Rossi-Tamisier M, Caputo A, Raoult D, Fournier PE. | Stand Genomic Sci | 10.4056/sigs.5399696 | 2014 | |
| Methanomethylophilus alvi gen. nov., sp. nov., a Novel Hydrogenotrophic Methyl-Reducing Methanogenic Archaea of the Order Methanomassiliicoccales Isolated from the Human Gut and Proposal of the Novel Family Methanomethylophilaceae fam. nov. | Borrel G, Fadhlaoui K, Ben Hania W, Gaci N, Pehau-Arnaudet G, Chaudhary PP, Vandekerckove P, Ballet N, Alric M, O'Toole PW, Fardeau ML, Ollivier B, Brugere JF. | Microorganisms | 10.3390/microorganisms11112794 | 2023 | ||
| Phylogeny | Catabacter hongkongensis gen. nov., sp. nov., isolated from blood cultures of patients from Hong Kong and Canada. | Lau SK, McNabb A, Woo GK, Hoang L, Fung AM, Chung LM, Woo PC, Yuen KY. | J Clin Microbiol | 10.1128/jcm.01831-06 | 2007 | |
| Phylogeny | Actinomyces cardiffensis sp. nov. from human clinical sources. | Hall V, Collins MD, Hutson R, Falsen E, Duerden BI. | J Clin Microbiol | 10.1128/jcm.40.9.3427-3431.2002 | 2002 | |
| Phylogeny | Hugonella massiliensis gen. nov., sp. nov., genome sequence, and description of a new strictly anaerobic bacterium isolated from the human gut. | Elsawi Z, Togo AH, Beye M, Dubourg G, Andrieu C, Armsrtong N, Richez M, di Pinto F, Bittar F, Labas N, Fournier PE, Raoult D, Khelaifia S | Microbiologyopen | 10.1002/mbo3.458 | 2017 |
| #1003 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 2243 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 ) |
| #46592 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 17323 A |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #66793 | Mukherjee et al.: GEBA: 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the tree of life. 35: 676 - 683 2017 ( DOI 10.1038/nbt.3886 , PubMed 28604660 ) |
| #66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 ) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68380 | Automatically annotated from API rID32A . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive3054.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data